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Abstract 
Timely detection of prostate cancer (PCA) with prostate-specific antigens (PSA) and 
digital rectal examinations (DRE) are essential in optimizing incidence, minimizing 
prevalence, and reducing mortality rates. Given the low levels of participation in cancer 
screening, this study was conducted to examine the factors men consider when deciding 
whether to screen for PCA in Nigeria. A cross-sectional, online-based survey of 180 
consenting Nigerian men 50 years old and older was carried out. Logistic regression 
analysis and descriptive statistics were used to analyze the data. Based on the data, there 
was a moderate positive association between the health belief model constructs and 
DRE/PSA screening intentions, which were statistically significant (p < 0.05). The results 
also demonstrated that there were no statistically significant associations between 
previous screening and age, previous screening and ethnicity, and previous screening and 
education among men in the sample (all p > 0.05). Of the 180 men surveyed, 29% (n = 
53) had been screened for PCA before, while 76% (n = 137) reported no health insurance. 
Factors significantly associated with screening included income, insurance, and family 
history of PCA (all p < 0.05). Cancer fatalism, pain, and embarrassment were the most 
common barriers to screening reported. Focused interventions that help healthcare 
providers identify barriers quickly could improve screening outcomes. The implications 
for positive social change from this study include an increase in PCA screening, positive 
screening intentions, and a decrease in PCA mortality rate among men in Nigeria.   
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Chapter 1: Introduction to the Study  
Introduction 
Despite the advent of prostate-specific antigen (PSA) as a screening tool, prostate 
cancer (PCA) still kills 26 Nigerian men every day (Salau, 2017; see Figure 1). Given the 
elevated PCA mortality rate for Nigerian men, the PSA screening could potentially make 
a significant difference by allowing earlier diagnosis and treatment. Screening tools 
available for detecting PCA include PSA and the digital rectal examination (DRE; 
Akinremi et al., 2014). PCA screening is aimed at diagnosing the disease before the onset 
of symptoms (Centers for Disease Control and Prevention, 2018).  Although investigators 
continue to study the causes of the high rate of mortality, screening intents and the factors 
influencing Nigerian men to be screened remain poorly understood. For example, 
researchers have shown that most Nigerian men have limited knowledge of screening 
tools (Ebuehi & Otumu, 2011). According to Atulomah, Motunrayo, Ademola, and 
Omotoyosi (2010), levels of PCA awareness and screening behavior among Nigerian 
men are very low.  
The World Health Organization ranked Nigeria first among nine African countries 
with the highest prevalence of PCA, and third among countries with a significant number 
of deaths from PCA after the United States and India (Aisuodionoe-Shardrach, Oluwole, 
Magnus, & Ehighibe, 2016). In sub-Saharan Africa, Nigeria is ranked first regarding 
disability adjusted life years lost to PCA with the Democratic Republic of Congo and 
Uganda occupying the second and third places, respectively (Terwase, Chioma, Asuzu & 
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Mtsor, 2014). PCA accounts for 31% of all cancer deaths in Nigeria (Globocan, 2012; see 
Figure 1). 
In 2012, there were 307,481 deaths from PCA worldwide with about 30,383 
mortality cases in the United States, 22,603 cases in China, and 9,628 (i.e., 31%) cases in 
Nigeria (Hassanipour-Azgomi et al., 2016). According to the World Health Organization, 
in 2018, approximately 13,078 new cases of PCA were recorded in Nigeria, representing 
29.1 % of all male cancers.  Similarly, in 2018, the World Health Organization reported 
an estimated 5,806 PCA deaths in Nigeria (Globocan, 2019).  
Also, the U.S.-based National Comprehensive Cancer Network (2018) estimated 
that 29,430 men would die of the disease in 2018 in the United States. Jones, Steeves, and 
Williams (2009) noted that most African American men seek medical attention only 
when the disease has reached an advanced stage. Despite these stark statistics, very few 
Nigerian men attend screening programs (Oladimeji et al., 2010). Because Nigerian men 
experience a higher PCA mortality rate, studying their beliefs and perceptions about 
screening is essential and entirely consistent with a recognition that individuals are 
significantly constrained by specific barriers, cultural beliefs, and past experiences that 
prevent them from screening. Moreover, there are no definitive recommendations for 
screening explicitly tailored to men in Nigeria.  
Given that the incidence of PCA increases steeply with age, PCA screening tests 
are recommended annually after the age of 50 and even at lower ages among African 
Americans and people with a positive family history of PCA (American Cancer Society, 
2012). In Nigeria, PCA is a public health concern among the elderly, with most cases 
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diagnosed in men with an average age of 68.3 years old (Osegbe, 1997). Increasing the 
PCA screening rate, especially among older men, is essential, given that PSA screening 
still represents a vital step that leads to early identification and diagnosis. However, the 
reasons that Nigerian men are less likely than other populations to undergo PCA 
screening tests are still unclear.  
There remains some uncertainty about the benefits of screening. Ebuehi and 
Otumu (2011) noted that informed decision-making about screening supports the public 
health stance of PCA; however, there is always a fine line between the expected benefits 
and the potential harms of screening. The net benefits of screening are the potential for 
earlier detection of PCA before the usual time of diagnosis (Carter et al., 2013; Hayes & 
Barry, 2014). The goal is to save lives as well as reduce the possibility or onset of 
metastatic disease (Fornara et al., 2014). In other words, any form of PCA screening 
program aims to reduce the incidence of PCA, decrease overall mortality, and improve 
the quality of life. Possible quality-of-life benefits from screening include a reduction in 
PCA-related morbidity, health-promoting lifestyles, and reduction in anxiety (Fornara et 
al., 2014). However, the lack of PCA screening awareness as well as values and beliefs 
may affect a person’s intention to attend screening events (Forrester-Anderson, 2005). In 
this study, I examined whether the perception of the benefits of PCA screening is 
associated with PCA screening intention.  
The net harm of screening has been the topic of two randomized trials in Europe 
and the United States. One U.S. study showed no benefit from screening, while an 
extensive study conducted in Europe found a small reduction in PCA-specific mortality 
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(Howard et al., 2014; U.S. Preventive Services Task Force, 2018). Kilpeläinen et al. 
(2010) reported that the PSA blood test has a high false-positive rate. There may also be 
psychological effects of the screening process (U.S. Preventive Services Task Force, 
2018). Men with false-positive results may also worry more about increased costs and 
have decreased quality of life due to mental anguish (American Cancer Society, 2012). 
Most importantly, some prostate tumors can be missed at screening, leading to a 
false-negative result (American Cancer Society, 2012). Unlike PSA screening, DRE and 
prostate biopsy are invasive. As noted by Cui, Kovell, and Terlecki (2016), DRE is 
invasive and based on a doctor’s subjective opinions. Discomfort associated with DRE 
has been cited as a factor for nonparticipation in screening events among Black men 
(Macias, Sarabia, & Sklar, as cited in Ogunsanya et al., 2017). A prostate biopsy can also 
cause infection, bleeding, and discomfort and treatment for PCA can cause a sexual 
problem and unnecessary quality of life issues (Ilic, Neuberger, Djulbegovic, & Dahl, 
2013).  
In Nigeria, few researchers have explored the reasons for the low screening 
participation rate. A need exists for further studies investigating the population’s 
perceived harms and benefits regarding screening events and the attitudes, beliefs, and 
cultural barriers associated with low screening attendance. In this study, I examined the 
cultural barriers and perceptions that prevent Nigerian men from undergoing early 
screening.  
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Background of the Study 
The leading cause of death for Nigerian men is PCA (Morounke et al., 2017; 
Jedy-Agba et al., 2012), which poses a unique challenge where access to PSA screening 
is rare. Despite the high mortality rate for PCA and for unclear reasons, men are less 
likely to attend screening programs in Nigeria.  Nigerian men’s intent to be screened and 
perception of screening benefits are poorly understood. Some studies conducted among 
African American men found that the lack of screening centers, lack of education, and 
unavailability of resources could hinder participation (Plowden & Miller, 2000; Plowden 
& Young, 2003). 
Similarly, Plowden (2006) found that screening recommendation; the influence of 
significant others; and screening information, including lack of knowledge of the disease, 
constitute a barrier to attend screening tests. There is inconclusive evidence that cultural 
barriers significantly determine PCA screening behaviors in Nigeria (Olapade-Olaopa et 
al., 2014). What has yet to be established in the literature is the role of cultural barriers in 
PCA screening, the intent to be screened, and the perceived benefits of screening in 
Nigeria.  
In the remainder of this chapter, I summarize the problem, research design, and 
methodology. The problem statement, deficiencies in prior studies, purpose statement, 
and research design are outlined and justified from the standpoint of a theoretical 
framework. I then briefly present the research questions, the purpose of the study, and 
conceptual frameworks guiding the study, including the health belief model (HBM). 
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After defining key terms, I identify and describe the delimitations, limitations, and 
significance of the study.  
Problem Statement 
Given the high morbidity and mortality rates for PCA, the failure of most men in 
Nigeria to attend screening events illuminates a complex and hidden sociocultural 
problem: The low participation rate in screening events increases the likelihood of being 
diagnosed with advanced PCA, lowering survival rates. Another problem is that male 
cancer receives little attention, whereas much emphasis is placed on the breast and 
cervical cancer among women in Nigeria (Adibe et al., 2017). Because of these factors, 
PCA has become a significant medical problem for Nigerian men (Nnabugwu et al., 
2016; Ozoemena et al., 2015). For instance, Ebuehi and Otumu (2011) noted that PCA is 
likely to impact the life of a significant proportion of men that are alive today. Some 
studies in Nigeria found a 2% lifetime risk of being diagnosed with PCA based on a pool 
of 110,000 men (Osegbe, as cited in Ebuehi & Otumu, 2011).  
Despite the benefits of the screening test, intentions to attend screening programs 
remain problematic. Adibe et al. (2017) noted that the lack of a formal program targeting 
PCA might explain the lack of awareness and data about PCA among Nigerian men. 
Little research has focused on the knowledge, attitudes, and practices concerning PCA 
and the barriers associated with low screening rate in Nigeria (Ebuehi & Otumu, 2011). 
Although some research has suggested that education is associated with the intent to be 
screened, the research is far from conclusive (Enaworu & Khutan, 2016). In two studies, 
researchers explored the health beliefs, barriers, and perception of men concerning PCA 
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screening in Nigeria (Agbugui et al., 2013; Enaworu & Khutan, 2016). Agbugui et al. 
(2013) showed that reduced PCA awareness and lack of screening programs, including 
poverty, has been linked to the late presentation of the disease. The authors suggested an 
association between socioeconomic variables and intent to be screened for PCA. 
However, Agbugui et al. did not address the perception of screening benefits or the 
hidden cultural beliefs among men in Nigeria. Enaworu and Khutan (2016) noted that the 
availability of services and financial resources to afford the screening test represent 
significant factors preventing men from seeking PCA screening. Despite published 
reports of the impact of PCA, studies show that most men have never heard any 
information on cancer of the prostate (Enaworu & Khutan, 2016). The deficiency in the 
study by Enaworu and Khutan is that the results may not represent the thoughts of men 
with less education since the study comprised mostly educated men.  
The problems addressed in this study involved the perceptions of screening 
benefits and the cultural barriers affecting Nigerian men’s participation in PCA 
screening. Relative to these factors, the attitudes, perceived benefits of screening tools, 
and intentions are unknown. There is also inconclusive evidence that variables such as 
marital status, perceived barriers, income, fear of cancer, age, and past behaviors, 
significantly determine PCA screening behaviors in Nigeria.  
There is a gap in the literature concerning the cultural barriers associated with the 
intent to be screened and the perceived benefits of screening in Nigeria. Because cultural 
beliefs profoundly influence PCA screening, research is needed to identify the intention 
to screen problems and the factors associated with a low level of participation in 
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screening programs. Additional research is needed to explore the perceptions of Nigerian 
men that prevented them from seeking PCA screening. Of further interest is the 
association between demographic variables and the perceived barriers among Nigerian 
men 50 years old and older. 
A lot is known about how well early detection affects the incidence and 
prevalence rates of PCA; however, it is still unknown how the perceptions of screening 
benefits or cancer fatalism affect screening participation or the perceived factors that 
influence PCA screening among Nigerian men 50 years old and older. Among Black men 
in the U.S., for example, epidemiological investigations are focusing on screening 
behaviors (Plowden, 2006; Woods et al., 2004), rather than PCA screening intention. 
While it is known that PSA screening alone can detect cancer in patients, there is a gap in 
understanding the intention to screen problems and the cultural barriers associated with a 
low level of participation in screening programs.  
This study was guided by the current gaps on (a) whether the perception of 
screening benefits and intent to be tested will generate the most significant yield in 
Nigeria, (b) if demographic variables affect men’s participation in PCA screening, and (c) 
if cancer fatalism variables are associated with intent to be screened for PCA. The hidden 
factors associated with PCA screening formed the basis for this study. In this study, I 
examined the intent to be screened as well as identified the perception of the benefits of 
PCA screening among Nigerian men 50 years old and older. A proven approach to elicit 
information from men is the use of behavioral theory to predict, explain, and modify 
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target behaviors (Akigbe & Akigbe,2012). Therefore, in this study, I explored Nigerian 
men’s PCA screening behavior by testing the HBM.  
 
Figure 1. Cancer site mortality rates in Nigeria. From “Globocan 2012: Estimated Cancer 
Incidence, Mortality, and Prevalence Worldwide in 2012,” by the International Agency 
for Cancer Research (http://globocan.iarc.fr/Pages/fact_sheets_population.aspx). 
Purpose of the Study 
The purpose of this study was to identify barriers associated with intention to 
screen and examine the perception of benefits among Nigerian men 50 years old and 
older. With this study, I sought to examine the factors men consider when deciding 
whether to screen for PCA in Nigeria. This study was also aimed at determining cultural 
barriers that prevent PCA screening intent among adult Nigerian men using a cross-
sectional design. My overriding interest in this study was how to implement a PCA 
screening program so that the PCA screening rate will increase. The objectives of this 
study were to increase PCA screening awareness, identify the causes of barriers to 
screening, and look for an association between demographic variables and the perception 
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of the benefits of PSA as a screening tool for PCA among Nigerian men 50 years old and 
older. In doing so, I methodologically examined factors, such as attitude and beliefs 
toward PCA screening test, cancer fatalistic beliefs, perceived benefits of PCA screening, 
and barriers associated with the intention to attend screening events. This study was 
necessary due to the high morbidity and mortality rates of PCA, low screening 
participation, and high prevalence rates in Nigeria.  
Study Variables 
Creswell (2009) defined independent variables as factors, forces, or conditions 
acting on another variable to produce an effect of change in it; these variables affect the 
outcome. The independent variables for this study were age, family history of cancer, 
income, education, ethnicity, HBM constructs, marital status, insurance, and cancer 
fatalism. Dependent variables are those that depend on the predictor variables and are the 
results of the influence of the predictor variables (Creswell, 2009). These variables are 
influenced by and change as an outcome of another variable. The dependent variable in 
this study was screening behaviors. In this study, I identified an association between the 
independent variables and the dependent variable. 
Confounders 
According to Pourhoseingholi, Baghestani, and Vahedi (2012), a confounder is an 
“extraneous variable whose presence affects the variables being studied so that the results 
do not reflect the actual relationship between the variables under study” (p. 1).  In this 
study, all essential confounders were considered. Confounding factors might have 
influenced the independent and dependent variables in this study; however, I adjusted for 
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potential or residual confounding factors. I used multivariate methods (i.e., logistic 
regression) to control for confounding variables (see Pourhoseingholi et al., 2012).  
Internal Validity 
The level of control employed over potential confounding variables determines 
the level of internal validity (Slack & Draugalis, 2001). Therefore, one of the primary 
objectives of this study was to maximize internal validity (i.e., credibility). This study 
showed, in the absence of confounding factors, that some of the independent variables 
were associated with the dependent variable. 
External Validity 
Given that I employed the use of participants from Nigeria in this study, 
generalizability to other populations is unknown. It is a known fact that PCA is prevalent 
in African populations (Rebbeck et al., 2013). External validity (i.e., transferability) 
implies that the results will be generalized to a population other than the study population 
(see Pourhoseingholi et al., 2012). The fact that the participants are not representative of 
other African countries might weaken the external validity of this study; therefore, the 
generalizability to other populations is unknown. However, I established the inclusion 
and exclusion criteria and described participants regarding relevant variables to address 
external validity (see Slack & Draugalis, 2001).  
Measurement of Outcome and Exposure 
In this study, I measured the effects of demographic variables and cultural barriers 
on the perceptions and beliefs of men in Nigeria and their intent to be screened for PCA. 
To ensure consistent measurement, each respondent was asked the same set of questions. 
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The Powe Cancer Fatalism Index (Powe, 1995) was used to measure screening intention 
and barriers, specifically cancer fatalism. The Champion’s HBM questionnaire 
(Champion, 1999) was used to measure the screening intent, perceived barriers, perceived 
benefits of PCA screening, perceived severity, and perceived susceptibility. In other 
words, the concept of intention to screen was based on the HBM. The Cancer Screening 
Intention Scale-Prostate (Baker, 2008) was used to measure screening intention. I used a 
demographic form to gather data concerning an individual’s characteristics and measure 
variables such as age, marital status, income, and educational level. Specific variables, 
such as occupation, income, and education, were used to measure socioeconomic status. 
The intent to be screened for PCA was the outcome of this study. I gathered data on the 
exposures (i.e., independent variables) through the demographic form and the web-based 
questionnaires. 
Conceptual Framework 
In quantitative research, a theory is defined as an “interrelated set of variables 
formed into propositions, or hypotheses, that specify the relationship among variables 
typically regarding magnitude or direction” (Creswell, 2014, p. 235). The theoretical 
framework for this study was the HBM, developed by Hochbaum, Rosenstock, and 
Kegels in the 1950s. This theory indicates that health benefits and screening intentions 
are interwoven and has been used to study health behaviors (Janz & Becker, 1984). The 
HBM indicates that individuals have a propensity to justify their behaviors if there is a 
perceived benefit (see Janz & Becker, 1984).  
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In this study, I tested four constructs of the HBM: (a) perceived susceptibility, (b), 
perceived benefits, (c) perceived severity, and (d) perceived barriers (see Figure 2). As 
applied to this study, I used HBM to examine which of the four constructs served as a 
predictor of the intention to screen for PCA among Nigerian men. Specifically, regarding 
the research questions, I sought to determine if there was a strong association between 
HBM constructs and the intent to be screened for PCA among Nigerian men 50 years old 
and older.  
Research Questions and Hypotheses 
This study was guided by the following research questions and hypotheses 
concerning PCA screening in Nigeria: 
Research Question 1: Is there an association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
susceptibility) and the PSA/DRE intention to screen for PCA among Nigerian 
men 50 years old and older? 
H01: There is no association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
susceptibility) and the PSA/DRE intention to screen for PCA among 
Nigerian men 50 years old and older. 
H11: There is an association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
susceptibility) and the PSA/DRE intention to screen for PCA among 
Nigerian men 50 years old and older. 
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Research Question 2: Is there an association between demographic variables (i.e., 
age, education, income, and ethnicity) and the perception of the benefits 
of PSA as a screening tool for PCA among Nigerian men 50 years old and older? 
H02: There is no association between demographic variables (i.e., age, 
education, income, and ethnicity) and the perception of the benefits 
of PSA as a screening tool for PCA among Nigerian men 50 years old and 
older. 
H12: There is an association between demographic variables (i.e., age, 
education, income, and ethnicity) and the perception of the benefits 
of PSA as a screening tool for PCA among Nigerian men 50 years old and 
older. 
Research Question 3:  What are the perceived cultural barriers associated with 
intent to screen for PCA screening among Nigerian men 50 years old and older?   
H03: There are no perceived cultural barriers associated with intent to 
screen for PCA screening among Nigerian men 50 years old and older. 
H13: There are perceived cultural barriers associated with intent to screen 
for PCA screening among Nigerian men 50 years old and older.  
Research Question 4: Is there an association between cancer fatalism, PCA belief, 
and intention to screen for PCA among Nigerian men 50 years old and older?   
H04: There is no association between cancer fatalism, PCA belief, and 
intention to screen for PCA among Nigerian men 50 years old and older. 
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H14: There is an association between cancer fatalism, PCA belief, and 
intention to screen for PCA among Nigerian men 50 years old and older. 
Nature of the Study 
In this study, I employed a quantitative, cross-sectional, web-based survey 
method. In determining the appropriate research method for this study, I considered a 
qualitative study approach but determined that it would not have captured each 
participants’ hidden attitudes or PSA beliefs that a survey method would allow. Creswell 
(2009) noted that surveys are used to obtain facts and information from a sample of 
individuals about their habits, behavior, attitudes, knowledge, history, or beliefs. 
Respondents completed PCA screening questionnaires aimed at gathering information 
concerning the barriers associated with screening, intent to be screened, and the 
perception of the benefits of screening tools among Nigerian men 50 years old and older. 
In this study, I explored the cultural barriers associated with PCA screening and why 
some men chose not to attend screening events. Given that screening awareness and 
knowledge is low, research such as the current study was needed to bridge the knowledge 
gap concerning Nigerian men. 
Definitions 
The literature varies in the description and terminology used when researching the 
cultural factors influencing screening behaviors in Nigeria. In this section, I have clarified 
the definitions for these terms. 
Attitude: Hoggs and Vaughan (2005) noted that attitude represents an enduring 
framework of behavioral tendencies, feelings, and beliefs toward socially significant 
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events, symptoms, objects, or groups. For this study, the PCA questionnaires were used 
to measure respondents’ attitude toward PCA screening.  
Cancer: A disease in which abnormal cells divide without control. Cancer cells 
can invade nearby tissue. Cancer of the prostate is a type of malignant tumor that occurs 
mostly in the prostate (National Cancer Institute, 2012).  
Cancer fatalism: Powe and Ramona (2003) defined cancer fatalism as the “belief 
that death is inevitable when cancer is present” (p. 445).  The Powe Cancer Fatalism 
inventory was used to measure fear of cancer variable. Respondents responded to the 
question: “if someone gets PCA, their time to die is soon?” Nominal scale (i.e., 
categorical data; dichotomous: yes/no) was used to gather information from respondents.  
Digital rectal examination (DRE): Doctors perform this examination by inserting 
a lubricated, gloved finger into the rectum to look for lumps or asymmetrically positioned 
prostate gland (Centers for Disease Control and Prevention, 2017).  
Knowledge: Measured score on knowledge instrument of PCA and screening 
(Weinrich et al., as cited in Oliver, 2008). The PCA questionnaire was used to assess 
respondents’ knowledge of PCA. For example, respondents were asked to name their 
levels of PCA screening tools awareness. Public knowledge of PCA increases the 
likelihood of participating in screening events. Increased PCA knowledge brings a better 
outcome. For this study, intent to be screened for prostate was the outcome.  
Intention: Ajzen (1991) defined intention as a perceived likelihood or subjective 
probability that an individual will engage in a given behavior. The Champion’s HBM and 
the Cancer Screening Intention scale was used to measure men’s intent to be screened for 
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PCA. The validated Powe’s Cancer Fatalism questionnaire was also used to measure if 
cancer fatalism is associated with intent to be screened for  PCA. 
Perceived barriers: Beliefs about the cost of taking the necessary steps or actions 
(Nnoko,2017). Barriers are measured as a subscale of the health belief instrument and are 
defined as beliefs about the material and psychological costs of screening (Champion, 
1993). For this study, barriers were measured by using the validated Powe Cancer 
Fatalism Inventory and the Champion’s HBM scale.  
Perceived benefits: Beliefs about taking necessary actions that reduce the risks or 
consequences (Nnoko,2017). For this study, perceived benefits were measured by using 
the validated Champion’s HBM scale. 
Perceived susceptibility: The likelihood or vulnerability of getting a disease or 
condition (Champion, 1999). For this study, Champion’s HBM scale was used to 
measure the perceived susceptibility. 
Prostate-specific antigen (PSA): A protein produced by the prostate gland. PSA 
test measures the level of PSA in a man’s blood (National Cancer Institute, 2012). The 
prostate secretes PSA in the ejaculate, where its job is to liquefy semen, allowing sperm 
to swim toward their target, the PSA level may also be elevated in other conditions that 
affect the prostate (American Cancer Society, 2016; Centers for Disease Control and 
Prevention, 2016). 
Quantitative research:  Research approach for testing “objective theories by 
examining the relationship between variables” (Creswell, 2009, p. 3).  
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Screening: Testing to find cancer in people before they have symptoms 
(American Cancer Society, 2016).  
Sociodemographic status: Participants were asked their age, years of education, 
marital status, employment, and type of health insurance. The demographic form was 
used to measure self-reported sociodemographic data, such as age, educational level, 
marital status, income, and occupation. 
Limitations 
The first limitation related to this study was the use of cross-sectional study 
design. As such, causal inferences could not be deduced regarding the relationship 
between the independent and dependent variables. Moreover, I employed the use of self-
reported data from participants in this study; therefore, the results were based on a 
subjective response of participants.  
A second limitation was that the participant might not have been a random sample 
from the population of males 50 years old or older in Nigeria. As such, it was difficult to 
generalize the findings to other populations. Because participants were not randomly 
selected, this threat weakened the internal validity of this study. Participants in this study 
may not have represented the population enough to generalize results, and this threat 
weakened the external validity (i.e., transferability) of this study. The relatively small 
sample size also posed a threat to the results of the study. These limitations were less of a 
problem because of statistical power and effect size.  
Another limitation was the use of the Internet as a tool with which to collect data. 
The participants may not have had a practical understanding of computer technology. 
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This limitation could have affected the response rate, the response bias, and how the 
participants completed the web survey.  
Lastly, history was also a threat to internal validity. This threat occurs when there 
are unexpected events unrelated to the independent variables that influence the dependent 
variables. Information about the health effects of PCA, for example, may be seen in the 
media. Testing may have also been a threat to the internal validity of the research plan. 
For instance, some respondents in the study may not have known anything about the 
subject of the questions in the questionnaires but still answered them to avoid being 
considered uninformed. 
Assumptions 
I assumed that the willingness of the participants to volunteer for this study did 
not bias the results of the study. It was also assumed that the participants in the study 
completed the questionnaires truthfully and to the best of their ability, that married men 
in this study were influenced by their wives to participate fully in the research, and that 
the HBM was a suitable framework to guide this study. Additionally, it was presumed 
that the Powe’s Cancer Fatalism Index (PFI), Cancer Screening Intention Scale-Prostate 
(CSIS-P), the Champion’s Health Belief Scale (CHBMS), and the demographic form 
were appropriate means for measuring the designated variables.  
Scope and Delimitations 
The primary purpose of this study was to identify the cultural barriers associated 
with low PCA screening as well as examine the opinions and beliefs of survey 
respondents concerning the intention to screen and perception of the benefits of PCA 
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screening. This study was not meant to examine the genetic component of PCA risks or 
the use of a free PSA test. Additionally, factors that identify the delimitations of the study 
included participants who could not read, understand, and speak English and who could 
not access the Internet.  
Participants reported having Internet connections to access the questionnaire. 
Employing the use of an online survey and enrolling men 50 years old and older were 
essential delimitations of this study. Therefore, the sample of this study was delimited to 
men 50 years old and older. I selected this age range because it includes ages that made 
up the majority of PCA cases identified. Moreover, this age range had not been studied 
satisfactorily in Nigeria.  
Significance 
The results of this study contribute to the PCA research concerning the intent to 
be screened and the hidden barriers associated with low turnout during PCA screening 
events. In this study, I unearthed the hidden barriers associated with low participation in 
PCA screening. Most importantly, PSA screening planners and stakeholders must be 
aware of the cultural barriers faced by Nigerian men that prevented them from taking part 
in screening events. More men will come forward for a PSA screening test if barriers are 
identified, and medical professionals are aware of their patients’ needs. Using a cross-
sectional design, I explored the knowledge, attitude, and socio-cultural barriers of 
Nigerian men towards PCA screening tests. Understanding the significance of PCA 
screening methods can help enhance men’s peace of mind, reduce the cost of overseas 
treatment, and reveal the underlying logic behind the late presentation of the disease.  
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Implications for Social Change 
The implications for positive social change from this study include an increase in 
PCA knowledge, benefits, and positive intentions among men in Nigeria. Data from this 
study can be useful in developing culturally relevant awareness literature and media 
content that address the cultural barriers associated with PCA screening in Nigeria. 
Healthcare workers must address and subsequently remove any stated barriers when 
attempting to schedule PCA screening in Nigeria. Additionally, social change can be 
created if the determination can be made that PCA awareness, attitudes, beliefs, barriers, 
and education are generating the ideal effect, leading to a reduction of the mortality rate 
of PCA among Nigerian men 50 years old and above. The results of this study will also 
help policymakers, stakeholders, and healthcare providers in Nigeria to develop 
guidelines for the implementation of community-based screening events. Lastly, the 
findings of this study advance knowledge and awareness of PCA as well as improve the 
diagnostic information and capabilities of using PCA screening tools.  
Summary and Transition 
PCA is the Number 1 killer of men in Nigeria and is a disease that kills 9,628 men 
a year in the country (Globocan, 2012). Therefore, I looked for an association between 
demographic variables and the perception of the benefits of PSA as a screening tool for 
PCA among Nigerian men 50 years old and older in this study. In Chapter 1, I introduced 
the study rationale and justified my use of a cross-sectional design as appropriate to 
answer the research questions. The review of the literature will be presented in Chapter 2, 
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correlating all epidemiological studies and peer-reviewed articles concerning the factors 
associated with intent to screen and the perception of screening benefits. 
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Chapter 2: Literature Review 
Introduction 
PCA is the most common cancer among men and the leading cause of death in 
Nigeria (Jedy-Agba et al., 2012). The fact that PCA is a significant public health concern 
reflects the health problems in Nigeria. Despite the health burden of PCA, screening for 
the disease remains low (Akinremi et al., 2014). The reasons for the low rate of screening 
participation remain poorly understood; therefore, there is an urgent need to identify the 
reasons why Nigerian men are less likely to participate in PCA screening. 
In this chapter, I describe related literature and compare findings. Furthermore, I 
discuss the boundaries of this research and present current peer-reviewed and credible 
information on PCA screening, barriers, benefits of testing, and the opinion and beliefs of 
men in Nigeria. The approaches and methodology for this research are presented and 
justified with support from current literature. The goal of this research was to examine 
the participants’ perceived barriers and determine the intents to be screened for PCA. 
The literature presented is grounded in the conceptual frameworks outlined in Chapter 1.  
Literature Search Strategy 
I began my literature review on the perception of screening benefits and the 
barriers associated with PCA screening in Nigeria with Internet searches at credible sites. 
Secondary sources led to primary sources. I also reviewed the recommended books on 
PCA. This reading laid the foundation and understanding of the concepts of PCA 
screening, cancer fatalism, and the conceptual framework and theory guiding this study. 
Original scholarly research began through the Walden University Library, where I used 
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EBSCO host to access databases including CINAHL, Health Sources, PsycINFO, 
Academic Search Premier, PubMed, and Medline. My Internet search was updated in 
March 2019 as well. For cultural factors, intention, and perception articles, I limited the 
search to studies conducted between January 2009 and May 2018. To make sure no 
relevant reviews were overlooked, I searched the references of all related studies to 
identify any additional peer-reviewed research. I also included other seminal resources in 
my review. 
I used the following keywords in the systematic search of these computerized 
databases: the health belief model and  PCA; PCA screening intent to be screened in 
Nigeria and prostate-specific antigen; cancer fatalism and PCA in Nigeria; and PCA 
risks,  benefits, perceptions, and cultural beliefs in Nigeria. The inclusion criteria for the 
literature review were as follows: (a) original studies and review articles; (b) publication 
in the English language; (c) articles discussing cancer fatalism, screening barriers in 
Nigeria, and mortality rate; and (d) showing sufficient quality and quantity of evidence 
based on study design and validity. The selected databases were consistently and 
concurrently used as the central databases for each topic searched.  
HBM formed the building block to the literature review, summarizing the body of 
evidence, for example, with competent evidence to support study conclusions on PCA 
screening barriers, intent to be screened, the perception of benefits, epidemiology, and 
screening events in Nigeria.  An individual may see PCA in terms of its medical 
consequence and whether PCA could lead to his death or reduce his physical or mental 
functioning for long periods,  including expressing his feeling that he is in real danger of 
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being diagnosed with the condition (Rosenstock, 1974). Therefore, HBM was used in this 
study to explain and predict PCA screening behaviors.  
 
 
Theoretical Foundation 
Health Belief Model (HBM) 
Throughout this study, the framework I used to conceptualize and operationalize 
the association between health behaviors and screening intention was the HBM. The 
HBM is the conceptual framework that guided this study and the bedrock for the 
empirical investigation of behaviors and their influence on health (see Figure 2). 
According to Glanz, Rimer, and Lewis (2002), HBM attempts to explain and predict 
behavioral health changes and is focused on the attitudes and beliefs of the individuals. 
My use of the HBM in this study hinged on the stated assumption that a person will 
undergo PCA screening if that person feels that PCA can be avoided. According to 
Robert, Muriel, and Vagasi (as cited in Abamara et al., 2017), HBM is a framework for 
understanding health motivation, attitudes, and belief determining a person’s health-
related behaviors.  
Developed in the 1950s by social psychologists, Hochbaum et al. working in the 
U.S. Public Health Services, the HBM tends to predict health behaviors and explain why 
people would or would not use health services (McKenzie et al., 2009). The HBM was 
used, for instance, to quantitatively explain the association between variables in the study 
(Creswell, 2014).  Researchers have used HBM widely to measure health beliefs and 
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behaviors about cancer screening (Champion, 1999). Although individual beliefs are not 
fixed, this model assisted me in understanding why men may take part in a screening 
program and which of the four HBM constructs served as a predictor of the intention of 
Nigerian men.  
Enawaru and Khutan (2016) noted that HBM is a synchronized process used to 
encourage healthy behavior among individuals who face health-related situations. In 
other words, HBM is a cognitive model that tries to identify patterns of healthy 
behaviors.  HBM measures four concepts: perceived barriers, perceived benefits, 
perceived susceptibility, and perceived severity (Janz & Becker, 1984; see Figure 2). The 
likelihood of action includes perceived benefits (Burke, n.d.). Examining the role of the 
HBM constructs is important in understanding the usefulness of PCA screening 
programs.  
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Figure 2. The health belief model. The items in figure 2 of my study are reproduced or 
adapted from another source: The Health Belief Model. Glanz et al., 2002, p. 52 
Perceived Barriers 
Perceived barriers refer to adverse outcomes related to health-promoting behavior 
(Champion, 1999). Sly et al. (2012) also found that PCA screening barriers include 
negative beliefs; fears; and socioeconomic status, including limited education and 
anxiety. Perceived barriers are variables that hinder an individual from seeking behaviors 
through the perceptions they hold about illness and disease (see Champion; Figure 2). 
Several researchers have studied the mechanisms by which barriers influence cancer 
screening, such as breast cancer screening. For example, Akhigbe and Akhigbe (2012) 
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sought to understand the perception of Nigerian women about breast cancer screening 
and found that perceived barriers to performing breast cancer screening include 
transportation to screening centers and the cost of the imaging study.  
Barriers may hinder a person from seeking or changing his behaviors. Shelton, 
Weinrich, and Reynolds (1999) sought to identify the association between perceived 
barriers and participation in free PCA screening events. Shelton et al. concluded that 
significant barriers to screening practices were “refuse to go” (p = 0.09), “would be 
embarrassed” (p = 0.03), and “no way to get there” (p = 0.08). In the study, two barriers 
were specifically noted as significant to PCA screening among African Americans: “no 
way to get there” and “refuse to go” (p = 0.08 and p = 0.09, respectively). Shelton et al. 
also found embarrassment as a significant barrier to screening. Similarly, Meyer et al. 
(1995) cited embarrassment as a barrier to screening by 40% of the respondents, while 
impotence was cited as a barrier to screening by 18% of the respondents.  
Interestingly, Weinrich, Reynolds, Tingen, and Starr (2000) noted that fear of 
impotence was not a significant barrier toward PCA screening; however, PCA screening 
barriers were significant in predicting participation in PCA screening. The authors 
observed that “put it off,” “doctor hours not convenient,” “didn’t know kind of doctor,” 
“didn’t know where to go,” and “refuse to go” constituted highly significant barriers to 
involvement in screening events (Weinrich et al., 2000, abstract). In another study, 
Robert, Vegas, and Muriel (2003) cited barriers as negative perception about pain, 
embarrassment, wearing of diapers, incontinence, and impotence resulting from PCA 
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screening and treatment. Robert et al. also stressed that these barriers pose a significant 
block to screening intentions.  
A growing body of literature suggests that, even among immigrants, barriers can 
deter individuals from getting screened for the disease (Akpuaka et al., 2013; Boyd, 
Weinrich, Weinrich, & Norton, 2001; Price, Colvin, & Smith, 1993). For example, 
Akpuaka et al. (2013) conducted a study of 22 Nigerian male immigrants to the United 
States to explore their barriers and beliefs towards PCA screening of Nigerian male 
immigrants residing in the Washington DC metropolitan area. Participants cited 
embarrassment, masculinity, and lack of information as barriers to screening for PCA, 
and the authors concluded that cultural beliefs, lack of health insurance, and social norms 
might have influenced participants’ decisions about PCA screening (Akpuaka et al., 
2013). Also, Price et al. (1993) noted that socioeconomic inequities, access to health care, 
and cultural beliefs are associated with barriers to screening in Black males, whereas 
Boyd et al. (2001) cited lack of transportation and inability to read the preappointment 
information as a significant barriers to screening among 549 men from the southern 
United States. 
In summary, lack of knowledge, fear of cancer, embarrassment, and threats to 
manhood were prominently noted as significant barriers to intent to screen for  PCA in 
the study by Forrester-Anderson (2005). Forrester-Anderson indicated that discomfort 
regarding the physical nature of DRE was found to be extremely uncomfortable among 
men in the study. Therefore, barriers such as fear of DRE prevents Black American men 
from undergoing prostate cancer screening. 
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Perceived Benefits 
Champion (1999) defined perceived benefits as the perception of positive 
outcomes resulting from performing a specific behavior. Abamara, Ezeh, Anazodo, and 
Onyejiaka (2017) described perceived benefits as a person’s belief that performing a 
specific health behavior will reduce the threat of that condition. Regarding the perceived 
benefits that performing a specific behavior will reduce the threat of PCA, Robert et al. 
(2003) noted that efficacy of early detection and screening examination strongly 
predicted African American men’s intention to undergo early screening. Growing 
evidence supports the role of perceptions of the benefits of screening regarding PCA. For 
example, Abamara et al. stressed that having a screening test will increase the chances of 
identifying PCA at a very early stage, while Akhigbe and Akhigbe (2012) noted that 
perceptions of benefits measure the usefulness of new behavior in decreasing the risk of 
developing a disease. Therefore, the perception of the benefits of health-related actions 
might motivate an individual to take corrective action toward screening (Akhigbe & 
Akhigbe; see Figure 2). However, it is complicated for a person to change their health 
behaviors or enroll in a PCA screening program if there is no benefit attached to it.  
For example, McCurdy et al. (2015) studied the factors affecting PSA screening 
benefits in men with considerable risks in the United Kingdom and the United States. The 
study published in Praxis Klinische Verhaltensmedizin und Rehabilitation suggested that 
the perception of screening benefits is associated with knowledge of PSA blood test. 
According to the authors, there are higher odds of perceiving a benefit from screening 
among those with PSA blood test awareness, which suggests an association between 
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individual beliefs and PSA uptake and may reduce the chances of contracting PCA, 
especially among high-risk men.  
Perceived Susceptibility 
Witte (1992) defined perceived susceptibility as the perception of the harm or the 
chances of contracting a health disease or condition. It is assumed that by performing 
cancer screening; individuals would reduce their susceptibility to or the severity of the 
illness (Janz, Champion & Stecher, 1995; Figure 2). Champion (1999) conducted a 
critical study to measure the revised scales of perceived susceptibility to breast cancer. 
The author noted that perceived susceptibility is the threat variables or the perception of 
developing a disease. The likelihood of experiencing a potentially harmful health 
condition such as PCA has been defined as the perceived susceptibility of the HBM 
(Champion, 1999). If this assertion is correct, some different conclusions may be drawn. 
For instance, Nigerian men with a family history of PCA (i.e., high-risk) might feel the 
need to screen for the disease. 
Perceived Severity 
Perceived severity is associated with the Health Belief Model constructs. 
Champion (1999) defined perceived severity as the belief of the seriousness of the 
disease (see Figure 2). Some authors noted that perceived severity includes how 
individuals perceive the harmful outcome of a severe health condition. For example, 
among African American men, the study shows that the intent to be screened for PCA 
depends on the severity of the disease (Robinson, Ashley, & Haynes, 1996). Also, Meyer 
et al. (1996) found that screening intention was predicted by the cultural factors and 
32 
 
absolute belief in the effectiveness of a screening program. Therefore, understanding 
participant perceived severity are critical for addressing the intention to attend for 
screening events 
Intention to Attend Screening Programs 
Cultural and social factors might impact Black men’s intent to be screened for 
PCA. Much of the literature on the intent to be screened for PCA and low attendance 
relates to the mechanism connecting barriers, perception, and screening awareness. We 
know that PCA awareness is low among Black men, but other factors might deter Black 
men from getting tested for PCA or seeking PCA information. Pedersen, Armes, and 
Ream (2012) conducted a systematic review of the literature to evaluate research on 
knowledge and perceptions of PCA among Black men. The authors set out to provide 
answers to the questions concerning how knowledge and perceptions of PCA screening 
translate to intent to be screened for the disease. The findings show that cultural and 
social factors are likely to impact Black men’s intent to be screened for PCA.  
Moving from Nigeria to the United States has a cultural and social impact on PCA 
knowledge and the intent to be screened for the disease. In other words, geography plays 
a role in screening decisions. Odedina et al. (2008) used a cross-sectional method to 
explore the PCA cognitive behaviors among native Nigerians and Nigerian immigrant 
residing in the United States. The cognitive behavioral themes examined in the study 
include past PCA screening behaviors, information on screening tests, and the intention 
to screen in the future. The result published in the Journal of Immigrant Minority Health 
is significant given that perception of screening benefits and intention account for a 
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significant determining factor in higher incidence and mortality rates of PCA in Nigeria. 
Thus, information concerning PCA might motivate men to attend screening events. 
Prostate Cancer Information and Screening Intentions 
The intent to be screened for PCA might be perceived through the lens of quality 
information concerning PCA. For example, Oladmeji, Bidemi, Olufisayo, and Sola 
(2010) conducted a cross-sectional study in Oyo State, Nigeria, to assess the  PCA 
knowledge, awareness, and screening intention among Nigerian men. The authors found 
that if given the needed information, most of the respondents were willing to be screened 
for the disease. Regarding information, intention, and beliefs, the evidence base for 
screening has grown increasingly intense. The evidence shows that information is related 
to the intent to be screened for PCA. For example, Ajape et al. (2010) conducted a cross-
sectional study consisting of 156 Nigerian men to evaluate the awareness and intention of 
men to screen for cancer of the prostate. The results are published in the Nigeria Journal 
of Hospital Medicine. The result of the study shows that majority of the respondents have 
never heard any information concerning  PCA screening test. These findings are a 
critically important one considering that their value lies in the ability to increase 
awareness and to correct impressions about PCA screening intentions.  
 A growing body of research has examined the factors affecting PCA, linking it to 
information, intention, and beliefs. Although most of the studies concerning PCA 
intentions are inconclusive, awareness of PCA among Nigerian men was found to be poor 
(Ajape, Babata, & Abiola, 2010; Ogundele & Ikuerowo,2015) leading to low intent to be 
screened. In a similar study investigating the prevalence of PCA risk in a previously 
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unscreened cohort of rural Nigerians, Ukoli et al. (2003) cautioned that PCA awareness 
and education campaign would be beneficial among rural Nigerian men.  
For instance, a descriptive cross-sectional study conducted by Ogundele and 
Ikuerowo (2015) noted some association between a low level of awareness and low 
participation in the screening program in Nigeria. The primary purpose of the study was 
to evaluate PCA information and screening intention among 146 male patients of the 
Lagos State University Teaching Hospital, Ikeja. The results are published in the 
Nigerian Journal of Surgery: Official Publication of the Nigerian Surgical Research 
Society. The authors found that 53% of the respondents have never heard of PCA, while 
only 8.2% have had any form of  PCA screening. However, the authors found a 
significant association between the level of information and PCA screening intention.  
 PCA screening intent among males in Nigeria is significantly low, and their 
attitude and screening practice towards PCA are equally low. Another innovative study in 
screening intention is the work by Atulomah, Olanrewaju, Amosu, and Adedeji (2010) in 
which perception was found to be associated with screening intention. The purpose of the 
study is to determine the perception of the seriousness and susceptibility to  PCA and if 
such perception contributes to intent to be screened for the  PCA among men in Ilishan 
Remo,  in south-western Nigeria. Atulomah et al. noted that perception and screening 
behaviors variables are positively and significantly correlated. The authors also noted that 
the information, knowledge, and beliefs of PSA screening are related to low participation 
in screening events.  
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Knowledge of screening refers to whether the individual is aware of PCA 
screening methods used to detect PCA and the screening process. Higher levels of 
screening knowledge are related to intent to be screened for cancer. A group of 
researchers in Nigeria set out to understand screening behaviors among students at the 
Benue State University. The results are published in the 2014 edition of the International 
Journal of Cancer and Clinical Research. Terwase, Asuzu, and Mtsor (2014) found that 
among male students, knowledge, attitude, and screening behavior influences PCA 
vulnerability. The instrument for the study was a PCA questionnaire administered to 245 
male students of Benue State University. Participants in the study reported a low level of 
screening for PCA. In the study, demographic variables were not significant. These 
findings are consistent with the finding by Asuzu et al. (2012) who evaluated screening 
intent and behaviors among the University of Ibadan teaching and nonteaching staff. In 
another study, Miller (2014) found that lack of PCA knowledge might lead to 
nonparticipation in screening events while Agho and Lewis (2001) found that among 
African American men, the higher the level of school education and income, the lesser 
the knowledge of PCA.  
The general objective of the study conducted by Asuzu et al. (2012) was to assess 
the knowledge, attitudes, and practices of male workers at the University of Ibadan about 
PCA. The finding shows that only a few men in the study have screened for PCA. 
Generalizability beyond University of Ibadan male workers remains to be established. 
Despite the noted limitations of the study and given the health burden of PCA, most 
African countries record low screening participation turnout. For example, in Namibia, 
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Kangmennaang, Mkandawire, and Luginaah (2016) conducted a study with the stated 
aim of identifying the underlying factors associated with the low levels of  PCA 
screening test. The authors used the 2013 Namibia Demographic and Health Survey. The 
authors found that Namibian men residing in affluent areas with health insurance 
coverage and access to  PCA screening information were more likely to screen for PCA. 
Therefore, poor socioeconomic factors underscore the kinds of barrier that poor men in 
Namibia face regarding access to PCA screening tests. 
  In Ghana, Binka, Nyarko, Doku, and Antwi (2015) has argued that even though 
PCA is prevalent with increasing age, all men are at risk for PCA. Although study 
participants had limited knowledge of the disease, most of the participants have a good 
perception of PCA. The authors noted that 88 % of the participants have heard of PCA, 
while 11.9% had not heard anything concerning PCA. In South Africa, Mofolo et al. 
(2015) examined the knowledge of PCA among men attending the urology outpatient 
clinic at a tertiary hospital in South Africa. The survey was conducted from February to 
March 2010 with 346 men 35 years of age and older. The South African authors found 
that the level of school education was statistically significantly associated with the level 
of PCA knowledge, whereas age and marital status were not statistically significantly 
associated with the level of PCA knowledge. The results revealed that 45.7% of the 
respondents indicated that they had heard of PCA with television (71.7%) and radio 
(66.8%) as the most common medium of exposure to PCA.  
The fact that Nigerian men have high  PCA morbidity and mortality rates and low 
screening attendance records indicate that knowledge is key to  PCA screening. One 
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interpretation of this assertion, then, is the inverse relationship. Adibe et al. (2017) 
examined the knowledge base, attitudes, and perceptions of PCA among 655 male staff 
of the University of Nigeria. The cross-sectional descriptive study published in the Asian 
Pacific Journal of Cancer Prevention employed the use of a self-administered 
questionnaire. Although a considerable number of the respondents reported poor 
knowledge and negative perception of PCA, these investigators reported that the 
knowledge level of the prostate was high among 57.8% of respondents. This finding 
concerning education and uptake of screening was replicated by Ebuehi and Otumu 
(2011). The results by Ebuehi and Otumu implies that variables such as age, educational 
level, cadre, and occupation were positively associated with uptake of screening. In the 
study, Enuehi and Otumu recommended that respondents follow-up with their healthcare 
provider. Oliver et al. (2008) also found a similar association between education and 
income with prior screening and willingness to undergo  PCA screening in the future. In 
summary, screening is used to control for the onset of PCA, and delays in PSA screening 
for any reason suggests negative implication. 
Cancer Fatalism 
Cancer fatalism refers to the belief that a cancer diagnosis inevitably ends in death  
(Powe & Finnie, 2003). Powe and Finnie (2003) noted that fatalism is a significant 
barrier to participation in cancer screening because it is assumed that higher power 
ordained it to happen. Researchers suggest that fatalism is more common among African 
American men as well as among elderly African Americans regardless of gender 
(Underwood, 1992; Vetter, Lewis, & Charny, 1991). Specifically, Underwood (1992) 
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believed that hopelessness and helplessness are related to the concept of fatalism; that is, 
individuals might skip screening events since death will result regardless of screening 
status. 
Similarly, cancer fatalism is frequently reported among those with limited cancer 
awareness and underserved medical persons (Powe & Finnie, 2003). Cancer fatalism, 
according to Talbert (2008), is the “belief that situations, such as illnesses or catastrophic 
events, happen because of a higher power or they are just meant to happen, and cannot be 
avoided,” (Talbert, as cited in Akhigbe & Akhigbe, 2012, p.74). Society researchers set 
out to understand the role of fatalism in PCA screening intention. For example, Allen, 
Kennedy, Wilson-Glover, and Gilligan surmised that black men perceive cancer as a 
death sentence while abject poverty was blamed as the primary cause of cancer fatalism 
among African Americans (Freeman, 1989). In one study, Powe et al. (2007) found that 
among older African Americans, fatalism is a significant factor for the lower rates of 
cancer screening observed in these populations. 
Fundamentally, many Nigerians believe that they cannot have cancer, which is 
why they do not seek PCA screening (Azubuike & Okwuokoli, 2013). In Nigeria, Akigbe 
and Akigbe (2012) noted that religious beliefs including fatalism, witchcraft, magical 
powers, and demon usually influence their belief and cultural values, and these in turn 
influence health behavior of men to seek screening (Akigbe & Akigbe, 2012, as cited in 
Abamara et al., 2017). However, the finding by Azubuike and Okwuokoli has been 
replicated by other researchers. For example, Bache, Bhui, Dein, and Korszun (2012) 
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suggested that men saw PCA as a punishment from God while Nanton and Dale (2011) 
found that religion could be a vehicle used to cope with a PCA diagnosis.  
 In 1995, Powe conducted a study utilizing the Powe Fatalism Index to examine 
the association between selected demographic variables and cancer fatalism among 
elderly Caucasians and African American women. The results of the study revealed 
fatalism as a significant predictor of colorectal cancer screening among elderly African 
American women. The author opined that cancer fatalism might influence individuals to 
believe that they have no control of their health and that fatalism implies hopelessness 
and worthlessness.  Powe (1995) found an inverse association between education, 
income, and cancer fatalism while Cobran et al. (2014) believe that the fundamental 
assumptions underlying fatalistic attitudes towards cancer include poverty, racism, 
discrimination, unemployment, and inadequate access to healthcare.  
Factors that Influenced Late Presentation of Prostate Cancer 
Numerous studies have identified behavioral, environmental, and individual 
factors that influence the late presentation of PCA in Nigeria. Lack of health insurance 
policy, avoidance of the screening test, and cultural factors were consistently cited as 
possible reasons for late presentation of PCA among Nigerian men. However, no studies 
have examined the full continuum of screening, intents, and perception. Social scientists 
such as Ekwere and Egbe (2002) noted that reports from all regions of the country 
emphasize late presentation as the pattern in Nigerian PCA patients. Studies in both 
South of Nigeria (Ekwere & Egbe, 2002) and North of Nigeria (Dawam, Rafindadi & 
Kalayi, 2000)  shows that  about two thirds of patients presented with PCA while 94.2% 
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(Badmus et al., 2010) and 91% (Yawe et al., 2006) presented with  PCA complications 
respectively.  
The concern that lack of PSA blood test or awareness accounts for late 
presentation of the disease in Nigeria has been studied by researchers in Nigeria 
(Abamara et al., 2017; Ozoemena et al., 2015). The assumption is that most Nigerian men 
are aware of cancer of the prostate. However, the authors reasoned that men are aware of 
the use of PSA as a screening test but would prefer not to be treated if diagnosed with 
asymptomatic PCA. In their study, Ozoemena et al. (2015) found that this delay in 
undergoing the screening test and treatment usually leads to the late manifestation of the 
disease.  
 The major problem with early detection of PCA in Nigeria, according to 
Abamara et al. (2017), is the lack of knowledge about screening and poor detection 
guideline among medical professional groups. Further, Wood et al. (2004) identified 
DRE as a significant problem as it hinders men’s sexuality. Also, the high rate of death 
associated with PCA seen in Nigeria men can be attributed to lack of PSA screening test 
leading to late presentation. In other words, there is significant morbidity and mortality 
associated with PCA (Agbugui et al., 2013), and studies have shown that about 64 % of 
patients diagnosed with PCA die within two years in Nigeria (Osegbe et al., 1997, as 
cited in Udeh et al., 2016).  
Among African Americans, for instance, researchers found little or no knowledge 
about DRE, lack of information concerning PSA screening, and hesitancy toward 
screening (Ekúndayò & Tataw, 2013). These cultural barriers lead to a late presentation 
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at the hospital. In summary, there is an underlying assumption that awareness and early 
detection of the disease are associated with a higher chance of finding cancer of the 
prostate in a more localized area and treatable stage. Late presentation is attributed to 
poor awareness, inadequate health education, lack of screening programs for  PCA, 
poverty, inadequate healthcare facilities, and the paucity of specialist urological care. 
Prostate Cancer Education and Awareness of Screening Tools 
Olapade-Olaopa et al. (2014) conducted a study in Nigeria to determine the level 
of awareness about PCA among adult men in Ibadan, Nigeria. The authors employed the use 
of four focus group discussions with randomly selected volunteers and questionnaire 
surveying 656 men participating in a health screening exercise. The volunteers were aged 40 
years and above. In the study, 43 % of the respondents had prior knowledge of the prostate 
gland, while 29% had heard of PCA. The respondents said that they received information from 
friends/family/colleagues, and the television (33%, 23.8%, 19%, and 19.5%) while 13% of the 
respondents received PCA information from newspapers. The authors suggested that most 
adult Nigerian men are unaware of the prostate anatomy irrespective of their socio-
economic status and level of education. 
There can be no doubt that PCA awareness among individual, and tribes is a 
defining characteristic of their level of health and disease. A growing amount of studies 
supports such a view. For example, in a critical study conducted in Nigeria, Enaworu and 
Khutan (2016) supported the notion that culture and health are interrelated. Enaworu and 
Khutan revealed that there continues to be a considerable lack of awareness and 
knowledge about PCA and screening in Nigeria (Enaworu & Khutan, 2016). Also, 
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accessibility to testing services and knowledge of the PSA test accounts for some of the 
reasons. This finding by Enaworu and Khutan lend credence to the theory employed in 
the current study. 
For some time, epidemiologists have accepted that there is a relationship between 
lack of PCA awareness and PCA screening. For example, Ajape et al. (2010) conducted a 
study in Nigeria to evaluate the knowledge and attitude of the populace to screen for 
PCA. Among other findings, the authors reported a remarkable lack of awareness of PCA 
among Nigerian men. Thus, the authors argued that PCA screening and serum PSA test 
for screening are unknown among the participants (Ajape et al., 2010). Ajape et al. stated 
that there is lack of PCA awareness among the Nigerian urban populace, concluding that, 
among other variables, PCA screening and serum PSA test for cancer screening is 
globally unknown among them. 
 This emphasis on the importance of screening awareness is seen in several other 
types of research. For instance, Oladimeji, Bidemi, Olufisayo, and Sola (2010) found that 
81.5% of men in the study were willing to be screened for the disease. Similarly, Odedina 
et al. (2008) opined that the exodus of Nigerian men from Nigeria to the U.S. has a 
significant impact on PCA knowledge and education. Akpuaka et al. (2013) echoed a 
similar conclusion. Regarding screening awareness, Atulomah et al. (2010) conducted a 
cross-sectional design utilizing a pre-tested 36-item questionnaire to measure the level of 
awareness, specific knowledge, perception and screening behavior of PCA patients in 
Nigeria. In another study, Abdulrahman et al. (2013) found that screening for PCA was 
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very low, with only 13.2% of the respondents reported screening for PCA; 60.4% of the 
participants were aware of the disease while 51.3% have inadequate knowledge of PCA. 
Regarding the impact of education and intention, Ukoli et al. (2013) also found 
that 15-minutes education interventions might lead to improved knowledge, beliefs, and 
action among 539 low-income African Americans men enrolled in the study. Ukoli et al.  
found that health insurance, the discomfort of the digital rectal exam, and fear of cancer 
diagnosis constitute barriers to PCA screening and inversely related to intent. The study 
published in the Journal of Health Care for the Poor and Underserved found that men 
with high school education reported less PCA awareness. The study was conducted to 
evaluate a 15- minute informative education module aimed at low-income African 
American men aged 42 years and older. 
Age (of the Individual) and Screening Intentions 
Age is a significant risk factor for PCA, and relative risk is inversely related to the 
person’s age (Bloom et al., 2006). Researchers have posited that socioeconomic variables 
such as age have been showed to influence the decision to screen for cancer (Chen, 
Kessler, Mori & Chauhan, 2012; Elit et al., 2012). Chen, Kessler, Mori, and Chauhan 
(2012) found that age was significantly associated with never screened for cervical cancer 
(p < 0.001). Also, Elit et al. (2012) found that women aged 18 to 24 years old were 
slightly less likely than older women to have cervical cancer screening and follow-up of 
abnormal results. In another study, Bloom et al. (2006) reported that older men are more 
likely to have had a recent DRE and that older men with less education were more likely 
to perceive that they were at no risk. For instance, increased perception of cancer risk and 
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moderate worries are reliable predictors of screening (Bloom et al., 2006). The authors 
found that being older was associated with having had a recent DRE or a recent PSA test. 
These findings are not startling because it is assumed that as men grow in age, their 
emotional and physiological needs also increase. The American Cancer Society (2016) 
noted that PSA levels normally go up slowly as men get older, even if there is no prostate 
abnormality.  
Literature Review: Theoretical Framework 
Theoretical models of health behaviors have received substantial research 
attention over the past two to three decades (Abrams et al., 1997; Glanz et al., 1997). 
Therefore, careful attention to theoretical constructs is an essential intervention strategy. 
There is increasing recognition of the role that health behaviors play in PCA screening. 
Understanding why people failed to screen for cancer requires a shift in understanding-
specific behaviors once thought of as falling exclusively within the realm of individual 
choice now occurs in a social setting. In other words, the environment influences 
behaviors. As several authors noted, the HBM enforces a pattern of health control 
(Enaworu & Khutan, 2016). Thus, if men perceived themselves to be at risk, then they 
will take up health preventive measures to reduce their risk of contracting the disease 
(Enaworu & Khutan 2016). The authors stressed that an application of the HBM in 
channeling health promotional activities produces a favorable outcome by increasing 
PCA screening practices. Therefore, this study determined which of the four constructs of 
the HBM are associated with the intent to be screened for PCA among Nigerian men 50 
years old and older.  
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Summary and Conclusions 
PCA is the most frequent nondermatological malignancy worldwide, and 
significant public health concern (Whitmore,1994; World Health Organization, 2012). 
Equally devastating is the fact that the disease is burdensome in Nigeria. A striking 
example is that 26 Nigerian men die daily from the disease. This study brought together 
much of the literature on PCA screening benefits and barriers in Nigeria. In doing so, this 
study exposed the reader to a much broader understanding of the enormous task of 
increased citizen’s participation in screening to reduce the burden of PCA caused by the 
late presentation. However, the cultural factors and intent to be screened for PCA has not 
been sufficiently studied in Nigeria.  
Based on data from various researchers and given that Nigeria is the most 
populous country in Africa, information from the literature translates to an enormous 
burden for men affected by PCA. According to the literature, PCA screening is low 
despite a higher death rate. PCA is prevalent due to the late presentation of the disease. 
The late diagnosis implies that men do not seek screening for PCA. The reasons for such 
attitudes and perception toward PSA and DRE testing remain unclear. Therefore, this 
study was conducted to understand better the significance of testing as well as the 
intentions to attend screening events including the association between demographic 
variables and perception of benefits among men 50 years old and above.  
As noted concerning HBM constructs, the evidence is in favor of the view that 
social constructs might be associated with participation in a screening program. If indeed 
HBM constructs are associated with changes in behaviors, the implications are far-
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reaching. There is a need to understand the cultural barriers that deter Nigerian men from 
having adequate PCA awareness as well as PSA blood test screening. I discuss the 
methodological design for the current study in Chapter 3. I provide an overview of the 
population, sampling procedures, and processes specific to online recruitment, 
participation, and data collection methods. Finally, I discuss the use of informed consent 
and the actions taken to prevent ethical concerns among study participants and ways to 
prevent undue harms.  
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Chapter 3: Research Method 
Introduction 
The problems examined in this study were based on the recognition that PCA 
screening is low among Nigerian men 50 years old and above. To date, despite efforts to 
study the intent to be screened, and the perception of screening benefits, the studies I 
reviewed in Chapter 2 were insufficient and deficient in exploring the hidden barriers 
towards PCA screening. Therefore, as stated in Chapter 1, the problems addressed in this 
study involved the perception of screening benefits and the cultural barriers affecting 
Nigerian men’s participation in PCA screening.  
In Chapter 3, I present the methodology of this study. The research design is 
presented and justified as appropriate for the study. The use of a cross-sectional design 
was appropriate to answer the research questions. The sample is described including data 
collection methods, participant eligibility criteria for inclusion and exclusion, and 
justification of a sample size of 180 participants. I also present the role of the researcher 
in data collection and data analysis. Strategies for ethical protection of participants are 
presented, and data analysis for a cross-sectional design is described. At the end of 
Chapter 3, the reader will have an in-depth understanding of the approaches taken to 
evaluate the barriers associated with screening intentions and the perception of screening 
benefits. 
Purpose of the Study 
The purpose of this study was to quantitively identify cultural factors associated 
with intention to screen for PCA as well as examine the perception of benefits and 
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barriers among Nigerian men 50 years old and older. Factors such as knowledge, 
socioeconomic status, and psychosocial factors (i.e., fear and fatalism) were also 
investigated. In doing so, I examined the opinions, experiences, and beliefs of study 
respondents concerning their intentions to screen and the perceptions of screening 
benefits.  
Research Design and Approach 
In this study, I sought to understand the cultural barriers associated with PCA 
screening and the experiences and beliefs of study respondents. I conducted an 
Institutional Review Board (IRB) approved, cross-sectional, Web-based survey with a 
sample of men 50 years old and above living in Nigeria. In this study, I employed the use 
of a quantitative, cross-sectional design to explore intention to screen as well as the 
association between demographic variables and the perception of the benefits of PSA as a 
screening tool for PCA among Nigerian men 50 years old and older. Data were 
distributed and collected through an online survey created and housed by Survey 
Monkey, which specializes in measuring patients’ experiences by using the Internet to 
reach a wide range of respondents. E-fliers were also posted on social media, such as 
Facebook, Twitter, and LinkedIn. The e-flyer contained detailed information concerning 
my study, including a contact number for my advisor and Walden University IRB.   
 In this study, I used quantitative data to numerically describe what is occurring 
concerning the cultural factors associated with the low PCA screening participation rate 
of Nigerian men aged 50 years and older. Quantitative methods were also employed to 
examine various independent variables and dependent variable to realize the goals and 
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objectives of this research. Participants were recruited to be a cross-section of a 
population. This method was appropriate for this study because participants were 
retrospectively reporting their intent to be screened and the perceptions of PCA screening 
methods. Most importantly, I did not randomly assign participants to a group where the 
experience of PCA was manipulated; instead, data on the PFI, the CSIS-P, and the 
CHBMS tools reflected the perceived level of awareness, barriers, and experiences.  
In Nigeria, the use of the Internet and mobile communication tools has become 
increasingly popular in recent years, enabling me to gather data from a sample at one 
specific point in time. According to Internet World Statistics (2017), it is estimated that 
over 98,391,456 people from Nigeria had accessed the Web by the end of 2017. Nigeria 
is also ranked in the Top 10 of the world Internet users (Internet World Statistics, 2017). 
The advantage this provided was that data were collected in a cost-effective and timely 
method. In this study, respondents completed the survey anonymously on their own time 
and at their own pace. I anticipated that about 80% of eligible respondents would 
complete the questionnaire. The disadvantage of this design is that cross-sectional studies 
do not necessarily establish causal associations. 
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Table 1 
Variable Operationalization and Statistical Analysis 
 
Research questions 
 
 
Variables 
 
Statistical test 
 
RQ1: Is there an 
association between 
constructs of the health 
belief model (i.e., 
perceived severity, 
perceived benefits, 
perceived susceptibility, 
and perceived barriers) and 
the intention to screen for 
PCA among Nigerian men 
50 years old and above? 
 Independent variables: 
HBM constructs 
Dependent variable: 
PSA/DRE screening 
behaviors 
 
Somer’s d; Gamma, 
descriptive statistics; 
means and percentages, 
frequencies by variable   
 
RQ2: Is there an 
association between 
demographic variables 
(i.e., ethnicity, age, 
education, and income) and 
the perception of the 
benefits of PSA as a 
screening tool for PCA 
among Nigerian men 50 
years old and above? 
Independent variable:  
Age, education, income, 
and ethnicity 
Dependent variable: 
Screening behavior 
Logistic regression, 
descriptive statistics; 
means and percentages, 
frequencies by variable 
 
RQ3: What are the 
perceived cultural barriers 
associated with intent to 
screen for PCA among 
Nigerian men 50 years old 
and above?   
Independent variables: 
PSA/DRE barriers 
Dependent Variable: 
Screening behavior 
Logistic regression, 
Descriptive statistics: 
means and percentages, 
frequencies by variable 
RQ 4: Is there an 
association between cancer 
fatalism, PCA belief, and 
intention to screen for PCA 
among Nigerian men 50 
years old and above?   
Independent variables: 
Cancer fatalism and 
 PCA belief 
Dependent variable: 
Screening behavior  
 
Logistic regression, 
Descriptive statistics: 
means and percentages, 
frequencies by variable 
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Research Questions: Variables Operationalization and Statistical Analysis 
For Research Question 1, I sought to address the following question: Is there an 
association between constructs of the HBM (i.e., perceived severity, perceived benefits, 
perceived susceptibility, and perceived barriers) and the PSA/DRE intention to screen for 
PCA among Nigerian men 50 years old and older? (see Table 1). In addition to other 
statistical analysis, Somer’s d analysis was used to determine which of the HBM 
subscales (i.e., susceptibility, benefits, severity, and barriers) are predictors of PCA 
screening intentions. The CHBMS was used to measure and provide answers to the 
themes in Research Question 1.  
For Researcher Question 2, I sought to address the following question: Is there an 
association between demographic variables (i.e., age, education, income, and ethnicity) 
and the perception of the benefits of PSA as a screening tool for PCA among Nigerian 
men 50 years old or older? In this study, I employed the use of counts, percentages, and 
proportions to summarize the categorical, demographic variables. Means and standard 
deviations were also used to summarize descriptive data or continuous variables. Binary 
logistic regression analysis was used to test the second research question. I used logistic 
regression to calculate the unadjusted odds of screening (i.e., yes vs. no) as a function of 
age, education, income, and ethnicity. Logistic regression analysis was chosen because it 
allowed for the use of a binary dependent variable and multiple independent variables. 
The dependent variable was screening behavior. It was coded as 0 for no and 1 for yes. 
Data from the demographic form and the CSIS-P (Baker, 2008) were used to provide an 
answer to the themes in Research Question 2.  
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For Research Question 3, I sought to address the following question: What are the 
perceived cultural barriers associated with intent to screen for PCA screening among 
Nigerian men 50 years old and older?  PSA/DRE barriers served as the independent 
variables, while the intention to screen represented the dependent variable. The CSIS-P 
and the CHBMS were used to measure and test the themes in Research Question 3. 
Binary logistics regression was used to analyze the data for the research question. 
Logistic regression analysis was chosen because it allowed for the use of a binary 
dependent variable and multiple independent variables. I used logistic regression to 
calculate the unadjusted odds of screening (i.e., yes vs. no) as a function of PSA and DRE 
barriers. The dependent variable was coded as 0 for no and 1 for yes. 
For Research Question 4, I sought to address the following question: Is there an 
association between cancer fatalism and intention to screen for PCA among Nigerian men 
50 years old and older?  The CSIS-P, the PFI, and the CHBMS were used to measure and 
test Research Question 4. Binary logistic regression was used to analyze the data 
concerning the research question. Logistic regression analysis was chosen because it 
allowed for the use of a binary dependent variable and multiple independent variables. I 
used logistic regression to calculate the unadjusted odds of screening (i.e., yes vs. no) as a 
function of fatalism and beliefs. The dependent variable was screening behavior, which 
was coded as 0 for no or 1 for yes. 
Independent Variables 
For this study, the exposure variable was the independent variables. The 
independent variables for this study were age (continuous variable); marital status 
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(nominal variable); educational levels (nominal variable); income; ethnicity. Others 
include HBM constructs (i.e., perceived susceptibility, perceived severity, perceived 
benefits, and perceived barriers) fatalism; PCA belief; health insurance; and family 
history of PCA (see Table 1).  
Dependent Variable 
For this study, the outcome variable was the dependent variable. The dependent 
variable was screening behavior. Screening behavior was coded as 1 for yes and 0 for no. 
PSA/DRE barriers were ordinal and measured on a 5-point Likert scale. The participants 
were asked whether they had ever received PCA screening in the past 12 months. 
Furthermore, I used frequency distributions to describe the demographic variables 
of the respondents. Several statistical tests analyzed the variance of the dependent 
variable against the variance of the independent variables. Logistic regression models 
were used to estimate the odds ratios, 95% confidence intervals, and p values. 
Quantitative variables were described as follows: n, mean, ± standard deviation and 
percent (%) for categorical data. All the statistical analysis mentioned in this chapter will 
be addressed in-depth in Chapter 4. 
Role of the Researcher 
Among other goals, I conducted this study to (a) identify cultural factors 
associated with intent to be screened, (b) assess the HBM association with PCA screening 
awareness and perceptions, and (c) examine the association between demographic 
variables and the intent to be tested for PCA. I defined the population, selected the 
sampling frame, and the unit of analysis. Using the Survey Monkey website, participants 
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were invited to the study through social media posts. I designed the demographic form, 
collected and analyzed data from the questionnaires, and obtained informed consent from 
all respondents before collecting data. Making realistic and sound decisions about the 
appropriateness and compatibility of the data was a focus as I monitored data collection, 
interpreted and analyzed data, and applied ethical standards in collecting data. 
After completing the questionnaire, I numbered and stored the survey results and began 
to enter the data from each questionnaire into a statistical computer program software 
(i.e., Statistical Package for the Social Sciences (SPSS) for Windows), after the first 80 
participants completed their survey. I did not manipulate the answers; instead, they were 
merely recorded or summarized in percentages, tables, and figures. To ensure data 
quality, I completed Clinical Research Training courses certified by the National Institute 
of Health Office of Clinical Research Training and Medical Education.  
Sample Size and Power Analysis 
I employed statistical power to, among other things, reject the null hypothesis and 
decrease the chances of committing Type II error. Statistical power represents the 
probability that a given statistical test will detect a real treatment effect (Burkholder, 
n.d.). A Type I error (i.e., false positive) happens when a researcher wrongly concludes 
that the null hypothesis is false when it is true (Banerjee et al., 2009). In the same vein, a 
Type II error (i.e., false negative) happens when a researcher wrongly concludes that the 
null hypothesis is true when it is false (Banerjee et al., 2009). Burkholder (n.d.) stated 
that a high statistical power helps improve the chances that study findings are not only 
due to chance (i.e., avoids a Type I error).  
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 Therefore, I anticipated using .80, which is the accepted value for power- some 
authors argue for higher powers such as .85 or .95 (Lenth, 2001). In other words, using 
this power implies that this study will have to show that, given the sample size, I can 
expect to find a real treatment effect 80% of the time. Put differently; if this study is 
repeated 100 times, the null hypothesis will be rejected 80 times if there is indeed an 
effect (Burkholder, n.d.).  
A search of historical data yielded the following results: Mazzuca (1982) 
conducted a systematic study to establish the association between patient education and 
chronic diseases. The author found a mean effect size of 0.52 and a sample size of 27. 
Posavac (1980) studied patient behaviors, self-care, and treatment regimes. The author 
employed the use of a mean effect size of 0.74 with a sample size of 23. Additionally, test 
anxiety studies were conducted by Dole, Rackey, and DiTomasso (1983). In the meta-
analysis, Dole, Rackey, and DiTomasso found a mean effect size of .80 and a sample size 
of 46. In another study, Garrin (2014) conducted a web-based survey to, among other 
things, understand self-efficacy, dispositional confidence, and apparent stress in College 
Senior. However, budget constraints restricted Garrin’s study to a final sample size of 
138 participants.  
 Baguley (2004) stated that it is necessary to specify at least one principal 
hypothesis to set the sample size or estimate the power of the proposed study in a study 
with multiple hypotheses. In most social science research, for instance, an over-powered 
study may be as undesirable as an underpowered study.  Baguley furthermore suggested 
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that increasing sample size comes with financial and other costs associated with it. For 
this study, G*Power 3.1 was utilized to conduct power analyses for sample size. 
G*Power is a tool used to compute statistical power analyses as well as compute 
effect sizes. The tool is commonly used in the social, behavioral, and biomedical sciences 
(Faul et al., 2009). Faul et al. stated that Cohen’s (1988) is used as an effect size measure. 
According to Burkholder (n.d.), three things influence power in a study: (a) alpha level; 
(b) effect size; (c) and sample size. Cohen’s d is a popular measure of effect size. Thus, 
Cohen specified the following effect sizes: small, medium, and large (Burkholder, n.d.).  
Using Cohen’s measure of effect size, namely small, medium, and, large and, to 
maintain the effect size of .80, the medium size was used for this study. A medium effect 
size reduced the occurrence of Type II errors in the study (i.e., could this study miss a 
true association) and at the same time, enough to produce statistically significant results. 
Kerlinger and Lee (2000) surmised that the most commonly used and acceptable effect 
size in behavioral research is a medium effect size. Therefore, the medium effect size was 
chosen for this study.  
Power Analysis: Research Questions and Hypothesis 
In this study, Somer’s d analysis was used to test for an association between 
constructs of the HBM (i.e., perceived severity, perceived benefits, perceived 
susceptibility, perceived barriers) and the intention to screen for PCA among Nigerian 
men 50 years old and older. If the p-value resulting from the analysis is less than 0.05, the 
null hypothesis was rejected. Champion’s revised health belief questionnaire used a 5-
point Likert scale reflecting knowledge of PCA barriers, susceptibility, severity, and 
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benefits to screening using screening tools. A response of strongly agree was scored as 
five and strongly disagree as one. The questionnaire measured the HBM constructs: 
perceived susceptibility (i.e., a 5-item scale); perceived severity (i.e., a 6-item scale); 
perceived benefits (i.e., a 6-item scale); and perceived barriers (i.e., a 6-item scale). 
For the logistic regression used to evaluate the second research hypothesis, a 
power analysis calculation that used a medium effect size (.30) yielded a total sample size 
of 196 and an actual power of 0.9501020. For the current study concerning an association 
between demographic variables (i.e., age, education, income, ethnicity) and the 
perception of the benefits of PSA as a screening tool for PCA among Nigerian men 50 
years old and older, the variance of the dependent variable was compared against the 
independent variables. I used logistic regression to calculate the adjusted odds of 
screening (Binary: Yes vs. No) as a function of the independent variables. The 
independent variables have two or more levels. Further, an alpha level of 0.05 was used 
to increase the likelihood of finding any statistical significance between 
sociodemographic variables.  
Hypothesis Testing 
Test of significance was used to test the hypothesis. For this study, the level of 
significance was set at p < 0.05. Conventionally, results are statistically significant (the 
result is not by chance) if the p value is less than 0.05 or less than 5%. If the probability 
exceeds 0.05 (p > 0.05), the null hypothesis was accepted, and the alternate hypothesis 
was rejected. Therefore, if the null hypothesis is true and is rejected, this study will 
commit a Type I error (i.e., false-positive). Likewise, if the null hypothesis is false and 
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this study fails to reject it, a Type II error (i.e., false-negative) will be committed. In this 
study, the chances of committing Type I error increased when analyzing several 
independent or dependent variables.  
Also, logistic regression analysis was used to determine which of the independent 
variables best explain the intention to screen variables. Regression analysis was used to 
test the hypotheses at 0.05 levels of significance and confidence interval (95% CI) using 
IBM SPSS statistical software. For this study, the null hypothesis (Ho) states that there is 
no association between the independent variables and the dependent variable. The 
alternate hypothesis (Ha) states that there is an association between the independent 
variables and the dependent variable. This study demonstrated that the potential findings 
from this study are significant. A sample of 180 respondents was to provide enough 
power. 
Sample Size Analysis 
Thus, the final size of 180 participants was enough to yield significant results and 
most importantly reduce the occurrence of Type II errors (i.e., could this study miss a true 
association between the outcome and exposure) in the current study. Garrin (2014) stated 
that statistical power is enhanced when larger sample sizes are employed (Chadha, 2006; 
Wilson-Van Voorhis & Morgan, 2007, as cited in Garrin, 2014). However, according to 
Linsey and Wilson (1993), the mean effect size based on the small subject sample is 
biased upward as a statistical estimator of the population effect size. That is, the total 
sample size should be less than 10 before the bias is recognized (Hedges, 1981, as cited 
in Linsey & Wilson, 1993). 
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Similarly, Baguley (2004) argued that larger samples provide diminishing returns 
regarding increased power since the relationship between sample size and power is not 
linear. Moreover, researchers are advised not to recruit sample sizes higher than 
necessary for a reasonable level of power (Baguley, 2004). Attrition is a common factor 
in research; hence, it must be accounted for (Portney & Watkins, 2008). Therefore, the 
proposed sample size of 196 participants was enough to allow for attrition and missing 
data or incomplete data. Given that every eligible Nigerian man could not participate in 
the study because of time, death and lack of the Internet, the final size of 180 participants 
was deemed enough to yield statistically meaningful results and most importantly reduce 
the occurrence of Type II errors. The alpha level of 0.5 was used to reduce Type 1 error, 
and the power level of 80% was used to reduce Type 2 error. 
Context 
Five weeks of electronic surveying was offered to respondents who identify 
themselves as an adult male 50 years old and older and currently living in Nigeria. 
Nigeria accounts for the highest concentration of black people in the world and the most 
populous country in Africa. Situated in West Africa, Nigeria boost of communication 
apparatus and inadequate health care mechanism. Granted, the burden of PCA in Nigeria 
is comparable to the burden of PCA among African American men. Nigerian men suffer 
the burden of PCA more than any other male in Africa. Despite the high mortality rate of 
PCA, participating in screening events remains very low. Therefore, Nigeria was an 
appropriate unit of analysis for this study.  
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Inclusion and Exclusion Criteria 
Table 2 
 
Inclusion and Exclusion Criteria for Study Eligibility 
 
Inclusion Criteria 
 
 
Exclusion Criteria 
 
   
Nigerian male residing in Nigeria Not Nigerian male   
Aged >=50 years old Aged <50 years old   
Ability to give informed consent Not capable of giving informed consent 
Have access to the Internet Inability to access the Internet 
Fluent in the English Language Not fluent in the English Language 
Participants 
The study population consisted of Nigerian men who are 50 years old and above. 
One hundred ninety-six Nigerian men responded to a social media advertisement to 
participate in a Web-based survey. All participants received recruitment flyers through 
social media platforms such as Facebook, LinkedIn, Twitter, and WhatsApp. Further, this 
study explored the experiences of study respondents as well as the intention to screen and 
the perception of the benefits of screening. The respondents were drawn from rural and 
urban areas in Nigeria, surrounding a major metropolitan area with a population of about 
one million people. A brief demographic form inquired as to the state of residency, faith, 
family history of PCA, age, educational background, and income of participants.  
The Population of Nigeria 
PCA alone kills 26 Nigerian males daily. Due to population growth, the incidence 
and prevalence rates of PCA will increase. In 2012, the country recorded 11,944 new 
cases of PCA (World Health Organization, 2014). The current population of Nigeria is 
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196,094,688 based on the latest estimate of the Population Division of the Department of 
Economic and Social Affairs of the United Nations (United Nations, 2017). Nigeria is the 
most populated country in Africa and accounts for approximately one-sixth of the African 
Populations (Wikipedia, 2012). There are 36 states in Nigeria. According to the United 
Nations, the population of Nigeria will reach more than 410, 638 million by 2050. 
Nigeria might then be the third largest country in the world. All things being equal, the 
population of Nigeria may reach more than 793, 942 million people in 2100 (United 
Nations, 2017). According to the 2006 Nigeria Census figures, Nigerian males between 
the ages of 40 years old to 44 years old accounts for 3395,489.00 of the total population 
while those from 60 years to 64 years old represent 1363,219.00 of the total population 
with a total life expectancy at birth of 51.58 years (CIA World Factbook, 2014).  
Population 
I recruited a sample of 180 Nigerian men who are 50 years old and older. A total 
of 196 men responded to the survey. Due to missing data and skipped questions, I 
excluded 10 participants. Three men assessed the survey but did not provide any data 
while three men answered more than 95% questions with missing data but were included 
in the final analysis. Respondents to the survey reported lower participation in PCA 
screening in the past 12 months (see Figure 3). The participants in this study were a 
cross-sectional sample of Nigerian men recruited through social networking sites. Survey 
Monkey website link was embedded in the mass media recruitment channels. 
SurveyMonkey Inc. is an American based web-based provider of an electronic survey.  
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Participants 
Informed consent was obtained from the participants and indicated an 
understanding that they can withdraw from the study at any time without penalty. 
Informed consent was an agreement to participate voluntarily and willingly in the study 
and was based on full disclosure of what constitutes participation in this study and what 
will be the risks and benefits of participating in the study. There are no physical risks of 
participation in the study. However, if they felt stressed or embarrassed from completing 
this survey, a toll-free number and email address were provided to contact for counseling. 
It is stated in the informed consent form that all records in this study were confidential 
and that only the researcher has complete access to the questionnaires and demographic 
records. There is no compensation for taking part in this study. The Walden University 
IRB reviewed the research and approved to conduct research. The IRB approval # is 12-
06-18-0290399. Participants’ health and demographic information were protected. 
Privacy and anonymity formed the cornerstone of this study. 
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Figure 3. Recruitment screening diagram and study screening outcome.  
  
Nigerian men invited to participate in 
questionnaire 
 
 
Responded to questionnaire (n = 196) 
 
Surveys excluded due to missing and 
incomplete data (n = 10) 
 
 
Questionnaires used for final analysis 
 (N = 180) 
 
Outcome: Screen 
for PCA 
(29.4%) 
 
Outcome: Did not 
screen for PCA 
(70.6%) 
 
 No response to 
questionnaire (n = 3) 
 
Questionnaire with > 95% 
complete data (n = 193) 
Questionnaire with 
incomplete data and 
included (n = 3) 
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Data Collection 
The data collection process was implemented via an anonymous web-based 
survey design that was made available to all participants via the Survey Monkey web 
link. The estimated time for completion of the questionnaire was 18 minutes, depending 
on participants speed and typing skills. I downloaded the survey from SurveyMonkey 
domain into an Excel spreadsheet and then into SPSS software application for coding, 
recoding, and analysis. I computed and analyzed the scores to identify the respondent’s 
level of awareness about PCA screening. Data gathered for analysis included 
demographic information, barriers, and benefits of screening, screening intentions, 
experiences, and opinion. 
Quantitative Instruments 
The following tools were used to address the research questions guiding this 
dissertation: The researcher’s developed demographic questionnaire, the CSIS-P (Baker, 
2008), the PFI (Powe, 1995) and the CHBMS (Champion, 1999). These tools are 
presented in Appendices A-D. I used a 5-point Likert scale ranging from 1 (strongly 
disagree) to 5 (strongly agree) and “Yes” and “No” on a model that has been revised and 
analyzed for construct validity on studies utilizing African Americans. I sought and 
obtained permission via student e-mail address from Drs. Champion, Baker, and Powe to 
use their tools. These tools took each respondent approximately 18 minutes to complete.  
Survey Pretest 
The questionnaires were pretested by five Nigerian men (aged 50 years old and 
above). The responses to the questions were timed. Participants were asked to identify 
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problematic issues such as time to complete the survey. Also, participants are expected to 
assess the validity and reliability of the questionnaires.  
Demographic Questionnaire 
A demographic questionnaire was designed to collect data on the descriptive 
characteristics of participants, one of which, age, was analyzed in the current study. In the 
sociodemographic questionnaire, participants self-selected their age. Also, data about 
ethnicity, income, family history and marital status, the state of residence, and 
educational levels, among other characteristics and variables were gathered. Standard 
demographic data was collected and used to describe the population. The demographic 
data sheets were carefully protected. Only the researcher has access to this document that 
was deleted after this study ended. Specific procedures were performed to ensure 
instrument reliability among data-gathering instruments. To gather reliable information 
and to quantify the relationship between the variables, the sociodemographic 
characteristics of the participants were explored. These variables are listed below: 
Age 
Advanced age is one of the primary risk factors for PCA. The demographic form 
contained a question about age (age: an interval-level measurement also serves as an 
inclusion criterion). For this study, age (i.e., independent variable) was measured by 
asking respondents: “What is your date of birth?” The age variable was coded into five 
categories: 50 – 55 = 1; 56 – 66 = 2; 67 – 77 = 3;78 – 88 = 4; 89+. It was dummy coded 
and collapsed into two categories. Age group was measured as ordinal variables. 
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Education  
Patel et al. (2010) found a significant association between educational level and 
the intention to screen for cancers in various population. Individuals with higher 
education tend to be more inclined to engage in screening events than those with less 
education. For this study, participants were asked to indicate their highest educational 
achievement. Years of schooling completed by the respondent was coded as an ordinal 
variable. These variables were coded as less than high school education = 1, high school 
= 2, college degree = 3, or graduate degree including doctorate degree = 4. 
Ethnicity  
For this study, ethnicity was coded as a nominal variable. Ethnicity variable was 
measured by asking study respondent to indicate which of the listed categories best 
describes their ethnicity. Participants in my study hailed from eleven ethnic groups in 
Nigeria. Ethnicity was coded into eleven categories.  
Income Level 
There is an association between health behaviors, such as increased PCA 
screening and the level of income (Patel et al., 2010). A 2002 study found that individuals 
are less likely to engage in PCA screening if the level of their household income is low 
(Peterson et al., 2002). For this study, income was measured by asking the respondents to 
indicate their income level. Respondent annual income was coded as a continuous 
variable. 
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Family History of Prostate Cancer 
 The family history of PCA is a significant risk factor. For this study, a family 
history of PCA was measured by asking the participant to indicate if they have any blood 
relatives diagnosed with the disease(yes/no). A “Yes” response was coded as “1,” and a 
“No” response was coded as “0.” 
Marital Status 
Respondent’s current marital status was coded as nominal variables. Marital 
status was measured as single, in a relationship; single, not in a relationship; married, 
partner/living together; divorced/separated, or widowed. Marital status was coded into six 
categories. This variable was later dummy coded and collapsed into three categories.  
State of Residence in Nigeria 
There are 36 states in Nigeria and the Federal Capital Territory (FCT). 
Respondent’s state of residency was code as a nominal variable. Participants from 12 
states, including the Federal Capital Territory, responded to the survey. 
Powe’s Cancer Fatalism Index (PFI) 
Fatalism is defined as a lack of control over events related to a cancer occurrence 
leading to perceptions of hopelessness, worthlessness, meaninglessness, powerlessness, 
and social despair (Powe, 1995). The PFI comprises 15 items that assess participants fear 
of cancer and the belief that cancer will end in death. The word “prostate” replaced the 
word "bowel" to align with the purpose of this study. Cancer fatalism was measured 
using 15 items from the PFI (Powe, 1999). This world-renowned index used for this 
study with the permission of the author include questions such as “I think if someone gets 
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PCA, that is the way they were meant to die," and "I think if someone gets PCA, it was 
meant to be." In a 1999 study, Powe found that PFI recorded a coefficient alpha 
reliability of 0.84. For this study, cancer fatalism is one of the independent variables.  
Champion’s Revised Health Belief Model Scale (CHBMS) 
The CHBM Scale is a renowned tool used by many researchers to study health 
behaviors. The CHBMS tool (modified for PCA screening) subscales: (Susceptibility, 
Severity, Benefits, and Barriers) was used to obtain data from respondents. A five-point 
Likert scale was used to measure responses. The questionnaire asked series of questions 
based on the research questions assumption and to test for an association between 
constructs of the HBM (i.e., perceived severity, perceived benefits, perceived 
susceptibility, perceived barriers) and the intention to screen for PCA among Nigerian 
men 50 years old and older.  
 In 1999, Champion tested and revised the HBM scales from its 1984 version with 
a sample of women (N = 804). Champion(1999) argued that the HBM is a function of 
perceived susceptibility, perceived severity of the disease, perceived benefits of the 
behavior, and the perceived barriers to the screening behavior. However, Champion also 
found that perceived severity is an unnecessary measurement scale. In the 1999 study, 
Champion found susceptibility (r = .62), benefits (r = .61), and barriers (r = .71) and the 
correlations of all test-retests were noted to be significant at the .01 level. The author 
realized a final standardized alpha for each construct: susceptibility (α = .87), benefits (α 
= .75), and barriers (α = .88).  
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 Although Champion (1999) initially used this questionnaire to study breast 
cancer, it can be used to study any type of cancer, and in this study, it was modified to 
examine perceptions related to PCA. Champion stressed that the perceived susceptibility 
might include the risk of cancer diagnosis within a period. Perceived severity is the 
perceived threat to cancer or how people perceived the seriousness of cancer. Severity 
might include the impact of cancer on financial, social, or psychological outcomes 
(Champion, 1999). Perceived benefits of early detection of cancer screening behaviors 
constitute the third HBM constructs and defined by Champion as one’s belief that 
specific behavior is correlated with preventing or detecting disease. Champion noted that 
the “perceived benefits refer to the perception of positive outcomes thought to accrue 
from a behavior” (p. 342). Perceived barriers refer to anticipated cancer screening 
behaviors related to emotional, social, and physical barriers. In another study, Champion 
and Skinner (2008) found that the perceived susceptibility, perceived benefits, and 
perceived barriers were significant predictors regarding health care behaviors.  
Cancer Screening Intention Scale-Prostate (CSIS-P) 
CSIS-P (Baker, 2008)  was used to measure the intent to be screened for PCA. 
The stated intention to be screened for PCA includes a question concerning using either a 
PSA blood test and a digital rectal exam (DRE). The questions include: “I believe that 
getting a DRE and the  PSA blood test for PCA will lower my chances of getting PCA,” 
“I think most Nigerian men do not know about the DRE and the PSA blood test for 
PCA.”  
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According to Baker (2008), the CSIS-P consists of 43 items, developed by 
utilizing the results of the focus groups and assessed for content validity by a panel of 
oncology. Baker found a content validity index for the scale as .90, and internal 
consistency was found to be .92. Test-retest procedures were also conducted to assess the 
stability of the CSIS-P, and the reliability coefficient was .93 (Baker, 2008). According to 
Tabachnick and Fiedell (1990), test-retest reliability has been used to assess the stability 
and consistency of an instrument. 
Scoring the PCA Screening Questionnaire 
The CHBMS questionnaire used a 5-point Likert scale reflecting knowledge of 
PCA barriers, severity, and benefits to screening using screening tools. A response of 
strongly agree was scored as 5 and strongly disagree as 1. If responses to the constructs 
(i.e., susceptibility, severity, barriers, benefits) are 1, then, a respondent’s motivation to 
screen for PCA should be low. The questionnaire measured the HBM constructs, 
including susceptibility (i.e., a 5-item scale); severity (i.e., a 6-item scale);  benefits (i.e., 
a 6-item scale; and barriers(i.e., a 6-item scale). Mean scores subscale was calculated. 
Higher means indicated that a respondent’s motivation to screen was high. The questionnaire 
was modified and adapted to align with the purpose of this study. For this study, the word 
“prostate” replaced the word “breast” with the written permission of the author. 
Also, the PFI questionnaires were coded “1,” for YES responses while NO 
responses were coded “0.”  PFI questionnaires have 15-questions items. Scores from all 
15 items were summed; the maximum possible score was 15, and the minimum possible 
score was 0 with higher scores on the index representing higher marks of cancer fatalism 
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(see Table 3). Total scores of 0 to 5 correlated to a low mark of fatalism, scores from 6 to 
10 represented a moderate mark of cancer fatalism, and scores from 11 to 15 indicated a 
high mark of cancer fatalism. PFI questions were intended to assess four attributes of 
fatalism (a) inevitability of death, (b) pessimism, (c) fear, and (d) predetermination 
(Cobran et al., 2014).  
Responses to the items in the CSIS-P (Baker, 2008) was scored using a 5-point 
Likert-type scale (see Table 4). In the study, strongly agree = 5, agree = 4, neither agree 
nor disagree = 3, disagree =2, and strongly disagree =1, was numerically scored from 
five to one. Mean scores subscale was calculated. Respondent’s higher scores on the scale 
reflected higher intentions to attend PCA screening. 
Table 3 
Scores and Level of Prostate Cancer Fatalism 
 
Level of Fatalism 
 
   
Score 
 
Low   0-5 
Moderate   6. -10  
High   11.-15 
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Table 4 
 
Scores and Level of Prostate Cancer Intention 
 
Levels of Intention 
 
 
Scales 
 
 
Scores 
 
 
Very low intention Strongly disagree 1 
Low intention Disagree 2 
Moderate intention Neither disagree nor agree 3 
High intention Agree 4 
Very high intention Strongly agree 5 
 
Reliability 
Reliability of data means that the measurement does not vary due to how the data 
was measured (McKenzie et al., 2009). That is, whether the data collection instrument is 
measuring concepts consistently. Reliability of the research means that the questionnaire 
was filled with specific questions so that respondents were sure what to answer. The 
instruments measured concepts consistently. In so doing, it is essential that the data 
collection methods were reliable and valid. The reliability of such research instruments 
was upheld to ensure accuracy. Therefore, the ordinal measure and Likert Scale was used 
to measure reliability for this study. The online questionnaire gathered information by 
using measures such as: Strongly Agree; Agree; Neither agree nor disagree; Disagree; 
Strongly Disagree. The combined use of Likert Scale and Ordinal measures improved 
data reliability and validity. Reliability coefficient, including equivalent forms and 
internal consistency approaches, was used to measure reliability. The CHBMS has been 
tested for content and constructs validity as well as for internal consistency and test-retest 
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reliability. A Cronbach-alpha of .93 was realized with test-retest reliability of .70 
(Champion, 1999). Cronbach’s alpha (α) is a reliability index that estimates the internal 
consistency of an instrument (Polit & Beck, 2012). It ranged from 0.0 to 1.0; thus, an 
alpha of .7 is said to be acceptable. Using the PFI, Powe (1995) found a Cronbach’s alpha 
ranging from 0.84 to 0.89, in analyses of a sample of (N = 192) participants.  
Validity 
I considered content, criterion, and construct validity. Validity suggested 
trustfulness or measurement validity. The validity coefficient ranges from 0.0 to 1.0. The 
goal was to capture health issues in a manner that produces the diagnostics value of PCA 
screening tools. The questionnaires were able to measure what it is intended to measure, 
thus ruling out other possible explanation for the result. In so doing, this study employed 
the use of content, face, criterion, and construct validity. Content validity was used to 
consider the instrument’s items of measurement. Criterion-related validity was used in 
this quantitative study based on a cross-sectional design to make sure that the data 
generated from the questionnaire tools was correlated with the data generated from a 
measure of access to PCA screening test. For this study, face validity was used to 
measure the value it purports to measure by addressing the research questions and 
conceptual frameworks.  
Administration of the Questionnaires 
I employed the use of an electronic questionnaire administrated by online survey 
provider. The survey questions focused on the perceived benefits, perceived barriers, 
perceived susceptibility, perceived severity, fatalism, screening intentions, and 
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demographic information. The questionnaire took most participants about 18 minutes to 
complete and was given accurately following my directions for survey administration.  
Raw Data 
Raw data from the study were collected, ordered, coded, recoded, and stored for 
five years. After 5 years, the data will be deleted. Any requests for access to raw data 
made after 5 years will be invalid.  
Data Analysis 
Data for this study included quantitative information. Data for this study was 
collected using the validated CSIS-P (Baker,2008), PFI (Powe, 1995) and CHBMS 
(Champion, 1999) through an online self-reporting platform. Quantitative data analysis 
involved general demographic data, the Web-based questionnaire, and self-reported age, 
PSA screening history, beliefs, attitudes, and opinions. The data analysis for this study 
comprised two general phases. The first phase of the analysis compared and interpreted 
quantitative measures from the demographic form and the questionnaires. The second and 
final phase of the analysis integrated the data into a computerized statistical database 
using SPSS software application.  
Statistical analysis was developed in three stages: descriptive analysis, Somer's d 
analysis, and binary logistic regression analysis. Logistic regression was used to analyze 
the independent and dependent variables (Table 6). The analysis was performed using the 
program SPSS V24 describing according to the nature and distribution of the quantitative 
and ordinate variables with measurements of the mean and dispersion using the standard 
deviation and variance. Data were presented in the form of frequency, tables, and cross-
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tabulations. Frequency distributions were used to detect any outliers. Also, frequency 
analysis and regression analysis were used to explore the four research questions. 
Predictors for PCA screening behavior was estimated using odds ratios (ORs) and 95% 
CIs. The significance was set at p ≤ .05. 
Data Cleaning 
Data were presented in the form of frequency, tables, and cross-tabulations. 
Before I entered the data into SPSS software for analyses and interpretation, each 
questionnaire was examined for any incomplete data. A questionnaire is considered 
complete if at least 95% of the questions were answered. Any questionnaire with less 
than 94% missing data was excluded from data entry and analyses. Frequency 
distributions were used to detect any outliers or flawed data. The data were stored in both 
flash drive and external drive and will be deleted after the completion of the study. 
Analysis of Quantitative Data 
Data collected for this study included demographic data and web-based 
questionnaire results. The research questions and the hypotheses reflect this type of 
analyses. Also, Somer’s d and logistic regression analyses were used to test the 
hypothesis. If a sample characteristic is not representative of the population, the 
limitations were noted in the Discussion section. The SPSS software was used for all data 
analysis. 
Summary 
I examined the hidden factors associated with low screening attendance in 
Nigeria. Of further interest were the impact of culture, attitudes, and perception of 
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screening benefits as well as the intentions to attend screening program. This topic is an 
excellent area in which to do research. The survey was conducted in an online setting 
using the demographic form, Baker’s CSIS-P, Powe’s PFI, and the Champion’s CHBMS 
questionnaire. Data from completed questionnaires were analyzed via the SPSS statistics 
application. Ethics approval for this study was obtained from the Walden University IRB. 
The results of the study were reported in Chapter 4. 
77 
 
Chapter 4: Results  
Introduction 
The primary purpose of this study was to quantitatively identify cultural factors 
associated with the intent to be screened for PCA and  examine the perception of benefits, 
barriers, and screening behavior of PCA among Nigerian men 50 years and older. A 
concurrent purpose of the study was to identify the sociodemographic variables as well as 
the perceived seriousness and susceptibility associated with screening intention. In this 
quantitative study, I employed a cross-sectional design using pretested instruments. The 
HBM was the theoretical framework for this study.  
In this chapter, I present the findings from statistical analyses performed to test 
the hypotheses that were generated from the research questions of this study. This chapter 
consists of four sections: introduction, data collection, results, and summary. I also 
describe the demographic characteristics of the study respondents using means, mode, 
median, standard deviation, frequencies, and percentages for all variables. The IBM 
SPSS statistical software was used to analyze all data collected. I used the following tools 
to address the research questions guiding this dissertation: The researcher-developed 
demographic questionnaire, the CSIS-P (Baker, 2008), the PFI (Powe, 1995), and the 
CHBMS (Champion, 1999). 
The demographic questionnaire included items such as age, income level, 
educational attainment, and exposure to PCA screening in the past 12 months. Questions 
concerning the participants’ marital status, health insurance access, family history of 
PCA, and ethnicity were also included. I assessed the reliability of various scales using 
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Cronbach’s alpha. An acceptable value of internal consistency (i.e., alpha of .70) 
measures the extent to which all the variables in the scale are positively related to each 
other (Nunnally, 1978).  
 Using the CHBMS, Champion (1998) conducted a landmark study with 618 
women aged 50 years and over who were enrolled in a mammography screening for 
breast cancer. Champion found a Cronbach’s alpha of .93 for susceptibility, .80 for 
severity, .80 for benefits, and .88 for the barrier. This current study involved elements of 
the CHBMS (Cronbach’s alpha of .95 in this study). This scale consisted of four 
subscales. Items for each subscale are arranged on a 5-point Likert-type scale with 1 
indicating strongly disagree and 5 indicating strongly agree. For the subscales of 
perceived susceptibility, perceived severity, perceived benefits, and perceived barriers 
measured on a Likert scale, the respondents scored a mean of 9.39 (SD = 7.05; α = .97), 
M = 10.71 (SD = 7.88; α = .96), M = 10.90 (SD = 7.69; α = .95), and M = 9.87(SD = 6.45; 
α = .93), respectively. The CHBMS has 23 question items; all 23 items were summed by 
subscale; the maximum possible score was 30, and the minimum possible score was 0 
with higher scores on the index representing higher marks. The mean, standard deviation, 
and alpha scores are presented in Table 7.  
The CSIS-P (with a Cronbach’s alpha of .94 in this study) consists of 43 items 
measured on a 5-point Likert-type scale. Baker (2008) found.90 as content validity. In the 
same study, Baker also found the reliability coefficient of the scale to be .93. In this 
study, the Cronbach’s alpha for the CSIS-P subscale was .91 for DRE intention, .92 for 
PSA intention, .90 for a healthy lifestyle, and .93 for PCA belief. For the subscales of 
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DRE intention, PSA intention, healthy lifestyle, and PCA belief measured on a Likert 
scale, the respondents scored a mean of 35.92, 23.9, 18.9, and 14.3, respectively. These 
subscale items were summed and represent a composite score of each subscale. The 
mean, standard deviation, and alpha scores are presented in Table 13. Responses included 
strongly agree (coded as 5), agree (coded as 4), neither agree nor disagree (coded as 3), 
disagree (coded as 2), and strongly disagree (coded as 1) and were numerically scored 
from 5 to 1. A score of 1 signifies very low intention and a score of 5 signifies high 
intention. Negative items in the scale were reverse scored where 5 = 1, 4 = 2, 3 = 3, 2 = 4, 
and 1 = 5.  
For the 15-item PFI scale (Cronbach’s alpha of 0.98 in this study), respondents’ 
answers were measured on a yes/no scale. The scores on the PFI scale ranged from 1 to 
15. Scores from all 15 items were summed; the maximum possible score was 15, and the 
minimum possible score was 0 with higher scores on the index representing higher marks 
of cancer fatalism. Total scores of 0 to 5 correlate to a low mark of fatalism, scores from 
6 to 10 represented a moderate mark of cancer fatalism, and scores from 11 to 15 
indicated a high mark of cancer fatalism (see Table 4). In a study conducted among 
elderly African Americans to evaluate fatalistic belief and intent to screen for colorectal 
cancer, Powe (1995) found a Cronbach’s alpha of 0.84 (N =1 92).  
Research Questions and Hypotheses 
Research Question 1: Is there an association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
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susceptibility) and the PSA/DRE intention to screen for PCA among Nigerian 
men 50 years old and older? 
H01: There is no  association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
susceptibility) and the PSA/DRE intention to screen for PCA among 
Nigerian men 50 years old and older. 
H11:  There is an association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived 
susceptibility) and the PSA/DRE intention to screen for PCA among 
Nigerian men 50 years old and older. 
Research Question 2: Is there an association between demographic variables (i.e., 
age, education, income, and ethnicity) and screening intention for PCA among 
Nigerian men 50 years old and older? 
H02: There is no association between demographic variables (i.e., age, 
education, income, and ethnicity) and screening intention for PCA among 
Nigerian men 50 years old and older. 
H12: There is an association between demographic variables (i.e., age, 
education, income, and ethnicity) and screening intention for PCA among 
Nigerian men 50 years old and older. 
Research Question 3: What are the perceived cultural barriers associated with 
intent to screen for PCA screening among Nigerian men 50 years old and older?   
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H03: There are no perceived cultural barriers associated with intent to 
screen for PCA screening among Nigerian men 50 years old and older. 
 H13: There are perceived cultural barriers associated with intent to screen 
for PCA screening among Nigerian men  50 years old and older.  
Research Question 4: Is there an association between cancer fatalism, PCA belief, 
and intention to screen for PCA among Nigerian men 50 years old and older?   
H04: There is no association between cancer fatalism, PCA belief, and 
intention to screen for PCA among Nigerian men 50 years old and older. 
H14: There is an association between cancer fatalism, PCA belief, and 
intention to screen for PCA among Nigerian men 50 years old and older. 
Pilot Study 
To test the questionnaire, I conducted a small-scale pilot study with five 
individuals to ensure the content validity of all questions. The validity and reliability of 
the scale have been established by the respective authors; however, the use of only five 
individuals in the pilot study was deliberate to improve response rates as well as test the 
readability of the tools. In this study, I conducted the pilot study to (a) determine if there 
were any problems with the way the questions were constructed; (b) ensure the questions 
were easy to understand; and (c) determine if the time to complete the questionnaires was 
realistic. The pilot study was conducted during two weeks from December 11, 2018, to 
December 27, 2018. Before taking the survey, each pilot study participant consented by 
checking the “yes” button in the survey. All men in the pilot study met the inclusion 
criteria of being a Nigerian male currently living in Nigeria and able to understand the 
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English language. The pilot study was composed of adult men aged 50 – 55 years old (n 
= 4, 80 %) and 56 – 66 years old (n = 1, 20 %). Three of the 5 participants in the pilot 
study belonged to the Igbo ethnic group, while two men hailed from Edo ethnic group. 
Four (80%) respondents stated that they had not screened for PCA in the past 12 months, 
while one respondent reported that he had screened for the disease using screening tools 
(i.e., PSA blood test and DRE).  
Reliability and Validity 
I assessed the internal reliability of the tools used in this study. Cronbach’s alpha 
was determined for the CHBM subscale and the CSIS-P scale. The Cronbach’s score for 
the CHBM instrument used for the pilot study was .85, showing more reliability. The 
Cronbach’s score for PSA intention subscale, DRE intention subscale, and the combined 
PSA and DRE intentions for the pilot study was .80. 
Pilot Study Results and Conclusions 
All five-pilot study respondents did not suggest any correction or modification to 
the questionnaires. The five pilot participants confirmed that the survey questions were 
easy to understand. The time to complete the questionnaires was approximately 18 
minutes. Based on the data collected and the reliability of the instruments, I found it 
appropriate to use the tools for my study; nevertheless, due to insufficient data points, the 
statistical analysis of the pilot study was not meaningful, and therefore, the results of the 
pilot study were not included in the final study.  
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Data Collection 
I prepared the survey using the Web-based SurveyMonkey platform. The survey, 
approved by Walden University IRB, was voluntary and confidential. The questionnaire 
was subdivided into sections. Data collection began about a week after IRB approval. 
The IRB approval # is 12-06-18-0290399. The IRB approval date was November 29, 
2018, and data were collected from December 11, 2018, until January 18, 2019. All 
ethical procedures, as required by Walden University, were followed throughout the 
study. To reach a geographically diverse male sample, I posted recruitment flyers in 
social media, such as Facebook, Twitter, WhatsApp, and LinkedIn, inviting potential 
participants for the study. The recruitment flier described the purpose of the study as well 
as eligibility criteria and provided a link for interested men to enroll in the study.  
To ensure adequate power to decrease the probability of accepting an incorrect 
null hypothesis, I used a G*Power calculator to determine the minimum sample size to 
employ to test the four hypotheses of this study. The sample estimations were outlined in 
Chapter 3. In this study, I included all respondents who completed the surveys with less 
than three missing responses. The inclusion criteria in this study were as follows: 
Nigerian male 50 years and above and currently living in Nigeria (see Table 2). A total of 
196 men responded to the survey with a completion rate of 94%. Ten surveys were 
excluded due to missing data or incomplete answers. Of these total numbers (N = 180), 
three respondents missed less than three questions and were included in the final study. 
The survey contained a consent form indicated that the study would be anonymous, and 
that participation was strictly voluntary. Participants checked a box to indicate they had 
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read the consent form and agreed to the terms to take the survey. Most importantly, the 
consent form also included my contact information as well as that of my advisor and an 
e-mail address to contact the IRB at Walden University. 
Adverse Events 
There are no reported cases of emotional effects throughout the data collection 
phase. The informed consent form contains a paragraph for toll-free counseling services 
if they notice any adverse effects. However, positive comments were posted by 
respondents wishing me well and expressing their intent to read the final dissertation 
report and interest in the results of this study.  
Data Cleaning 
The most frequently encountered issues in data analysis were insufficient data due 
to missing values and outliers. Therefore, I cleaned the data before analysis to avoid 
errors due to missing data, keystrokes errors, outliers, and coding errors in data analysis. 
Sample Characteristics 
The sample comprises of 180 Nigerian men ages 50 years and above (M = 59, 
±SD = 5.3). Demographic data were collected from all respondents regarding age, 
educational level, ethnicity, income, marital status, and screening behavior. Most were 
married (n = 131; 73%, Figure 4), were aged 50 to 55 years old (n = 105; 58%), had 
college education (n = 81; 45%, Figure 5), had no form of health insurance (n = 137; 
76%), had family history of PCA (n = 134; 74%), and had been screened for PCA in the 
past year using PSA blood test and DRE method (n = 53; 29%). Only 29% (n = 52) of the 
sample had a high school education, while 17% had a graduate degree. Most of the 
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respondents were Catholics (50%), Christian/Protestant/Methodist/Lutheran/Baptist 
(26%) and Muslims (18%). Nearly 60% of the sample reported that they were employed 
full time while 19% were unemployed. The median annual income was within the range 
of ₦50,000 and ₦74,999.  
There were some significant differences in the demographic characteristics of the 
sample. For instance, 9% (n = 16) of the sample were single, and in a relationship, 
whereas 6% (n =12) of Nigerian men reported they were divorced or separated. 
Descriptive analyses were performed to summarize the respondent’s dependent variable 
and independent variables. The independent variables are age, marital status, educational 
levels, income levels, ethnicity, fatalism, religion, family history of PCA, barriers, HBM 
constructs, and health insurance. The dependent variable is screening behavior. 
Demographic characteristics of the study population are presented in Table 5. As Table 6 
illustrates, several respondent’s characteristics were found to impact the odds of 
screening. 
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Figure 4. Histogram of marital status with mean and standard deviation. 
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Figure 5. Histogram of educational levels with mean and standard deviation.  
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Table 5 
Sociodemographic Characteristics of the Study Sample 
 
 Characteristics                                                n                                                                                                                                                                                        
                                                                                                                    
Percentages   
             
Age y (M = 59; ±SD =5.4) 
50-55 105 58.3                               
 >56 75 47.7                   
Marital status     
    Single in a relationship 16 8.9                    
    Single not in a relationship 7 3.9                     
    Married 131 72.8 
    Not married or divorced 26 14.4 
Education                              
   <High School 16 8.9                  
    High School 52 28.9 
    College degree 81 45 
   >College 31 17.2 
Ethnicity    
   Hausa 20 11.1 
   Fulani 3 1.7 
   Yoruba 19 10.6 
   Ijaw 6 3.3 
   Igbo 90 50 
Income level                                                                
   <₦15,000 23 12.8 
   Between ₦15,000 and ₦29,999 11 6.1 
   >₦29,000 146 81.1 
Religion                               
    Protestant 47 26.1 
    Catholic 90 50 
    Muslim 33 18.3 
Family history of PCA                            
    Yes 134 74 
    No 46 25.6 
Screen for PCA   
   Yes 53 29.4 
    No 127 70.6 
Health Insurance                            
   Yes 43 23 
   No 137 76.1 
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Table 6 
Logistic Regression Analysis of Selected Independent Variables to Determine Odds of 
Screening 
 
 Variables 
 
 
Type of 
variables 
 
 
Odd ratio (95% CI) 
 
 
p-value 
 
 
Married status IV 0.86 (0.49-1.52)   0.623 
Religion IV 1.06 (0.71-1.58)   0.772 
Susceptibility IV 0.64 (0.36-1.12)   0.119 
Severity IV 0.97 (0.91-1.03)   0.333 
Benefits IV 0.96 (91-1.02)   0.280 
Barriers IV 0.98 (0.90-1.06)       0.640 
Note. Dependent variable entered: Screening for PCA. IV= Independent Variable 
Data Analysis 
The survey questionnaire that was distributed online among participants is given 
in the Appendix at the end of this research paper. Questions 2–18 in the survey 
questionnaire was meant to capture the demographic variables of participants. This 
questionnaire included items related to age, educational level, income, ethnicity, 
occupation, family history of PCA, and PCA screening. Questions 19–23 were related to 
the perceived susceptibility of PCA, while Questions 24– 29 were to identify the 
perceived severity among Nigerian men for undergoing the screening process. The 
purpose of Questions 30 – 35 was to identify the perceived benefits information among 
Nigerian men, whereas Questions 36– 41 were to investigate what barriers were 
perceived by Nigerian men as impediments to PCA screening. The fear of PCA among 
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men in Nigeria was investigated through Questions 42–56. Questions 57–74 were meant 
to provide an understanding of which screening tools would prompt a Nigerian man to 
seek or not seek a PCA screening. Questions 75– 85 examined the awareness and 
knowledge of PSA screening tool among men in Nigeria. In Questions 86–93, 
participants evaluated their experiences, severity, and perception of PCA as a disease. 
Questions 94–99 focused on lifestyle changes and decision- making regarding PCA 
screening intentions and barriers. 
Likert Data Descriptive Statistics 
The responses of the participants were extracted and exported to SPSS software 
for interpretation and analysis. I ran a descriptive statistic of Likert Scale items, including 
the mean to measure the average of the score for a given variable, the standard 
deviation(±SD) to measure the typical amount the scores differ from the mean, frequency 
to measure the responses and the variance to measure how spread out the scores are 
around the mean. Sullivan and Artino (2013) stated that the Likert scale is used to 
measure the degree to which respondents agree or disagree with a statement. In this 
study, responses to items were scored using a 5-point Likert-type scale. Responses 
included strongly agree, agree, neither agree nor disagree, disagree, and strongly disagree 
and were numerically scored from 5 to 1. The sample data were then summed, coded, 
recoded, reverse coded, and tested with descriptive statistics. I used factor analysis to 
calculate an index score for the CHBMS Likert- type questions and Powe’s fatalism 
index questions.  
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Analysis: Champion’s Health Belief Model Scale 
The modified CHBMS instrument includes 23 questions on four subscales: 
susceptibility (five items), severity (six items), benefits (six items), and barriers (six 
items). The subscales were summed and measured with an ordinal scale using a 5–point 
Likert scale. Strongly agree were coded as 5, agree coded as 4, neither agree nor disagree 
coded as 3, disagree coded as 2 and strongly disagree coded as 1. The CHBM subscale 
items were subjected to factor analysis to measure the composite index. A principal 
component analysis was used to extract the factors. Any factor with an eigenvalue of 
greater- than or equal to 1 was considered significant for factor extraction and factor 
rotation. The obtained factors were rotated orthogonally using the Promax with Kaiser 
Normalization method. The arbitrary criterion that variables with a factor loading of > 
0.40 be retained was applied in this study (Straub, Boudreau, & Gefen, 2004, cited in 
Baker, 2008).  
The CHBM Composite Index calculation for one person who completed the 
survey are presented in Appendix E. The responses to each survey question are multiplied 
with the corresponding eigenvalue. The resulting values are summed and subtotaled for 
each factor. The sum of the results from each factor equates to the overall composite 
index. The use of a weighted questions formula based on eigenvalues is appropriate 
because all questions are Likert questions measured on a scale of 1 to 5. The composite 
score for perceived susceptibility, perceived severity, perceived benefits, and perceived 
barriers for respondents who checked strongly disagree (coded as 1) are 1.59, 5.37, 5.32, 
and 4.81, respectively. The composite score for respondents who checked strongly agree 
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(coded as 5), for susceptibility, severity, benefits, and barriers are 22.3, 26.8, 26.6, and 
24, respectively.  
Perceived Susceptibility 
Perceived susceptibility is defined as the perception of the harm or the chances of 
contracting a health disease or condition (Witte, 1992). In Questions 19 – 23 in the 
survey questionnaire, the risk factors that would worsen the chances of developing PCA 
were examined. Responses ranged from 1 to 5 (where 1 = strongly disagree and 5 = 
strongly agree). The 5-item subscale was summed with a mean score of 9.44, ± SD = 
7.05, with a Cronbach's alpha of .97(N = 180). The maximum possible score was 25, and 
the minimum possible score was 0 with higher scores on the subscale representing higher 
marks of susceptibility. The mean scores are presented in Table 7. The mean of this 
subscale items was used as a measure of the susceptibility level. The standard deviation 
(±SD) indicates the typical amount the scores differ from the mean. Also, the composite 
score for respondents who checked strongly agree (coded as 5), for susceptibility were 
22.3. The composite score for respondents who checked strongly disagree (coded as 1) 
for susceptibility were 1.59. The composite score table is presented in Appendix E.  
Seventy-two percent of the sample surveyed in this study believes they were 
susceptible to PCA, even though 67 % strongly believe that they are more likely than the 
average man to get PCA. For the perception of susceptibility to PCA, 68% of respondents 
(n = 123) admit that they will get cancer of the prostate in the next 10 years, 73 % (n = 
130) admit that they are extremely sure that they will develop PCA and 70 % (n = 126) 
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feel they will get the disease in the future. Model questions used to assess the level of 
susceptibility in this study are featured in Appendix A.  
Perceived Severity 
Questions 24–29 in the survey questionnaire were used to investigate which 
factors are considered by Nigerian men 50 years and older to have related to a severe case 
of PCA. Responses ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly 
agree). The 6-item subscale was summed with a mean score of 10.7, ±SD = 7.8, and a 
Cronbach's alpha of .96 (N = 179; Table 7). The maximum possible score was 30, and the 
minimum possible score was 0 with higher scores on the subscale representing higher 
marks of severity. The mean score of this subscale item was used as a measure of the 
severity level. The standard deviation (±SD) indicates the typical amount the scores differ 
from the mean. Also, the composite score for respondents who checked strongly agree 
(coded as 5), for severity were 26.8. The composite score table is presented in Appendix 
E. The composite score for respondents who checked strongly disagree (coded as 1) for 
severity were 5.37.  
       The survey showed that 75 % (n = 136) of the respondents thought of PCA as a scary 
disease, 68 % (n = 124) was afraid to even think of PCA while 72% strongly agree that 
PCA would threaten their relationship with girlfriend, wife, or partner. Nearly 70 % (n = 
126) of the respondents strongly agree that a diagnosis of PCA will change their whole 
life. Approximately 68 % responses to the perceived severity constructs strongly agree 
with the statement, “I think about PCA; my heart beat faster.”  Model questions used to 
assess severity levels in this study are featured in Appendix B.  
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Perceived Benefits 
The aim of Questions 30–35 in the survey questionnaire was to identify the 
benefits of undergoing PCA screening as perceived by Nigerian men. I seek to find 
through this study the belief that a specific benefit will reduce the threat of PCA. 
Responses ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly agree). The 
6-item subscale was summed with a mean of 10.9, ±SD = 7.69, and a Cronbach’s alpha 
of .95 (N = 179; see Table 7). The maximum possible score was 30, and the minimum 
possible score was 0 with higher scores on the index representing higher marks of the 
benefit level. The mean of this subscale item was used as a measure of the benefits of the 
screening level. The standard deviation (±SD) indicates the typical amount the scores 
differ from the mean. 
Furthermore, the composite score for respondents who checked strongly agree 
(coded as 5), for perceived benefits were 26.6. The composite score for respondents who 
checked strongly disagree (coded as 1) for benefit were 5.52. The composite score is 
featured in Appendix E.   
Approximately 62% of survey respondents said a key reason for wanting to screen 
for PCA is to find cancer early. The survey showed that 65% would feel good about 
using the PSA blood test or DRE to screen for PCA. The perception was that the benefits 
of screening outweighed any discomfort of testing and believed that prostate screening is 
an effective way to treat PCA early. Among the respondents, some of the benefits of 
seeking screening include the prevention of illness and a feeling of comfort. In summary, 
engaging in screening activities will increase the incidence rate of cancer as well as 
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reduce the morbidity and mortality rates. Model questions used to assess benefits level in 
this study are featured in Appendix C. 
Perceived Barriers 
Questions 36–41 in the survey questionnaire focused on identifying which factors 
prevented Nigerian men 50 years old and older from seeking PCA screening. Responses 
ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly agree). The 6-item 
subscale was summed with a mean score of 9.8, ±SD = 6.45, and a Cronbach’s alpha of 
.93 (N = 180; see Table 7). The maximum possible score was 30, and the minimum 
possible score was 0 with higher scores on the index representing higher marks of the 
barrier level. The mean of this 6-item subscale was used as a measure of the level of 
screening barriers based on the responses to the questions. The standard deviation (±SD) 
was used to show how the scores differ from the mean. Barriers to screening may be 
deeply entrenched in the customs, experiences, and practices of Nigerian men and the 
nexus between these barriers are noticeable among the study respondents. Being 
embarrassed, time factors and cost are the top reasons for not getting screened (Table 8). 
The composite score table is presented in Appendix E. The model questions are presented 
in Appendix D. These themes demonstrated that Nigerian men often avoid screening.  
Approximately 69.44% strongly believe that PSA blood and DRE screening tools 
will make them worry about PCA. Squeamishness about DRE is seen as a significant 
reason for not getting screened. A significant barrier to screening in this study was 
“would be embarrassed.” Asked to name the greatest concern with PSA blood test 
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screening, survey respondents cited the following: 63% said the test would be harmful; 
62% said painful, and 68% checked lack of transportation to screening sites 
Table 7 
 
CHBM Sub-scales Scores Characteristics 
 Constructs 
 
 
N 
 
 
M¹ 
 
 
Median 
 
 
Mode 
 
 
      SD 
 
 
 α 
  
 
Perceived 
Susceptibility 180 9.39 5 5 7.03 0.97 
Perceived 
Severity 179 10.71 6 6 7.88 0.96 
Perceived 
Benefits 179 10.88 6 6 7.69 0.95 
Perceived 
Barriers 180 9.87 6 6 6.45 0.93 
Note. Due to missing responses, the values may not total to 180. The score for the sub-
scale calculation based on 180 responses¹. Ratings based on 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree 
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Table 8 
 
Summary of the Reasons for not Getting a Prostate Cancer Screening Tests 
 
Reasons Test          Percentage                    n                                                   
          
  DRE/PSA       
Worried about the test   69.44% 125   
Embarrassing   75.56% 136   
Too much time   74.44% 135   
Unpleasant   75.56% 136   
Cost too much   77.78% 140   
  DRE Method       
Harmful   70.56% 127   
Painful   73.56% 132   
Embarrassing   71.11% 128   
Scary   72.22% 130   
Worthless   62.22% 112   
  PSA Blood Test       
Harmful   63.69% 114   
Painful   62.57% 112   
Embarrassing   63.13% 113   
Scary   67.04% 120   
Useless test   59.22% 106   
Hours at my job   67.78% 122   
Lack of transport   68.72% 123   
  PCA       
Worried about cancer   73.74% 132   
          
Table 7 presents information on the descriptive statistics, sub-scale scores, and the 
reliability coefficients of the HBM scales utilized in this study. The Cronbach’s alpha 
reliability coefficients ranged from α = .93 to α = .97. This result suggested that all HBM 
scales had acceptable levels of internal reliability. Cronbach’s alpha tests of reliabilities 
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were conducted for internal consistency for the HBM subscales of perceived 
susceptibility, perceived seriousness, perceived benefits, and perceived barriers.  
In summary, the barriers stated in Table 8, are some of the reasons men decline to 
screen for PCA in Nigeria. For instance, 69% of study respondents are worried about 
using PSA/DRE test, while 71% thought that DRE screening is embarrassing.  
Concerning benefits, some 68% of survey respondents strongly believe that PSA blood 
test and DRE method will help them find cancer early before they are discovered by 
nurse or doctors. This factor might be the perceived benefit men consider before 
screening for PCA in Nigeria. These data underscore the need to recognize that Nigerian 
men tend to focus on screening barriers. Model questions used to assess screening 
barriers in this study are featured in Appendix D.  
Analysis: Powe’s Fatalism Index 
Cancer fatalism was operationalized through 15 items from the PFI. The 
responses to these items were dichotomized as either “Yes” or “No.”  The PFI was coded 
as 1 “Yes,” and 0 = “No.”  Cronbach’s alpha reliability for this scale was .98, which 
shows very high internal consistency in this sample of Nigerian men. The PFI items were 
subjected to factor analysis to calculate the score. A principal component analysis was 
used to extract the factors. Any factor with an eigenvalue of greater- than or equal to 1 
was considered significant for factor extraction and factor rotation. The obtained factors 
were rotated orthogonally using the varimax procedure. The response to each survey 
question is multiplied with the corresponding eigenvalue. The resulting values are 
summed and subtotaled for each factor. Fatalism scores are obtained by adding one point 
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to “yes” response (Powe, 1995). The sum of the results from each factor equates to the 
overall composite index are presented in Table 9. The weighted fatalism score for the 
sample who checked “yes” in the survey was 13.13 out of a possible maximum score of 
15. This score indicates that Nigerian men have a high degree of fatalistic tendencies 
toward screening for PCA. 
Table 9 
 
Prostate Cancer Fatalism Index Composite Score 
 
Question 
 
 
   Rank 
 
 
 
              Score 
 
 
      N 
 
 
Q42 1  0.78 180 
Q43 1  0.83 180 
Q44 1  0.86 180 
Q45 1  0.87 180 
Q46 1  0.89 180 
Q47 1  0.91 180 
Q48 1  0.94 180 
Q49 1  0.81 180 
Q50 1  0.84 180 
Q51 1  0.74 180 
Q52 1  0.94 180 
Q53 1  0.93 180 
Q54 1  0.93 180 
Q55 1  0.94 180 
Q56 1  0.92 180 
Score =  13.13   
 
Cancer Fatalism 
Cancer fatalism is a barrier to cancer screening, detection, and treatment. Powe 
and Finnie (2003) defined cancer fatalism as a belief that a cancer diagnosis inevitably 
ends in death. This study explored cancer fatalism as a significant barrier that prevented 
Nigerian men from seeking PCA screening. Questions 42–56 in the survey questionnaire 
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were used to examine fatalism of PCA and if there is a statistically significant association 
between cancer fatalism, belief, and intention to screen for PCA.  
Nigerian men in the sample believed that if they were meant to get PCA, nothing 
could stop it, and they would rather not know about it. Seventy percent of the respondents 
believe that if someone is diagnosed with PCA, that is the way they were meant to die. 
Only 32% of the respondents disagree that PCA will not kill them despite the stage of 
diagnosis or the treatment protocol. There is a high degree of fatalism among men in the 
sample. This finding closely aligns with the results by Powe (1995) who also found a 
high degree of fatalism among African American men with colorectal cancer. Model 
questions used to measure fatalism is featured in Appendix F.  
Analysis: Baker’s Cancer Screening Intention Scale-Prostate 
Questions 57– 85 in the survey questionnaire and presented in Appendix H were 
used to examine the intent to be screened for PCA among Nigerian men 50 years and 
older. The CSIS-P (Baker, 2008) was used to measure intent to be screened. Some 
negative questions in this scale were reverse coded to reflect that higher score indicates 
strongly agree with the intention to screen. The M, SD, and the mode are presented in 
Table 10.   The M represents the average of the scores for a given variable. Intent to 
screen for PCA using DRE scored a mean of 1.9 (±SD = 1.51). “I have already scheduled 
an appointment to get a DRE this year,” had a mean score of 3.42(±SD = 1.80, n = 58, 
32%). The lowest mean score came from, “I believe that it is completely up to me 
whether I have a DRE and the blood test for PCA,” with a score of 1.57 (±SD = 1.2, n 
=137, 76%).  
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 One hundred -twenty-two of the 180 respondents in the survey strongly 
expressed their intent to be screened for PCA using DRE tool. Among men in the 50–55 
years old group, approximately 17% intend to be screened using DRE compared with 
13% of men in the 56–66 years old. The significance of these results is that they provide 
evidence to argue that younger men are those most likely to screen for PCA using the 
DRE method. Model questions used to assess screening intention in this study are 
presented in Appendix H. 
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Table 10 
Descriptive Statistics to the DRE Intention CSIS-P Questions 
 
Question 
 
 
N 
 
 
M¹ 
 
 
Median 
 
 
Mode 
 
 
        SD 
 
 
Q57 180 1.91 1   1 1.51 
Q58 180 3.42 4   5 1.80 
Q59 179 1.71 1   1 1.35 
Q60 179 1.64 1   1 1.26 
Q61 180 1.60 1   1 1.23 
Q62 180 1.72 1   1 1.34 
Q63 180 1.70 1   1 1.27 
Q64 180 1.61 1   1 1.16 
Q65 180 1.67 1   1 1.24 
Q66 180 1.70 1   1 1.30 
Q67 179 1.63 1   1 1.24 
Q68 180 1.76 1   1 1.32 
Q69 179 1.78 1   1 1.33 
Q70 180 1.57 1   1 1.22 
Q71 180 2.17 1   1 1.56 
Q72 180 2.03 1   1 1.49 
Q73 180 2.17 1   1 1.56 
Q74 180 2.32 1  1       1.65 
Note. Due to missing responses, the values may not total to 180. The score for the sub-
scale calculation based on 180 responses ¹. Ratings based on a 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree. 
In terms of screening tools, most of the respondents (70.95%; n = 127) are not 
aware of the PCA screening test, and only 10% reported some knowledge of screening 
tools. Although the intent to be screened is on balance positive, they vary considerably 
among the respondents. Majority of the sample (67%) reported their intent to get a DRE, 
and 81.01% reported intent to get a PSA blood test. More than half of the respondents 
(59%; n =106) reported that PCA screening is useless, 5.59% (n =10) were not sure while 
(18.99%; n = 34) strongly disagree. The highest mean score was from, “I have already 
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scheduled an appointment to get the blood test for PCA this year,” (M = 2.68, ±SD = 1.8, 
n = 93, 52%). In the study, a large SD indicates that the scores differ substantially from 
the mean. Remarkably, the lowest mean score came from, “I intent on getting the blood 
test for PCA this year” (M =1.45, ±SD = 1.06, n = 145, 81%). In this study, a small SD 
indicates that the scores do not differ that much from the mean. Descriptive statistics and 
the mean score for PSA blood test intention are summarized in Table 11. 
In summary, it is remarkable to note that about half of the respondents did not 
schedule for DRE screening appointment. My findings suggest that fewer than a third of 
Nigerian men have confidence in PSA test, but DRE perception remains low. This is 
likely because Nigerian men exhibit strong intention to screen for PCA but demonstrated 
low interest in going through with their intention. Model questions used to assess PSA 
screening intention in this study are presented in Appendix I.  
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Table 11 
 
Descriptive Statistic to the PSA Intention CSIS-P Questions 
Question 
 
 
   N 
 
 
  M¹ 
 
 
Median 
 
 
Mode 
 
 
          SD 
 
 
Q75 180 1.45 1 1 1.06 
Q76 179 2.67 1 1 1.83 
Q77 180 1.53 1 1 1.17 
Q78 180 2.13 1 1 1.62 
Q79 180 2.08 1 1 1.57 
Q80 180 2.09 1 1 1.58 
Q81 180 1.95 1 1 1.53 
Q82 179 1.96 1 1 1.46 
Q83 180 2.25 1 1 1.65 
Q84 180 2.13 1 1 1.61 
Q85 180 2.26 1 1 1.65 
Note. Due to missing responses, the values may not total to 180. The score for the sub-
scale calculation based on 180 responses¹. Ratings based on a 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree. 
 
Prostate Cancer Belief 
Questions 86–93 gauged the knowledge of respondents concerning PCA. 
Responses ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly agree). A 
sizeable proportion of men who took the survey strongly agree that PCA is a severe 
disease (86%, M = 1.30; ±SD = .87). My study also identified factors for the low rate of 
screening, and therefore suggest a target for prevention, education, and motivation. 
Seventy-three percent of the respondents say that they worry about getting PCA while 
62% strongly agree that they are nothing they can do to prevent getting the disease. In the 
present study, mean scores for the PCA belief subscale ranged from 1.30–2.11. The mean 
(M) represents the average of the scores for a given variable. Table 12 presents 
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information on the descriptive statistics, including the mean score study questions. Model 
questions used to assess belief are presented in Appendix J. 
Table 12 
Descriptive Statistics to the Prostate Cancer Belief Questions 
Question 
 
 
  N 
 
 
M¹ 
 
 
Median 
 
 
Mode 
 
 
     SD 
 
 
Q86 180 1.30 1 1 0.87 
Q87 179 1.73 1 1 1.30 
Q88 179 1.69 1 1 1.33 
Q89 180 1.77 1 1 1.34 
Q90 180 1.91 1 1 1.44 
Q91 180 1.87 1 1 1.44 
Q92 180 2.08 1 1 1.58 
Q93 180 2.10 1 1 1.62 
Note. Due to missing responses, the values may not total to 180. The score for the 
subscale calculation based on 180 responses¹. Ratings based on a 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree. 
Lifestyles Changes 
Questions 94–98 focused on changes in lifestyle as a source of primary prevention 
of PCA. Responses ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly 
agree). The survey showed that 43% (n =78) of respondents ate well-balanced meals 
daily. Approximately 33 % (n = 59) of respondents reported getting yearly physical 
checkups while only 31.11 % (n = 56) of the respondents reported getting enough 
exercise at least three times a week. The mean is the best measure of central tendency. 
The mean (M) represents the average of the scores for a given variable. In the present 
study, mean scores for the healthy lifestyle subscale ranged from 2.61–3.40. The lowest 
mean score from this subscale came from responses to the statement “I eat well-balanced 
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meals daily” (M = 2.61; ±SD = 1.68, Q: 94). A small SD indicates that the scores do not 
characteristically vary that much from the mean. Table 13 presents information on the 
descriptive statistics and the reliability coefficients of the subscales utilized in this study. 
Means and SD for variables are presented in Table I4. The questions used to measure 
lifestyle changes are presented in Appendix K. 
Table 13 
Summary of Means, SD, and Cronbach’s Alpha of CSIS-P Study Instruments Sub-Scale 
Subscale 
 
 
M¹ 
 
 
 
SD 
 
 
# of  
Item     N 
 
 
Cronbach’s  
 alpha 
 
 
 
DRE Intent  35.9 14.8 18         177      0.91 
 
PSA Intent 23.9 10.3 11         178      0.92 
 
Healthy Life 18.9 8.4 6           178      0.90 
 
PCA Belief  14.3 9.2 6            177      0.93 
         
Note. Due to missing responses, the values may not total to 180. The score for the overall 
scale calculation based on 180 responses¹. Ratings based on a 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree. 
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Table 14 
Descriptive Statistics to the Healthy Lifestyles Changes Subscale 
 
Question 
 
 
N 
 
 
M¹ 
 
 
Median 
 
 
Mode 
 
 
         SD 
 
 
Q94 179 2.61 2 1 1.68 
Q95 180 3.00 3 1 1.66 
Q96 180 3.14 3.5 5 1.69 
Q97 180 3.40 4 5 1.68 
Q98 178 3.32 4 5 1.65 
Q99 180 3.31 4 5 1.78 
Note: Due to missing responses, the values may not total to 180. The score for the 
subscale calculation based on 180 response¹. Ratings based on a 5-point Likert scale: 1 = 
strongly disagree to 5 = strongly agree. 
Decision-Making 
Question 99 asked respondents to rate the confidence level talking to their 
healthcare provider concerning the benefits and risks of PCA screening. Responses 
ranged from 1 to 5 (where 1 = strongly disagree and 5 = strongly agree). Based on this 
decision-making question, nearly 31% (n = 55) strongly agree to the question, 8.89% 
agree while 47.22% strongly disagree. Overall, men are not confident discussing 
screening for PCA with their health care provider (47%, n = 85). This lower level of 
satisfaction may be attributable to the uncertainty and debate associated with the use of 
PSA test and DRE as a diagnostics tool. This one item subscale was summed with mean 
of (M = 3.32; ±SD = 1.78; N =180). The mean of this one item was used as a measure of 
the confidence level. Model questions used to assess decision-making in this study are 
presented in Appendix K.  
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Family History of Prostate Cancer 
The demographic questionnaire measured the family history of PCA among the 
respondents. Family history was coded as 1 for “Yes” and, 2 for “No.”  Along with age, 
and race, family history of PCA is a risk factor for the disease. Family history of PCA 
was moderately associated with screening behaviors. Majority of the respondents stated 
that they have a family history of PCA (74 %, n = 134). Approximately 26% (n = 46) 
reported that they have no family history of PCA. The results are presented in Table 15.  
Table 15 
Screening Behaviors and Family History of Prostate Cancer Crosstabulation 
 
Family History of PCA 
Total Yes No 
Screening Behaviors Yes Count 48 5 53 
% within Family 
History of PCA 
35.8% 10.9% 29.4% 
No Count 86 41 127 
% within Family 
History of PCA 
64.2% 89.1% 70.6% 
Total Count 134 46 180 
% within Family 
History of PCA 
100.0% 100.0% 100.0% 
Age (of the Respondents) and Screening Behavior 
The age factor is one of the risk factors of PCA. The screening behaviors were 
higher in younger men and those with a family history of PCA. Crosstabulation table 
shows that approximately 72 (56.7%) of those surveyed (i.e., 50–55 years old) did not 
screen for PCA in the past 12 months using a combination of PSA blood test and DRE 
method. Approximately 62% of men in the same age group screened for PCA according 
to data reported by respondents. Overall, screening is low among respondents aged 78–88 
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years old (n = 2; 1.6%; Table 16) This result suggests that men who engage with 
preventive behavior such as screening for PCA in early years are less likely to stay 
committed to those behaviors in their adult years. The table indicates that the probability 
of men in the 50 to 55 age groups not screening for PCA is 0.68, while the probability of 
men in the 67 to 77 age groups is 0.8. The probability of men turning out to be screened 
for PCA in Nigeria is 0.31 for men in the 50 to 55 age groups and 0.2 for men in the 67 to 
77 age groups. 
Table 16 
Age Group and Screening Behaviors Crosstabulation 
 
Age group                                                                      Screening behaviors 
 
 
 
Total (%) Yes (%) No (%) 
Age groups 50–55 100.0% 33(62.3%) 72(56.7%) 105(58.3%) 
56–66 100.0% 16(30.2%) 41(32.3%)  57(31.7%) 
67–77 100.0% 3 (5.7%) 12(9.4%) 15(8.3%) 
78–88 100.0% 1(1.9%)    2(1.6%) 3(1.7%) 
     
Health Insurance and Screening Behavior 
Although a lack of health insurance was associated with screening behaviors, the 
association between being uninsured and low screening was considerably more 
pronounced for men in the 50 – 55 years old range. In this study, 56.7% of respondents 
reported a lack of screening in the past 12 months. Overall, access to health insurance 
was remarkably low, at 76.11% (n = 137; see Table 17). Among the respondents, about 
70% (n = 127) did not screen for PCA in the past 12 months. Overall screening for PCA 
was low at 29% (n = 53). This result shows that access to health insurance plays a major 
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part in PCA screening attendance. Based on the data collected, the health insurance 
barrier is a significant factor in screening in Nigeria.  
Table 17 
Screening Behaviors and Health Insurance Crosstabulation 
 
 
Health Insurance 
Total Yes No 
Screening behaviors Yes Count 26 27 53 
% within health 
insurance 
60.5% 19.7% 29.4% 
No Count 17 110 127 
% within health 
insurance 
39.5% 80.3% 70.6% 
Total Count 43 137 180 
% within health 
insurance 
100.0% 100.0% 100.0% 
Screening Behavior and Intention 
Respondents were asked to indicate whether they were previously screened for 
PCA using the PSA blood test or DRE method, and the number of months since their last 
screen. Based on their responses, each participant was assigned a dichotomous 
measurement score of 1 = screened in the last 12 months or 0 = not screened in the past 
12 months. For this study, participating in PCA screening was defined as the respondent 
having a PSA blood test and DRE examination in the past 12 months. Among the 
respondents,70.56% (n = 127) did not screen for PCA in the past 12 months. Among 
younger men, intent to screen for PCA were moderately high. 
 However, 56% of younger men in the sample did not screen for the disease in the 
past 12 months. Majority of the sample (67%) reported their intent to get a DRE, and 
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81.01% reported intent to get a PSA blood test. However, most of the men in the sample 
reported low morale toward scheduling an appointment for the screening test. The DRE 
appointment variable had a mean score of 3.42 (±SD = 1.80, n = 58, 32%). The PSA 
blood test appointment variable scored a mean of (M = 2.68, ± SD = 1.8, n = 93, 52%). 
Covariates 
Three covariates were considered and adjusted for in this study: a family history 
of PCA, occupation, and health insurance. In the study, about 76% of the respondents 
reported no health insurance. Access to health insurance was reported as a significant 
predictor to screening. Also, family history was considered as a variable to adjust for 
because authors found that history of PCA has a direct impact on the decision to screen or 
not to be screened for PCA. Family history is also a known risk factor for developing 
cancer of the prostate, especially if he has first degree relatives with the disease. The 
inclusion of occupation as a covariate was justified because some workplace culture or 
occupation are known to influence screening time. In this study, participants cited cost, 
lack of transportation to screening venues, and work hours as barriers to screening.  
Statistical Analyses 
Logistic Regression 
Logistic regression analyses tested the relationships between the outcome and 
exposure. Co-primary outcomes comprised screening behaviors and intention. In this 
study, logistic regression was used to describe and test hypotheses about the association 
between a categorical outcome variable and one or more categorical or continuous 
predictor variables while controlling for covariates. In the study, logistic regression was 
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used to show the extent that such covariates predicated the odds of screening for PCA. 
The assumption for using logistic regression in this study was based on the dichotomous 
dependent variable and one or more independent (ordinal) variables. The results of 
logistic regression were presented as ORs. The OR is a measure that shows how strong 
the association is.  
The Exp(B) is the OR associated with each predictor in the logistic regression 
model. I expect predictors which increase the logit to display OR greater than 1.0; an OR 
of 1.0 does not influence the logit, and predictors which decrease the logit in the study 
will have OR values less than 1.0. I am also interested in knowing the behaviors of the 
odd crude ratio (COR) and the adjusted odds ratio (AOR). Significance levels were set at 
p < 0.05, and the CI was set as a 95% CI with lower and upper limits reported for each 
predictor. A narrow CI signifies more precise population estimates. The significance 
must fall below p = 0.05 to reject the null hypothesis; the smaller the p-value, the stronger 
the evidence to reject H0. 
Somer’s d Analysis 
Nonparametric Somer’s delta analysis was used to test the first research question. 
In this study, Somer’s d was used as a measure of association for ordinal variables with 
values -1 ≤ d ≤ 1. Values close to an absolute value of 1 indicate a strong relationship 
between the two variables. Also, values close to 0 specify little or no association (Göktaş 
& İşçi, 2011).  The assumption for using Somer’s d is based on the ordinal dependent and 
independent variables. Somers’ d plays a central role in rank statistics and are asymmetric 
in X and Y (Newson, 2014). Significance levels were set at p ≤ 0.05. 
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Gamma  Analysis 
To determine how significant Somer's results were, Gamma   was used to test the 
first research question. Gamma is a nonparametric measure of the strength and direction 
of association that exists between two variables measured on an ordinal scale at a = 0.05 
(Adeyemi, 1998). I am interested in knowing the strength and direction of the association 
between PSA/DRE intention and HBM constructs measured on an ordinal scale. Gamma 
 is an ordinal measure of association between two variables (Adeyemi, 2010). It 
measures the degree of agreement or association between two ordinal-level data.  
The assumption for using gamma  in this study is that variables are in the ordinal 
level of measurement. Adeyemi (2010) stated that gamma   is a flexible measure of 
association when compared to other measures. Also, gamma can fit tables of any size, as 
well as shows both positive and negative associations between variables, making it a 
useful statistic. The value of gamma ranges from -1 ≤  ≤ 1 (Göktaş & İşçi, 2011). If 
there is no association between the two-ordinal categorical variables, the estimator of 
gamma should be close to zero. Values of p ≤ 0.05 were considered significant. 
Results 
Between December 11, 2018, and January 18, 2019, 180 eligible men in Nigeria 
were offered participation and consented to demographic and survey details and assess to 
SurveyMonkey web domain. Respondents characteristics are presented in Table 1. Of the 
196 men who responded to the social media advertisement, 16 were not eligible for the 
current study due to missing or skipped questions (see Figure 3). Consequently, data from 
180 men were included. Mean age (±SD) of respondents in the current study was 59 (5.3) 
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years. Analyses of the data showed that approximately 70% of the respondents did not 
screen for PCA in the past 12 months. A numerically greater proportion of men who took 
the survey strongly agree that PCA is a severe disease. Respondents with a family history 
of PCA were 3.9 times more likely to screen (OR = 3.9; p = 010) and were 1.6 times 
more likely to report significant barriers (OR = 1.6; p =.000). The results indicate that 
men with health insurance were six times more likely to screen for PCA (OR = 6.2, p = 
0.000)  than those without health insurance and those who discuss the benefits and risks 
of screening with a  healthcare professional were less likely to test for PCA (OR = 1.09,  
p = 323). 
Analysis of Research Question 1 
The questions regarding HBM constructs and PSA/DRE intention are rated on a 
5-point Likert scale ranging from 1 to 5 with 1 being strongly disagree and 5 strongly 
agree. Somer’s d was run to determine the association between HBM (i.e., perceived 
barriers, perceived benefits, perceived severity, and perceived susceptibility) and 
DRE/PSA intention amongst 180 participants 50 years and older. Based on the data, there 
was a moderate, positive association between HBM constructs and DRE/PSA screening 
intentions, which were statistically significant (p < 0.05). The results are presented in 
Table 18. For example, perceived severity focuses on how serious Nigerian men believe 
PCA to be with 24.3 % reduction in error when predicting PSA intention and 35% when 
predicting DRE intention to screen using estimated probabilities over chance alone. 
However, there is a 29% reduction in error when predicting the use of both DRE and 
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PSA blood test to screen for PCA. Perceived benefits relate to taking preventive health 
action minus the perceived barriers of taking such preventive actions.  
 For the present model, Somers’ D is .319, indicating a 31.9% reduction in errors 
when predicting benefit outcome using estimated probabilities (see Table 18). The 
measure of association between perceived susceptibility and perceived barriers based on 
screening tools (i.e., PSA, DRE, and PSA/DRE test) was examined and found to be 
significantly associated. Based on the data, there is a 44.7%, 41% and 38.4% reduction in 
error-based on PSA, DRE, and PSA/DRE screening test. Concerning perceived barriers, 
Somer’s d analysis indicates a 39 %, 28.2% and 28.1% reduction in screening error based 
on PSA, DRE, and DRE/PSA screening tests. The association between the variables are 
statistically significant.  
 However, to determine how significant these results were, the same data was 
evaluated using gamma analysis. Gamma was computed to determine the association 
between PSA/DRE screening intention and HBM constructs. The output indicates a 
strong, positive association between PSA/DRE screening intention and HBM constructs 
(p = .000). This shows that the error in the predictability of PSA/DRE testing and the 
perceived barrier has been reduced by 380. Thus, there was a 38% agreement or 
association between the two variables. Also, approximately 67% of men in the study 
intend to get a DRE, while 63% lacked the courage to schedule an appointment to get a 
DRE test. Comparatively, about 81% of the respondents reported high intention to get a 
PSA blood test, while 43% lacked the will to schedule an appointment for a PSA blood 
test (see Appendices A-D). These results indicate that men who identified with PSA/DRE 
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screening as a barrier are also associated with HBM constructs. Therefore, the association 
between the variables are statistically significant. Because p < 0.05, I reject the null 
hypothesis. The results are featured in Tables 18 and 19.  
Table 18 
RQ1: Somers’ d Test Results for the Association between the Four Health Belief Model 
Constructs and Intention to Screen for Prostate Cancer 
 
Intention to have 
PSA 
Intention to have 
 DRE 
Intention to have 
PSA/ DRE 
 Value 
 
Sig. 
 
Value 
 
Sig. 
 
Value 
 
Sig. 
 
Perceived severity 0.243 0.010* 0.350 0.000* 0.291 0.000* 
Perceived benefits  0.319 0.001* 0.225 0.000* 0.237 0.002* 
Perceived susceptibility 0.447 0.000* 0.415 0.000* 0.384 0.000* 
Perceived barriers 0.390 0.000* 0.282 0.000* 0.281 0.000* 
* p is significant at the 0.05 level 
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Table 19 
RQ1: Gamma  Test Results for the Association between the Four Health Belief Model 
Constructs and Intention to Screen for Prostate Cancer 
 
Intention to have 
PSA 
Intention to have 
 DRE 
Intention to have 
PSA/ DRE 
 Value Sig Value Sig Value Sig 
Perceived severity 0.314 0.008* 0.456 0.000* 0.395 0.000* 
Perceived benefits  0.384 0.001* 0.301 0.000* 0.318 0.000* 
Perceived susceptibility 0.544 0.000* 0.546 0.000* 0.523 0.000* 
Perceived barriers 0.471 0.000* 0.377 0.000* 0.380 0.000* 
* p is significant at the 0.05 level 
Analysis of Research Question 2 
A logistic regression analysis was conducted to determine which independent 
variables (i.e., age, education, income, and ethnicity) were predictors of PCA screening 
behaviors. The dependent variable was binary and measured on a dichotomous scale. 
Logistic regression was used to test the hypotheses at 0.05 levels of significance and 
ninety- five percent confidence interval (95% CI). The OR estimates are the most 
descriptive regarding explaining the association between screening for PCA and the 
predictors. The OR estimates explain “odds” of men screening for cancer of the prostate. 
 In this study, a value of one for the OR means that there is no change in odds as 
the predictor increased. An OR value of less than one means that for any given predictor 
the odds of Nigerian men participating in screening decreased. An OR value of more than 
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one means that for every unit increase of a given predictor the odds of men participating 
in screening events increased. In addition to the OR, a 95% confidence interval for each 
of the OR was calculated. If the confidence interval included the value of one, it means 
the OR was not statistically significant. Therefore, OR with 95% confidence interval (CI) 
was used to assess the contribution of individual predictors. This research question used 
N = 180 samples to determine which predictor are most influential in determining 
screening behavior. To test the null hypothesis that the data fit the specified model, the 
Hosmer and Lemeshow Goodness-of-Fit test was conducted, and the null hypothesis was 
retained. The model was a good fit (Hosmer and Lemeshow, p =.144). 
There were no statistically significant association between Age (COR = 
0.834.,95% CI = [0.49-1.40], p = 0.493); Ethnicity (COR = 0.920, 95% CI = [0.80-
1.05],p = 0.246) and Education (C0R = 0.653, 95% CI = [0.41-1.039], p = .072) among 
men in the sample. There is a 95% probability that the .49 to 1.40, .80 to 1.05 and .41 to 
1.03 CI contains the populations true mean. A narrow CI in this study enables more 
precise population estimates.  
Regression analysis shows a positive association with income levels (COR = 
0.771, 95% CI = [0.61-0.961], p = 020). As the predictor increases, the odd of PCA 
screening occurring among men in Nigeria decreases. As income increases, the odd that 
Nigerian men will screen for PCA increases. Although income significantly increased the 
odds of screening, age, education, and ethnicity remains an insignificant predictor of 
screening behavior. When occupation was added as a covariate, income remains 
significant at (AOR = 0.782, 95% CI = [0.62-0.984], p = 0.36). Age was insignificant (p 
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= 0.883) after adding occupation as covariate. Taking the exponent of the log odds, 
indicated in the output as AOR gives the OR, which shows that a 1-year increase in age 
increased the odds of screening using DRE/PSA test by .94 times after adjusting for 
occupation. For income predictor, the null is rejected in favor of the alternative (p < 
0.05). The results are presented in Table 20.  
The classification table presents the degree to which predicted probabilities agree 
with actual outcomes. The correct overall prediction, 71.1%, shows an improvement over 
the chance level, which is 50%. With the classification table, sensitivity and specificity 
were measured. Sensitivity measures the proportion of correctly classified participation in 
PCA screening, whereas specificity measures the proportion of correctly classified, not 
screening for PCA. Results illustrate a specificity value of 1.04, which corresponds to a 
probability of 0.5. This means that 10% of men in the sample predicted the probability of 
screening. Also, the model produced a sensitivity value of 8.83. This value means that 
88% of men in the sample who had probabilities less than 50% for screening did not 
actually screen for PCA. 
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Table 20 
RQ2: Logistic Regression Analysis Results to Determine Odds of Screening for Prostate 
Cancer 
    
   95% C.I. for COR 
 
   
    95% C.I. for AOR 
 
 
 
Predictor 
 
 
COR 
 
 
           
Lower 
  
Upper 
 
 
  p-
value 
 
 
AOR 
 
 
             
Lower 
 
 
Upper 
 
 
P- 
value 
 
 
                  
Age 0.834 0.497 1.401  0.493 0.943 
              
0.545 1.629 0.883 
 
Ethnicity 0.920 
          
0.800 1.059  0.246 0.928 
              
0.803 1.072 0.309 
 
Income 0.771 0.619 0.961 
 
0.020* 0.782 
              
0.622 0.984 
 
0.36* 
Education 0.653 0.411 1.039 0.072 0.767 
              
0.466 1.264 
 
0.298 
Note. HLT= .144; Cox & Snell R Square= .161, Nagelkerke R Square =.161; *p is 
significant at the 0.05 level; COR = Crude Odds Ratio; AOR = Adjusted Odd Ratio; CI = 
Confidence Interval; Variable adjusted in the model: Occupation 
Analysis of Research Question 3 
I ran a logistic regression to test RQ3. The dependent variable was dichotomous 
(i.e., screening for PCA in the past 12 months: yes/no). The predictor's variables are 
ordinal in nature (i.e., PSA barriers and DRE barriers, using a 5-point Likert scale). The 
results indicate that DRE barrier (COR = .1.043; 95% CI = [0.98 -1.103]; p = 0.136) were 
insignificant. Also, PSA barriers (COR = 0.995; 95% CI = [0.94-1.049], p = 0.859) were 
insignificant. Access to health insurance and a family history of PCA was added as a 
covariate. However, after adding and adjusting for the  covariates, the association remain 
statistically insignificant for DRE barriers (AOR = 1.018; 95% CI = [.096 -1.077], p = 
121 
 
0.524). PSA test barriers remain insignificantly associated with screening after 
controlling for covariates (AOR =1.002; 95% CI = [0.94 -1.057], p = 0.956; Table 23). 
The model was a good fit (Hosmer and Lemeshow, p = .284). Similarly, the OR for these 
independent variables indicates that they are not statistically significantly likely to change 
the likelihood of predicting screening for PCA.  
The odds for screening among men in the sample are 1.04 and 0.99 times less 
likely to receive PCA screening based on DRE/PSA barriers. Also, DRE and PSA 
barriers had higher ORs after adjusting for covariates. This means that holding all other 
variables constant, the odds of men in the sample not screening for PCA were 1.0 times 
less likely to screen than others who did not choose DRE/PSA barriers as a significant 
obstacle to screening. The results are presented in Table 21.  
The model had a low level of sensitivity where 21.6 % of men who had 
probabilities of greater than 0.50 of PCA screening participated in one. However, the 
model had low specificity since only 11% of Nigerian men who had predicted 
probabilities of less than 0.50 of PCA screening did not participate in any screening 
based on DRE/PSA barriers preference. The low specificity and sensitivity of the model 
could be an area for further study. These results indicate that attention must be given to 
these barriers to increase screening behaviors among men in Nigeria. Based on the data 
presented, there is an insignificant association between DRE and PSA blood test barriers 
and screening for PCA even after adjusting for covariates. Because the p value is greater 
than 0.05, I do not reject the null hypothesis. 
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Table 21 
RQ3:  Logistic Regression Analysis Results to Determine Odds of Screening for Prostate 
Cancer 
    95% CI for COR     95% CI for AOR   
                  
  
COR 
 
         
Low 
 
Upper 
 
p 
value 
 
              
AOR 
 
           
Low 
 
Upper 
 
p 
value 
 
PSA 
Barriers 0.995 0.944 1.049 0.859* 0.998 0.946 1.054 0.956* 
DRE 
Barriers 1.043 0.987 1.103 0.136* 0.982 0.928 1.039 0.524* 
*p is insignificant at the 0.05 level; COR = Crude Odd Ratio; AOR = Adjusted Odds 
Ratio; CI = Confidence Interval; Cox and Snell R2 = .169; Nagelkerke R2 = .023; HLT = 
.054; Variables adjusted in the model: Family History of PCA and Health Insurance 
Analysis of Research Question 4 
I ran a logistic regression analysis to ascertain the effects of cancer fatalism on the 
likelihood that participants will screen for PCA. Regression analysis was used to test the 
hypotheses at 0.05 levels of significance and 95% CI. The model was a good fit (Hosmer 
and Lemeshow, p = .775). The odds for those who would not participate in PCA 
screening were COR = 0.90 (for cancer fatalism) and COR =1.03 (for PCA belief). The 
results are presented in Table 22.  As the predictor increases, the odd of PCA screening 
occurring decreases. Based on the data collected and presented in the tables, the finding 
for this research question confirmed that there was a negative association between PCA 
belief and screening intention and significant association between cancer fatalism and 
intention to screen for PCA using PSA blood test and DRE method among Nigerian men 
50 years old and older. After adding and controlling for family history of PCA to the 
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model, PCA belief remain insignificant (AOR =1.034, 95% CI = [0.99-1.078], p = 127) 
and significant for fatalism (AOR = .901, 95% CI [0.84-0.960], p =.001). 
In summary, an OR of .90 signifies that those who develop cancer fatalism have 
an odd that is .90 times less likely to screen for PCA after adjusting for the confounding 
effects of family history of PCA. Fatalism is associated with lower odds of screening for 
PCA. Also, men have an odd that is 1.03 times more likely to screen for PCA based on 
PCA belief after adjusting for the confounding effects of family history of PCA. The CI 
for PCA belief OR included “1,” which means that it was not statistically significant. 
Therefore, I accept the null hypothesis. For cancer fatalism, the p value is less than 0.05. 
Therefore, I reject the null hypothesis. 
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Table 22 
RQ4. Logistic Regression Analysis Results to Determine Odds of Screening for Prostate 
Cancer 
    
 
95% C.I. for COR 
 
   
95% C.I. for AOR 
 
 
Predictor 
 
 
COR 
 
 
           
Lower 
  
 
Upper 
 
 
 p 
value 
 
 
AOR 
 
 
      
Lower 
 
 
Upper 
 
 
   p 
value 
 
 
                  
Fatalism 0.916 0.863 0.972 0.004* 0.901 0.846 0.96 0.001* 
 
PCA 
belief 1.038 0.994 1.038 0.088 1.034 0.991 1.078  0.127 
Note. COR = Crude Odds Ratio; AOR = Adjusted Odd Ratio; CI = Confidence Interval; 
Cox and Snell R2 = .131; Nagelkerke R2 = .186; HLT = .775; *p is significant at the 0.05 
level; Variable adjusted in the model: Family History of PCA. 
Summary 
This study determined the issues Nigerian men considered when making the 
decision to be screened or not to be screened for PCA. Chapter 4 identified the factors 
associated with the intention to be screened for PCA. My study underscores the 
importance of barriers, especially among men 50 years and older. The data analysis for 
this research was generated using SPSS 24. In Chapter 5 of this study, an overview of the 
importance of this study and its contribution to the understanding of the topic was 
provided. Specific findings, limitations, and recommendations based on the data analyses 
were covered. Additionally, theoretical and future implications, including positive social 
change and recommendations for future research, will conclude the study. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
PCA represents a significant source of morbidity and mortality for men. In 
Nigeria, PCA claimed the lives of 26 men every day (see Figure 1). Despite the high 
mortality rate of PCA, Nigerian men are less likely to undergo screening for PCA. 
Therefore, the purpose of this study was to quantitively identify cultural factors 
associated with intention to screen for PCA as well as examine the perception of benefits 
and barriers among Nigerian men 50 years and older. I conducted this cross-sectional, 
quantitative study to establish factors men consider when making decisions whether to be 
screened for PCA using the PSA blood test and DRE method.  
 I used a 5-point Likert scale to assess the HBM constructs, screening intentions, 
and beliefs of the participants. The HBM was developed to explain and predict health 
behaviors and was considered appropriate for this study. The results of my study are in 
line with the HBM, in that perceived barriers, perceived severity, perceived benefits, and 
perceived susceptibility was significantly associated with low screening turnouts. The 
findings of this study contribute to the body of literature exploring the barriers and 
perceptions that Nigerian men have concerning PCA screening in addition to factors that 
could prevent men from participating in screening events. The results of this study have 
elucidated the factors affecting the low rate of screening among men in Nigeria. 
Interpretation of the Findings 
In this study, I identified the predictors of screening in men aged 50 years old and 
above. Of the 180 respondents in the study, the percentage age distribution was as 
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follows:50 –55 (59.12%), 56–66 (30.94%), 67–77 (8.29%), 78–88 (1.66%), and 89+ 
(0.00 %). One of the key findings was that only 29% of men reported ever screening for 
PCA in Nigeria. Prior studies have reported that screening was uncommon (Oladimeji et 
al., 2010; Were, Nyaberi, & Buziba, 2011). The lower screening rate among the 
participants was not surprising and may not represent a chance finding. The notion that 
men should be responsible for the cost of PCA screening may be one explanation. 
Another possible explanation is cultural barriers. Ambivalence toward the benefits of 
screening among the respondents may have also contributed to the lower screening rate, 
but this issue may be resolved because new data emerged that support the benefits of 
screening. Another reason for the lower screening rates is the distrust between healthcare 
providers and men in Nigeria. Most of the respondents (i.e., 42%) reported less 
confidence discussing the benefits and risks of screening with their healthcare provider, 
driven in large part by medical distrust. A greater proportion of respondents (67%, n 
=122) also reported that their work schedule would prevent them from screening. If 
confirmed in other studies, these barriers should be considered when developing 
screening programs.  
Evaluation of the distribution of demographic characteristics confirmed that most 
of the participants were married men (72%), had a college degree (45%), and had middle-
ranged annual incomes. Sixty-one percent of the respondents strongly relied on the 
influence of friends and family concerning screening, while 20% responded negatively to 
the statement: “Doing what my family and friends think I should do is very important to 
me.”  
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A large majority of the participants (49.73 %) were of Igbo ethnic extraction, 
followed by Edo (12.57%) and Hausa (11.58%) ethnic groups. A large percentage of the 
respondents (74%) reported having a family history of PCA, making my sample, 
particularly high risk. It is likely that these men who self-reported having a family history 
of PCA would benefit from screening. The high rate of family history of PCA reported by 
men in my sample probably explains the high degree of fatalism and fear toward PCA. 
As a result, nearly 83% of the respondents strongly agreed that PCA is a serious disease, 
making the findings of this study unique with respect to published studies. Whether men 
who reported a family history of PCA will have a low rate of PCA screening is an area of 
future research.  
The results of this study recognized significant predictors of screening among 
men in the sample. For example, I recognized cancer fatalism as an essential barrier of 
cancer screening among men in the sample. This barrier has implications beyond 
affecting the late presentation of the disease; most importantly, cancer fatalism tends to 
affect cancer-related morbidity and mortality. In this study, cancer fatalism had a score of 
13.3 out of a possible 15. These scores were compared to the findings from Powe (1995), 
which were comparable at a 10.9 fatalism score. This score suggests that these men were 
no more worried and fearful than the average man. This finding may explain findings in 
previous studies that interventions are needed to address fatalism to increase public 
interest in cancer screening (Kobayashi & Smith, 2016; Powe, 1995). 
Only 23% of men in my sample reported having health insurance, while 63% 
viewed the PSA test as a harmful procedure. Seventy percent were not aware of screening 
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tools, and about 72% of the participants felt that they were at risk of getting PCA. The 
results of this study indicate novel data showing that men with health insurance (OR = 
6.2, p = 0.00) were six times more likely to screen for PCA than those without health 
insurance, and those who discuss the benefits and risks of screening with a healthcare 
professional were less likely to test for PCA (OR = 1.09,  p = 323). People without health 
insurance are less likely to receive cancer screening tests than those with insurance 
(Breen et al., 2001; Gordon et al., 1998). Multiple potential explanations for this finding 
exist.  
One explanation is that the insignificant association between men discussing the 
benefits and risks of screening for PCA reflects more negative attitudes toward PCA 
screening and distrust of the healthcare workers about engaging in testing that may lead 
to early detection and prevention of PCA. It is also possible that men with a family 
history of PCA are not screened as recommended by different agencies. It is possible that 
there is no shared decision-making between men and their healthcare providers to weigh 
individual risks and benefits when deciding whether to screen or not to screen for PCA. 
This finding suggests that PCA screening education and the introduction of low-cost 
health insurance could improve the outcomes. Having a well-trained community health 
worker and cancer educators that can communicate with men regarding the risks and 
benefits of screening, engaging men as an active participant, and promoting shared 
decision-making are vitally important.  
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Interpretation of Findings from Research Question 1 
Research Question 1 was: Is there a statistically significant association between 
constructs of the HBM (i.e., perceived barriers, perceived benefits, perceived severity, 
and perceived susceptibility) and PSA/DRE intention to screen for PCA among Nigerian 
men 50 years old or above? The HBM was the theoretical foundation of this empirical 
study and helped me address the role of screening perception within the context of 
perceived susceptibility, perceived barriers, perceived benefits, and perceived severity. In 
this study, I sought to measure the association of HBM constructs and the intent to use 
DRE/PSA tests.  
The most compelling finding of my study was that 67% of participants (n = 122) 
in the study intend to get a DRE. However, 32% % (n = 58, M = 3.4; ±SD = 1.80) lacked 
the courage to schedule an appointment to get a DRE test. Based on the data reported, it 
is interesting to note that about 72% (n = 129) stated that getting a DRE would benefit 
them. The respondents felt that some of the benefits of seeking screening include the 
prevention of illness and a feeling of comfort.  
Another important finding of my study was that 81% of the respondents (n = 145) 
reported a high intention to get a PSA blood test. However, 52% (n = 93, M = 2.68; ±SD 
= 1.8) lacked the courage to schedule an appointment for a PSA blood test. The reasons 
for these findings could be multifactorial and may include time management, limitation 
in scheduling, or cultural factors such as embarrassment. Lantz et al. (1995) noted that 
people who take time off from work to see their healthcare providers are less likely to be 
screened. It is possible that work hours or family issues may make the tasks of scheduling 
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and traveling to appointments too time-consuming, inconvenient, and costly. 
Approximately 67% of the respondents in my study reported that work hours would keep 
them from getting screened. Another explanation for these findings is the underinsured or 
uninsured variables. I found that factors such as insurance were associated with 
screening. These results suggest that cultural education and a less invasive and careful 
DRE could reduce embarrassment as well as improve screening outcomes. 
Seventy-two percent of the sample surveyed in my study believe they were 
susceptible to PCA, even though 67% strongly believe that they are more likely than the 
average man to get PCA. Approximately 68% of the responses to the perceived severity 
constructs strongly agree with the statement, “I think about PCA; my heart beats faster.”  
Based on these findings, PCA severity, as perceived by the respondents, appears to play a 
significant role in the association between the dependent variable and the independent 
variables. Lifestyles factors may explain this finding. This important finding suggests 
that, as with all men, modifiable lifestyles factors might contribute to the perceived 
severity; therefore, men should be advised to adopt healthy lifestyle habits.  
In line with previous studies, the findings for this research question confirmed 
that there is a statistically significant association between constructs of the HBM (i.e., 
perceived barriers, perceived benefits, perceived severity, and perceived susceptibility) 
and PSA/DRE intention to screen for PCA among Nigerian men 50 years old or above. 
My findings suggest that these constructs predicted human health behaviors and was 
associated with PCA screening intent.  
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 Previous researchers have found a strong, statistically significant association 
between HBM constructs and screening intention. For instance, Zare et al. (2016) found 
that HBM constructs positively affects PCA screening behaviors by leaving positive 
effects on perceived susceptibility and severity given that perceived barriers, benefits, 
and health motivations can help improve knowledge of the disease. Therefore, it is 
noteworthy that my study, based on Nigerian men population, revealed that barriers 
toward screening are the negative aspects of the anticipated behavior, such as pain of 
screening tools, cost of testing and treatment, lack of transportation to screening site, and 
lack of health insurance. A significant barrier to screening in this study was “would be 
embarrassed.” In the same vein, Oliver, Grindel, DeCoster, Ford, and Martin (2011) 
conducted nonexperimental research using a sample of 94 male participants aged 40 
years old and older and found that both benefits and barriers were significantly associated 
with PCA screening. 
Another study also supported my findings. In a correlational, predictive, cross-
section study conducted among Haitian men, Louis (2016) found that perceived benefits 
have a predictive relationship to Haitian men’s intent to screen for PCA. As to the 
perceived susceptibility, the belief that the disease can occur without any symptoms leads 
to initiation of screening behaviors (Karimy, Hasani & Khorram, 2009). In a related study 
that also supports my findings, Weinrich et al. (2000) conducted a correlational study to 
explore barriers to PCA screening. The authors also reported a positive association 
between barriers and free PCA screening after a PCA education program. My findings 
complement other research that found a similar association. Such as, Champion (1991) 
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who reported that perceived susceptibility to breast cancer is a predictor of knowledge 
and use of mammography screenings.  
However, my findings were also inconsistent with other previous studies. For 
example, the results of Yarbrough and Braden (2001) contradict my results on the topic. 
Their findings indicated that while the HBM model provides some descriptors of the 
values, beliefs, and behaviors of middle-aged women, it does not appear to have the 
power to predict behavior (Yarbrough & Braden, 2001). One possible explanation for the 
findings in the current study is that educated men in the sample may be more proactive 
about engaging in cancer screening because of their literary knowledge of healthy 
behaviors. Another underlying explanation of this association is that it is likely that 
several relating factors, such as income, occupation, health insurance, and family history 
of cancer, may also be responsible.  
An HBM study conducted among African Americans by James et al. (2002) 
investigated perceived barriers and benefits of colorectal screening. Participants in their 
study that had stronger perceptions of barriers were less likely to report a recent fecal 
occult blood testing and that higher perceptions of benefits did not significantly affect 
fecal occult blood testing. Overall, understanding these associations could help healthcare 
workers better plan for future screening programs.  
In summary, I firmly believe that health care professionals should continuously 
consult with men about the risk of PCA progression and the benefits of screening. Men 
should also talk with the healthcare staff about the impediments that prevent them from 
participating in screening programs because it can increase their responsibility for their 
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health. I can conclude that such association between intent to have PSA/DRE screening 
and the HBM lies in the curiosity of the participants to find out more about the disease 
and increase their education and awareness about it as well as reduce their vulnerability 
to the condition. The mean number for perceived susceptibility, perceived severity, 
perceived benefits, and perceived barriers were (× = 9.39 ±SD = 7.03); (× = 10.71±SD = 
7.88);  (× = 10.88 ±SD = 7.69);  and (×  = 9.87 ±SD = 6.45), respectively (all p < 0.05). 
While further studies are needed to corroborate my findings, the results of 
Research Question 1 suggest that perceptions of the severity of the disease, the 
susceptibility men feel to the disease, the benefits associated with screening, and the 
barriers cited by men in the study are vital to whether men present for PCA screening or 
not. Therefore, the findings confirmed the predictive validity of the HBM.  The risks, 
benefits, discomfort, and other vital information about PCA screening tools should be 
discussed with men before commencing screening in Nigeria.  
Interpretation of Findings from Research Question 2 
Is there a statistically significant association between demographic variables (i.e., 
age, education, income, and ethnicity) and the perception of the benefits of PSA as a 
screening tool for PCA among Nigerian men 50 years and older?   There were no 
statistically significant association between  previous screening and age (COR = 
0.834.,95% CI = [0.49-1.40], p = 0.493); ethnicity (COR = 0.920, 95% CI = [0.80-1.05],p 
= 0.246), and education (C0R = 0.653, 95% CI = [0.41-1.039], p = .072) among men in 
the sample. However, only one of the predictors, income was significantly related to the 
intent to be screened for PCA. These findings were comparable to the findings by Mutua, 
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Pertest, and Otieno (2017) that age, and education, were not associated with the intent to 
screen for PCA among men in Kenya.  
 Concerning education, almost half of the respondents in my research had a 
college education (n = 81; 45%). Only 29% (n = 52) of the sample had a high school 
education, while 17% had a graduate degree. This could have biased the association 
between education and prior screening. Han et al. (2013) suggested that men with higher 
education had more screening participation than those men with less education. 
Compared to those in the less than high school category, engagement in risk-reduction 
behavior reduced with increasing educational levels. Also, Arora and McHorney (2000) 
suggested that highly educated people tend to be more proactive about their health than 
those with low education levels. This finding is similar to my results.  
In a related finding, Louis (2016) conducted a study among Haitian men that 
explored the HBM constructs as a predictor of Haitian men intention to screen for PCA 
and suggested that age does not influence the intent to screen for PCA. In my study, age 
was not a significant barrier for having a DRE and PSA test. The most plausible 
interpretation of the finding is that as the age of the men in the current study increases, 
the likelihood of having screening tests using both tools decreased. In another study, 
Whaley (2006) found that younger men were more embarrassed than older men. Similar 
to my findings, Whaley also found that age was not a significant barrier for having a 
DRE test but was significantly associated with having a PSA blood test.  
Agho and Lewis (2001) conducted a nonrandom study among a sample of 108 
African American men. The study aimed to examine the effects of education, income, 
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age, and health insurance coverage on actual and perceived knowledge of PCA. The 
authors found that the use of PCA screening service was negatively correlated with 
education, age, and income. These findings stand in contradiction to the findings in my 
study that income was positively associated with screening intention. The only 
explanation is the variability of income levels among African American men and 
Nigerian men. This concern can partially explain the discrepancies between the findings 
of prior study and my result. 
Multiple factors may explain the findings between screening intention and 
education in my study. One possible interpretation of the finding is that Nigerian men in 
my sample had higher education, are more likely to attend screening events and more 
likely to seek treatment. Another possible explanation is that sometimes, education may 
reflect other socioeconomic factors such as income or health literacy (Winterich et al., 
2009). As a result, a higher income may increase access to health care services 
(Ogunsanya et al., 2009). The result of my study also corroborates other published study 
showing income to be the strongest predictor of screening. For example, Clarke (2015) 
noted that as income increased, men were more likely to screen for PCA compared to 
men with lower incomes (β = .11, p <.05). Therefore, it is difficult to accept prior study 
results, which concluded that income was negatively associated with screening behavior. 
A third significant explanation is that majority of the respondents in my study are 
married. Thus, a spouse might be a key determinant of whether her husband attends 
screening events. Therefore, marital status and higher educational level might impact the 
decision to screen or not to screen for PCA. 
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 Because screening tools is a relatively controversial test, many men with higher 
education may be familiar with or aware of the guidelines. However, it is unclear if the 
degree to which screening guidelines differ might confuse Nigerian men, thus affecting 
attitudes and screening behavior but is an essential factor to consider. Screening tools 
education on guideline recommendations and the efficacy of screening is crucial, given 
that screening participation is low in Nigeria. However, education alone is unlikely to be 
successful in improving screening behavior due to multiple factors that influence these 
decisions. 
Interpretation of Findings from Research Question 3 
What are the perceived cultural barriers associated with intent to screen for PCA 
screening among Nigerian men 50 years old and older?  Cultural barriers increased the 
perception of the screening test or the motivation to obtain one. Despite the controversy 
of its use and given that cost of screening test and lack of transportation to screening sites 
has been cited as a significant barrier in my study, only 53% and 32% of men are willing 
to schedule a PSA blood test and DRE test respectively.  
In a related study in support of my findings, Shelton, Weinrich, and Reynolds 
(1999) found embarrassment as a significant barrier to screening. Other authors found 
that the invasive and subjective nature of the DRE method and PSA blood test might 
prevent men from screening. The most significant barriers to testing in the current study 
were embarrassment and pain. Similarly, Ogunsanya et al. (2016) found negative 
attitudes toward DRE among Black men due to pain and embarrassment. Winterich et al. 
(2009) also reported greater resistance to DRE test among black men. In a related study, 
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Sanchez et al. (2007) found that Black men perceived DRE as embarrassing and a threat 
to their masculinity. 
Based on the self-reported data, nearly 68% of the respondents think that most 
Nigerian men do not know about the DRE and the blood test for PCA. One possible 
explanation of this finding is that Nigerian men manifest a masculine tendency toward 
screening for cancer. This magnification of manly attitudes toward screening could be the 
results of relatively low awareness of screening tools. Only 10% of the respondents were 
aware of screening tools. As results, 70% of the respondents in this study has not 
screened for PCA. The low awareness and the limited mass media contribution to PCA 
knowledge suggest a still limited penetration of PSA/DRE tests in Nigeria. Another 
possible and intriguing explanation for this finding relates to a recent study by Whaley 
(2006) in which the author found that men who were not screened were more likely than 
those who were screened to report that they had no DRE or PSA knowledge. This gap in 
the knowledge of screening tools highlights the need for a multidisciplinary team of 
stakeholders, community workers, and the mass media to provide comprehensive 
information concerning PCA.  
Approximately 62% (n = 112) of men in the sample believe that PSA blood test 
will be a painful experience compared to 73% (n = 132) who reported that DRE test 
would be an unpleasant experience. Despite the stated barriers cited by men in the study, 
some of them did not feel comfortable scheduling a screening test. Majority of men in the 
survey intend to get a DRE, while 32% of men in the sample lacked the courage to 
schedule an appointment to get a DRE test. One plausible and intuitive explanation is that 
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the procedure is invasive and painful. Perhaps, further, analyses of the use of these tools 
with appropriate study design and analytic method are necessary to build the case for 
broader acceptance of the tools. 
In summary, despite the potential public health benefits of screening, low 
screening outcomes are likely to be evident and even when correctly diagnosed men may 
not seek treatment due to perceived barriers and lack of medical resources in Nigeria. 
Authorities in Nigeria might consider using educational materials to increase screening 
program attendance. Also, researchers might continue to search for better methods or new 
biomarkers that either alone or in combination with PSA for early detection of PCA in 
Nigeria. 
Interpretation of Findings from Research Question 4 
Is there a statistically significant association between cancer fatalism, PCA belief, 
and intention to screen for PCA among Nigerian men 50 years old and older?  Nigerian 
men perceive that PCA screening consumes a considerable amount of time, a source of 
embarrassment and costly. They also stated that they worry about being positively 
diagnosed with PCA. The fear of cancer also prevented men from registering for PCA 
screening. According to the self-reported data, there is a high degree of PCA fatalism 
among men in the sample. About 74% of the respondents think that if they are meant to 
have PCA, it does not matter what kinds of food they eat; they will get PCA anyway. 
Also, 63% of men in the survey believe that there is nothing they can do to prevent them 
from getting PCA. These are significant barriers for men in Nigeria to participate in PCA 
screening.  
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These findings in my study do not align with the results obtained by Baker 
(2008). Baker found a low degree of fatalism among men in her study. Most of the men 
in my study reported a high degree of fatalism. One reason for this finding may be that 
the sample in this study includes men with higher education than the men in Baker’s 
sample. A second reason may be that Baker conducted qualitative research with focus 
groups and that Baker’s work was conducted a decade ago. A third possible explanation 
is that most of the participants in Baker’s work knew the researcher, and as such, social 
desirability impacted their responses to the fatalism questions. Another weak but possible 
explanation is that 40% of men in Baker’s study were aged 40–49 years with a mean age 
of 50 years. A fifth possible explanation is that only 25% of men in Baker’s study 
reported a family history of PCA, while 70% of men in my study reported having a 
family history of PCA. It seems reasonable to hypothesize, therefore, that this concern 
may be an impediment to screen for PCA among the men surveyed. If this were the case, 
late presentation at the hospital could theoretically be reduced given that fatalism is a 
significant barrier to screen for PCA.  
However, my study data is supported by previous research. For example, in their 
study, Consedine, Morgenstern, Kudadjie-Gayamfi, Magai, and Neugut (2006) found that 
cancer fatalism constitutes a significant determinant of screening behaviors among men. 
In another study among African Americans men, Underwood (1992) found that cancer 
fatalism is more common while Vetter, Lewis, and Charny (1991) hypothesized that 
fatalism is more prevalent among the elderly regardless of gender. 
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In line with previous studies, my finding demonstrated that the fatalism scores 
reported by Nigerian men in my study were more strongly correlated with the fatalism 
scores reported by Powe (1999) among African Americans. Also, Vrinten, Wardle, and 
Marlow (2016) conducted a study in the United Kingdom and found that fatalism is 
associated with under-utilization of PCA screening. A study conducted among black 
Caribbean males found that there was a significant difference in perception of PCA 
fatalism (Cobran et al., 2014) while findings by Odedina et al. (2009) reported that Black 
men who were born in the USA had less PCA fatalism compared to Black men born in 
the Caribbean.  
Powe and Finnie (2003) also reported cancer fatalism among those with limited 
cancer awareness and underserved medical persons. The sample in my study also 
reported limited PCA awareness and poor screening tools knowledge. In another study, 
Underwood (1992) believes that hopelessness and helplessness are related to the concept 
of fatalism; that is, individuals might skip screening events since death will result 
regardless of screening status. These findings might be the reasons for the findings in my 
study. In Nigeria, for example, Akigbe and Akigbe noted that religious beliefs including 
fatalism, witchcraft, magical powers and demon usually influence their thinking and 
cultural values, and these in turn influence health behavior of men to seek screening.  
The findings by Powe and Finnie (2003) also support the conclusions of my study 
that fatalism is a significant barrier in cancer screening behaviors among Nigerian men. 
One plausible explanation of the findings in my study is that PCA fatalistic beliefs have 
been associated with low levels of PC education and low levels of awareness of PCA 
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with the misconception that men have no control over the events related to occurrence or 
management of cancer (Kobayashi & Smith,2016). 
Consistent with the findings in my study, Powe (1995) studied the relationship 
between fecal occult blood screening and cancer fatalism. In the study, only 29% (n=34) 
of the sample participated in fecal occult blood screening after instruction was given. 
Powe found that fatalism was the only significant predictor of fecal occult blood testing 
among the factors of age, income, education, and fatalism (p = 0.006). This finding by 
Powe seems to suggest that fatalism may be related to decreased participation in fecal 
occult blood testing by African Americans (Powe as cited in Baker, 2008). In a related 
study, Cobran et al. (2014) cited poverty, discrimination, unemployment, and lack of 
healthcare access as the fundamental assumptions underlying fatalistic attitudes towards 
cancer. These themes are consistent with the factors expressed by men in my study. 
  In summary, most of the respondents in my study had fatalistic beliefs towards 
PCA. The reasons for such an attitude may be rooted in religious beliefs, cultural beliefs, 
and fear of the unknown concerning cancer treatment. Fatalistic beliefs and fear of 
developing cancer are major barriers to the uptake of PCA screening. Therefore, fatalistic 
beliefs are associated with low screening turnout of men for PCA screening events in 
Nigeria. Cultural societies in Nigeria are best positioned to support health professionals 
in this educational goal, thanks to their role as a trusted source of information and 
guidance. Also, these findings highlight the need for community, municipal, and other 
stakeholders in Nigeria to target fatalistic beliefs in future screening promotion to change 
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the negative perception of the screening tools. An understanding of men’s values, 
attitudes, and perceptions will guide culturally competent whole-man healthcare.  
Limitations of the Study 
Study findings were interpreted considering the following limitations. The 
missing and skipped questions can result in reduced power and bias in my results. Also, 
due to the nature of the sampling, some members of the general population may not have 
been included in this study; therefore, the result may not apply to those men. Also, 
culture among various ethnic groups in Nigeria is diverse. Thus, the culture variables in 
this study cannot be generalized to other ethnic populations. The sample size was 
restricted to 180 respondents, which may not be adequate to be representative of men in 
Nigeria. Also, the data accuracy is another limitation since the participants may have 
misunderstood specific questions, though such a possibility appears to be small as per the 
outcomes of the pilot study.  
The data reported in the current study were based on self-report, which could be 
subject to social desirability bias and recall bias. Men tend to overreport having had a 
recent DRE and PSA blood test. There is no control over who responded to the survey. 
Therefore, responding multiple times may have biased the results. Finally, this study is 
cross-sectional design research, and, as such causal flow of variables were not 
accomplished. Therefore, the results showed an association and not causality. Further 
prospective studies are needed to infer causation.  
 Despite these limitations, this study has some implication for the future. For 
example, this study suggests the need for quality improvement in PCA screening and 
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screening barrier database. Most importantly, this database should be evenly distributed 
across rural and urban populations, implying that my findings are likely relevant despite 
these limitations. The results of my study are encouraging and may prompt healthcare 
workers to consider using the findings as a benchmark for PCA screening, the caveat 
being that this study was based on a limited sample size studied over a short period of 
time.    
Recommendations 
These study findings recommend that efforts should focus on the development 
and testing of interventions to increase informed decision-making, encourage men to 
have annual checkups with their healthcare providers and to address the cost of screening 
regarding PCA. It would be practical to target adult men with PCA fatalism beliefs. 
Strategies to address fatalism among Nigerian men would be a valuable response to men 
with a fatalistic attitude and a lack of interest to screen in the future. 
Education and Awareness 
When appropriate, culturally tailored interventions should target Nigerian men 
based on a predetermined cultural barrier. For example, PCA education and promotion 
should target men with fatalistic belief. These variables, along with screening 
embarrassment, were cited as a significant contributor to low screening intention in my 
study. These interventions will include the development of screening databases, risk 
stratification, and standardized management system to optimize outcomes as well as 
media advocacy spearheaded by national figures and celebrity to increase public 
awareness of the disease.  
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Federal and State Prostate Cancer Screening Initiatives 
The use of screening tools remains a decision that should involve a thoughtful 
discussion between a patient and his healthcare provider, given the need to weigh the 
barriers as well as possible cancer prevention and awareness against the risk and cost. 
Federal and state agencies should develop a program to screen men starting at age 50 and 
age 40 for those with a family history of PCA as well as equip and empower healthcare 
providers with essential incentives and tools. 
Mobile Screening Services 
One of the most significant barriers to screening identified in the current study is 
the lack of transportation to attend screening events (68%, n = 123). Men in rural regions 
of Nigeria reported significant transportation barriers and an inability to cover the cost. 
Mobile services for those without the method of transportation to screening site can be 
implemented. Mobile screening services can bring screening into areas with limited 
access to health screening. This free service will provide better access for care, increase 
screening rates while reducing the prevalence and mortality rates of the disease. Also, 
electronic medical records could be leveraged to identify eligible men for screening and 
notify healthcare providers as well as stakeholders of the need to address screening 
barriers cited by men in the study. The mobile screening services should be easily 
accessible in familiar locations and should be made available on hand-held electronic 
devices.  
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Implications 
This was a quantitative study based on a cross-sectional design using the HBM. 
Screening for PCA in Nigeria is low for unknown reasons. The evidence base is 
inadequate. However, these present findings established the evidence as eloquently and 
empirical as possible. 
Social Problems 
PCA is a social problem among men in Nigeria. This scourge has plagued 
Nigerian men from all walks of life. The high rate of PCA death among adult men in 
Nigeria poses a significant social problem, given that screening for the disease is low. 
Defining the populations most likely to benefits from testing and the factors associated 
with low screening rates continues to an area of considerable debate. Positive social 
change within the adult men population in Nigeria can be achieved through the 
evaluation of PCA screening barriers and education. Cost of screening is a significant 
barrier identified by most respondents in my study.  
Data from this study will be useful in putting together culturally relevant 
awareness literature and media content that addresses all cultural barriers identified in my 
study. Healthcare workers must address and subsequently remove any stated barriers 
when attempting to schedule PCA screening in Nigeria. Additionally, social change can 
be created if it is learned that PCA awareness, attitudes, beliefs, barriers, and education 
are generating the ideal effect that would lead to reducing the mortality rate of PCA 
among Nigerian men 50 years and above.  
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These findings have identified a solution to the social problem among men in 
Nigeria. However, understanding Nigerian culture, environment, and healthcare sector 
would prove helpful in future research studies. 
The Research Questions 
Delays in PCA screening can result in late presentation outcome as well as 
increased risks of death. This study considered the association between age, income, 
ethnicity, education, and screening behaviors among adult men in Nigeria. Of further 
interest are the factors associated with cancer fatalism, cultural barriers, the intent to be 
screened for PCA using PSA blood test and DRE method, and the effects of HBM 
constructs. Further research is needed to provide answers to the questions raised in my 
study.  
The Research Problems 
Despite advances in both prevention and screening, PCA remains the most 
common form of cancer among men in Nigeria. PCA screenings behaviors have not been 
thoroughly studied among men 50 years and older in Nigeria. I sought to find out what 
factors prevent men from seeking PCA screening in Nigeria. Based on data provided by 
the respondent, there is no association between educational level, age, ethnicity, and the 
intent to be screened for PCA. This study also supports the hypotheses that cancer 
fatalism is associated with low screening for PCA, given that demographic variables (i.e., 
age, ethnicity, education) are also not associated with screening intention. There is a 
significant gap in the literature concerning the salient barriers associated with low 
screening among men in the age group. Therefore, these findings will help bridge the gap 
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in the literature by adding additional data and value to our understanding of screening 
barriers and the reasons for the late presentation at the hospital.  
My study findings are supported by previous research. Growing evidence 
suggests that variables such as knowledge, beliefs, and intention to screen among men in 
Nigeria were low. For example, in their study, Oladimeji et al. (2010) found that the 
intention to test among older Nigerians were low. In another study, Blocker, Romocki, 
and Thomas (2006) and Webb, Kronheim, Williams, and Hartman (2006) put forth some 
suggestions which attempt to explain that being married is associated with significant 
intention. Therefore, among the more educated men, studies found that such variables 
influenced the likelihood to screen for PCA (Drake, Shelton, Gilligan & Allen, 2010). 
However, further research is needed to identify salient culturally barriers, educational 
incentives, as well as the effects of free and low-cost screening tools. Therefore, it is 
essential that the search for better and novel methods to increase PCA screening 
continues.  The findings of this study have helped to fill this knowledge gap. 
Implications for Theory 
The HBM was used as a base to guide my research. Due to the multicultural and 
ethnically diverse population of men in Nigeria, the HBM is a crucial construct when 
researching barriers associated with screening for PCA. In this study, the HBM provided 
an opportunity for the participant’s perceptions to be identified as well as the perceived 
severity, perceived benefit, perceived barriers, and perceived susceptibility. The action of 
participating in PCA screening or not, initially involves the individual perceived 
susceptibility to PCA, the perception of PCA severity, the perceived benefits from 
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screening, and the perceived barriers associated with screening. Therefore, the HBM 
explain and predict health behaviors and was considered appropriate for this study. 
Findings Help Fill Research Gap 
There is a gap in the literature concerning the cultural barriers associated with the 
intent to be screened and the perceived benefits of screening in Nigeria. These findings 
help fill a research gap by providing new data on the barriers associated with low 
screening rates among adult men in Nigeria. The current study provides evidence for a 
differential role of barriers in PCA screening. Findings from my study may help to 
remove some barriers that may be preventing Nigerian men from taking advantage of the 
screening benefits. This current study provides promising evidence that screening cost, 
fear of cancer, and lack of transportation could indeed serve as a barrier to screening, 
although more research is needed.  
Outcomes  
The primary outcome was the intent to be screened for PCA. Secondary endpoints 
were the need to increase screening to end the high mortality rate of PCA. Additionally, 
this study provided an opportunity to examine the salient factors associated with low 
screening behaviors and intentions among men 50 years old and older. A notable finding 
from my research was the significantly high proportion of men in the sample who did not 
screen for PCA. One possible explanation is the high cost of screening tools, inadequate 
health insurance, and perceived barriers toward screening. Another possible reason is the 
increased impact of fatalistic beliefs. A third possible explanation is that screening tools 
awareness is low. Because cultural beliefs profoundly influence PCA screening, further 
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research is needed to identify the intention to screen problems and the factors associated 
with a low level of participation in screening programs. 
That said, my study highlights the negative association between education and 
previous screening, between age and previous screening and between ethnicity and 
previous screening, a fact not previously identified by researchers in Nigeria. By 
identifying these barriers, interventions can be designed to increase PCA screening 
education among Nigerian men to reduce the high rate of mortality in PCA outcomes. 
These outcomes indicate that a one-size-fits-all approach will not be enough in the 
country, given the weak healthcare system. Instead, it will help to develop PCA screening 
databases to identify salient barriers and intentions. 
Stakeholders 
 There are works for stakeholders in Nigeria. Focused interventions that help 
healthcare providers identify barriers quickly could improve screening outcome. 
Stakeholders (i.e., churches, mosques, non-governmental organizations, community 
leaders, multinational corporation, the public, and government agencies) can design 
interventions to increase PCA screening education among Nigerian men to reduce the 
high rate of fatality in PCA outcomes. Educational awareness will increase the belief 
among Nigerian men that DRE method and PSA blood test can help diagnose PCA 
before the appearance of symptoms and that early screening can improve the diagnosis of 
the disease. Findings from my study may encourage stakeholders in Nigeria to focus 
attention on developing more effective screening events that will incorporate all the 
factors identified in my research. Therefore, federal, state, and local governments, as well 
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as nongovernmental organizations, might use the data of my finding to propose offering 
free screening events. Also, this present research will help policymakers, stakeholders, 
and healthcare providers in Nigeria develop guidelines for the implementation of 
community-based screenings events.  
Conclusions 
PCA, either indolent or aggressive, is sometimes detected through preventive 
screening using DRE and PSA tools. Despite the effectiveness of these tools, the 
prevalence rate of the disease continues to increase. PCA is common in Nigeria due to the 
low participation rate in screening events. This study identified the unique predictors of 
cancer screening. For example, barrier outcome remains a significant predictor of low 
testing using the PSA blood test and DRE method.  
This present research will help policymakers, stakeholders, and healthcare 
providers develop guidelines for the implementation of community-based preventive 
screenings measures. My study underscores the importance of screening tools as the 
backbone for the identification of cancer of the prostate. This study highlights the likely 
impact of cultural barriers for both adult male and the healthcare system in Nigeria. The 
take-home message from my study is that health beliefs and barriers, as well as 
intentions, regulate individual PCA screening actions.   
In this adequately powered study, there were significant findings. Chief among 
the results is the identification of screening barriers and what constitute the intents to be 
screened for the disease. Ethnicity, education, and age were not significant predictors of 
screening intentions, whereas income, health insurance, and family history of PCA were 
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found to be a significant predictor of screening intentions. There are, however, a 
significant association between the HBM and intention to screen using PSA/DRE tools. 
The full impact of cancer fatalism can be prominent among men 50 years old and older. 
Nigerian men with high fatalistic beliefs were less likely to attend PCA screening. Older 
men carry the overwhelming burden of PCA. Also, younger men were significantly 
different from older men in terms of testing for PCA. In this study, older men are likely 
to cite fatalism than younger men.  
Sixty-one percent of the respondents strongly relied on friends and family 
influence concerning screening. Therefore, it is wise to suggest that spouse or family 
members can be enlisted to prod men to attend screening events. The results from the 
current study suggest a role for the public. Therefore, research among this population is 
critically important.  
The distinctive feature of my study is that, to my knowledge, this is the largest 
online-based survey among men in the age group based on ethnicity, state of residence, 
education, screening behaviors, cancer fatalism, and income in Nigeria. Respondents 
from 12 ethnic groups and 11 states in Nigeria responded to the survey spanning adult 
men from different occupations, educational, and income levels.  
The results of this study if not censored by the medical community in Nigeria, 
will serve as a blueprint for future screening events in Nigeria. Unless attention is paid to 
the findings of the study, PCA mortality will likely increase due to lack of screening 
education, awareness, barriers, and epidemiologic research toward these variables. To 
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summarize, addressing biological differences of PCA has not been enough to increase 
screening rates, suggesting the contribution of cultural factors. 
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Appendix A: Responses to the Perceived Susceptibility Questions 
 
 
Question/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q19. It is extremely likely I will get PCA in the future 
Strongly agree 72.63% 130 
Agree 2.79% 5 
Neither agree nor disagree 8.38% 15 
Disagree 3.35% 6 
Strongly disagree 12.85% 23 
      
Q20. I feel I will get PCA in the future     
Strongly agree 70.39% 126 
Agree 4.47% 8 
Neither agree nor disagree 7.26% 13 
Disagree 3.35% 6 
Strongly disagree 14.53% 26 
    
Q21. There is a good possibility I will get PCA in the next ten 
years 
Strongly agree 68.72% 123 
Agree 6.15% 11 
Neither agree nor disagree 7.26% 13 
Disagree 3.91% 7 
Strongly disagree 13.97% 25 
Q22. My chances of getting PCA are great     
Strongly agree 68.33% 123 
Agree 5.00% 9 
Neither agree nor disagree 8.33% 15 
Disagree 5.00% 9 
Strongly disagree 13.33% 24 
Q23. I am more likely than an average man to get PCA     
Strongly agree 67.04% 120 
Agree 6.15% 11 
Neither agree nor disagree 5.59% 10 
Disagree 6.70% 12 
Strongly disagree 14.53% 26 
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Appendix B: Responses to the Perceived Severity Questions 
 
Question/Responses 
 
 
Percentage 
 
 
 n 
 
Q24. The thought of PCA scares me 
Strongly agree 75.56% 136 
Agree 7.78% 14 
Neither agree nor disagree 1.67% 3 
Disagree 4.44% 8 
Strongly disagree 10.56% 19 
Q25. I think about PCA; my heart beats faster     
Strongly agree 68.33% 123 
Agree 12.22% 22 
Neither agree nor disagree 2.22% 4 
Disagree 5.00% 9 
Strongly disagree 12.22% 22 
Q26. I am afraid to think about PCA     
Strongly agree 68.89% 124 
Agree 12.78% 23 
Neither agree nor disagree 1.11% 2 
Disagree 5.00% 9 
Strongly disagree 12.22% 22 
Q27. Problems I would experience with PCA would last a 
long time 
Strongly agree 69.83% 125 
Agree 7.82% 14 
Neither agree nor disagree 6.15% 11 
Disagree 5.03% 9 
Strongly disagree 11.17% 20 
Q28. PCA would threaten a relationship with my girlfriend, 
wife, or partner     
Strongly agree 72.78% 131 
Agree 5.00% 9 
Neither agree nor disagree 3.89% 7 
Disagree 3.89% 7 
Strongly disagree 14.44% 26 
Q29. If I had PCA my whole life would change     
Strongly agree 70.00% 126 
Agree 7.78% 14 
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Neither agree nor disagree 5.00% 9 
Disagree 2.78% 5 
Strongly disagree 14.44% 26 
 
Appendix C: Responses to the Perceived Benefit Questions 
(table continues) 
  
 
 
Question/Responses 
 
 
Percentage 
 
 
  n 
 
 
Q30. If I have PSA blood test or DRE, I feel good about 
myself 
Strongly agree 68.72% 123 
Agree 10.06% 18 
Neither agree nor disagree 5.59% 10 
Disagree 1.12% 2 
Strongly disagree 14.53% 26 
Q31. If I complete yearly PSA blood test or DRE, I do not 
worry as much about PCA     
Strongly agree 67.04% 120 
Agree 11.73% 21 
Neither agree nor disagree 4.47% 8 
Disagree 3.35% 6 
Strongly disagree 13.41% 24 
Q32. Completing PSA blood or DRE each year will allow 
me to find cancer early     
Strongly agree 67.22% 121 
Agree 14.44% 26 
Neither agree nor disagree 3.33% 6 
Disagree 3.33% 6 
Strongly disagree 11.67% 21 
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Question/Responses Percentage          n 
      
Q33. If I complete PSA blood test or DRE yearly, I will 
decrease my chances of dying from prostate cancer     
Strongly agree 67.78% 122 
Agree 12.78% 23 
Neither agree nor disagree 4.44% 8 
Disagree 3.33% 6 
Strongly disagree 11.67% 21 
Q34. If I complete PSA blood test or DRE yearly, I will 
decrease my chances of requiring radical surgery if prostate 
cancer occurs     
Strongly agree 67.78% 122 
Agree 10.56% 19 
Neither agree nor disagree 2.78% 5 
Disagree 6.11% 11 
Strongly disagree 12.78% 23 
Q35. If I complete yearly PSA blood test or DRE, it will 
help me to find prostate cancer before it is detected by a 
doctor or nurse     
Strongly agree 68.33% 123 
Agree 13.89% 25 
Neither agree nor disagree 2.22% 4 
Disagree 2.78% 5 
Strongly disagree 12.78% 23 
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Appendix D: Responses to the Perceived Barrier Questions  
 
Questions/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q36. I feel funny having a DRE or PSA blood test 
Strongly agree 72.78% 131 
Agree 6.11% 11 
Neither agree nor disagree 7.22% 13 
Disagree 6.11% 11 
Strongly disagree 7.78% 14 
Q37. Having a DRE or PSA blood test during the next 
year will make me worry about PCA     
Strongly agree 69.44% 125 
Agree 6.11% 11 
Neither agree nor disagree 6.67% 12 
Disagree 6.11% 11 
Strongly disagree 11.67% 21 
Q38. Having a PSA blood test or DRE will be 
embarrassing to me     
Strongly agree 75.56% 136 
Agree 6.11% 11 
Neither agree nor disagree 5.56% 10 
Disagree 8.33% 15 
Strongly disagree 4.44% 8 
 (table continues) 
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Question/Responses 
 
 
Percentage 
 
 
         n 
 
 
Q39. Having a DRE or PSA blood test will take too much 
time     
Strongly agree 74.44% 134 
Agree 5.56% 10 
Neither agree nor disagree 5.56% 10 
Disagree 8.89% 16 
Strongly disagree 5.56% 10 
      
Q40. Having a DRE or PSA blood will be unpleasant     
Strongly agree 75.56% 136 
Agree 6.11% 11 
Neither agree nor disagree 5.00% 9 
Disagree 7.78% 14 
Strongly disagree 5.56% 10 
Q41. Having a DRE or PSA blood test will cost too much 
money and time     
Strongly agree 77.78% 140 
Agree 11.11% 20 
Neither agree nor disagree 2.78% 5 
Disagree 3.89% 7 
Strongly disagree 4.44% 8 
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Appendix E:  CHBMS Likert Survey Composite Scores for Respondents that Checked 
Strongly Agree (Coded as 5) 
                                                                                                     
 Likert SUS BAR SEV BEN 
Weighted 
score 
weighted 
score 
Weighted 
score 
Weighted 
score 
Survey  F4 F3 F2 F1 F4 F3 F2 F1 
Q1 0.920       4.600       
Q2 0.980       4.900       
Q3 0.970       4.850       
Q4 0.801       4.000       
Q5 0.797       0.398       
Q6     0.910       4.550   
Q7     0.930       4.650   
Q8     0.886       4.430   
Q9     0.950       4.750   
Q10     0.861       4.300   
Q11     0.840       4.200   
Q12       0.876       4.380 
Q13       0.912       4.560 
Q14       0.920       4.600 
Q15       0.812       4.060 
Q16       0.911       4.550 
Q17       0.890       4.550 
Q18   0.748       3.740     
Q19   0.670       3.350     
Q20   0.855       4.270     
Q21   0.899       4.490     
Q22   0.839       4.190     
Q23   0.801       4.050     
Composite score       22.34 24.06 26.88 26.6 
Abbreviations:  SUS= Susceptibility; SEV = Severity; BEN = Benefits; BAR = Barriers; 
F=Factor 
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Appendix F: Responses to the Fatalism Questions 
  
Question/Responses 
 
 
Percentage 
 
 
     n 
 
 
Q42. I think if someone is meant to have PCA, it doesn't 
matter what kinds of food they eat; they will get PCA 
anyway     
Yes 74.44% 134 
No 25.56% 46 
Q43. I think if someone has PCA, it is already too late to get 
the treated for it     
Yes 69.44% 125 
No 30.56% 55 
Q44. I think someone can eat fatty foods all their life, and if 
they are not meant to get PCA, they won't get it     
Yes 74.44% 134 
No 25.56% 46 
Q45. I think if someone is meant to get PCA, they will get it 
no matter what they do     
Yes 70.56% 127 
No 29.44% 53 
Q46. I think if someone gets PCA, it was meant to be     
Yes 70.56% 127 
No 29.44% 53 
 (table continues) 
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Question/Responses 
 
 
 
Percentage 
 
 
 
        n 
 
 
 
Q47. I think if someone gets PCA, their time to die is soon.     
Yes 68.89% 124 
No 31.11% 56 
Q48. I think if someone gets PCA, that is the way they were 
meant to die     
Yes 70.56% 127 
No 29.44% 53 
Q49. I think getting checked for PCA makes people scared 
that they may really have PCA.     
Yes 79.44% 143 
No 20.56% 37 
Q50. I think if someone is meant to have PCA, they will 
have prostate cancer     
Yes 67.78% 122 
No 32.22% 58 
Q51. I think some people don't want to know if they have 
PCA because they don't want to know they may be dying 
from it     
Yes 80.56% 145 
No 19.44% 35 
 (table continues) 
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Questions/Responses 
 
 
 
Percentage 
 
 
      n 
 
 
Q52. I think if someone gets PCA, it doesn't matter 
whether they find it early or late, they will still die from it 
Yes 70.39% 126 
No 29.61% 53 
Q53. I think if someone has PCA and gets treatment for it, 
they will probably still die from the PCA.     
Yes 68.89% 124 
No 31.11% 56 
Q54. I think if someone was meant to have PCA, it doesn't 
matter what doctors and nurses tell them to do, they will 
get PCA anyway     
Yes 72.78% 131 
No 27.22% 49 
Q55. I think if someone is meant to have PCA, it doesn't 
matter if they eat healthy foods, they will still get PCA     
Yes 71.11% 128 
No 28.89% 52 
Q56. I think PCA will kill you no matter when it is found 
and how it is treated     
Yes 67.60% 121 
No 32.40% 58 
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Appendix G: Responses to the DRE Screening Intention Questions- CSIS-P  
 
 
Questions/Responses 
 
 
Percentage 
 
 
      n 
 
 
Q57. I intend to get a DRE this year 
Strongly agree 67.78%    122 
Agree 8.33%    15 
Neither agree nor disagree 5.56%    10 
Disagree 1.67%    3 
Strongly disagree 16.67%    30 
Q58. I have already scheduled an appointment to get a DRE 
this year     
Strongly agree 32.22%    58 
Agree 3.89%     7 
Neither agree nor disagree 3.33%     6 
Disagree 10.56%     19 
Strongly disagree 50.00%     90 
Q59. I believe that getting a DRE will benefit me.     
Strongly agree 72.07%     129 
Agree 9.50%     17 
Neither agree nor disagree 5.03%     9 
Disagree 1.68%     3 
Strongly disagree 11.73%     21 
Q60. I believe that getting a DRE and the blood test for PCA 
will lower my chances of getting PCA     
Strongly agree 72.63%    130 
Agree 11.17%    20 
Neither agree nor disagree 3.91%     7 
Disagree 3.35%     6 
Strongly disagree 8.94%     16 
    
(table continues) 
  
183 
 
Question/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q61. Getting the DRE and the blood test for PCA will help 
find PCA early 
Strongly agree 72.22% 130 
Agree 16.11% 29 
Neither agree nor disagree 0.56% 1 
Disagree 1.11% 2 
Strongly disagree 10.00% 18 
Q62. Getting the DRE and the blood test for PCA will keep 
me from worrying about getting PCA     
Strongly agree 71.11% 128 
Agree 10.00% 18 
Neither agree nor disagree 5.00% 9 
Disagree 2.78% 5 
Strongly disagree 11.11% 20 
Q63. I believe that a DRE will be harmful to me     
Strongly agree 70.56% 127 
Agree 10.00% 18 
Neither agree nor disagree 5.56% 10 
Disagree 6.11% 11 
Strongly disagree 7.78% 14 
Q64. I believe that the DRE will be a painful experience for 
me     
Strongly agree 73.33% 132 
Agree 8.33% 15 
Neither agree nor disagree 7.78% 14 
Disagree 5.00% 9 
Strongly disagree 5.56% 10 
(table continues) 
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Question/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q65. Getting the DRE is embarrassing to me 
Strongly agree 71.11% 128 
Agree 11.11% 20 
Neither agree nor disagree 4.44% 8 
Disagree 6.11% 11 
Strongly disagree 7.22% 13 
Q66. Thinking about getting the DRE scares me.   
Strongly agree 72.22% 130 
Agree 8.33% 15 
Neither agree nor disagree 6.11% 11 
Disagree 3.89% 7 
Strongly disagree 9.44% 17 
Q67. I think most Nigerian men don’t know about the DRE 
and the blood test for PCA.     
Strongly agree 70.95% 127 
Agree 15.08% 27 
Neither agree nor disagree 3.35% 6 
Disagree 0.56% 1 
Strongly disagree 10.06% 18 
Q68. The hours at my job will keep me from getting the 
DRE and the blood test for PCA.     
Strongly agree 67.78% 122 
Agree 12.22% 22 
Neither agree nor disagree 4.44% 8 
Disagree 6.67% 12 
Strongly disagree 8.89% 16 
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Questions/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q69. Lack of transportation will keep me from getting the 
DRE and the blood test for PCA. 
Strongly agree 68.72% 123 
Agree 9.50% 17 
Neither agree nor disagree 5.03% 9 
Disagree 8.38% 15 
Strongly disagree 8.38% 15 
Q70. I believe that it is completely up to me whether I have a 
DRE and the blood test for PCA.     
Strongly agree 76.11% 137 
Agree 10.56% 19 
Neither agree nor disagree 2.22% 4 
Disagree 2.22% 4 
Strongly disagree 8.89% 16 
Q71. I am confident that I will be able to get a DRE.     
Strongly agree 55.00% 99 
Agree 12.78% 23 
Neither agree nor disagree 10.00% 18 
Disagree 3.89% 7 
Strongly disagree 18.33% 33 
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Questions/Responses 
 
 
Percentage 
 
 
     n 
 
 
Q72. I believe that it would be worthless for me to have a 
DRE. 
Strongly agree 62.22% 112 
Agree 7.78% 14 
Neither agree nor disagree 6.11% 11 
Disagree 12.22% 22 
Strongly disagree 11.67% 21 
Q73. The people in my life whose opinions I value think I 
should have a DRE.     
Strongly agree 57.22% 103 
Agree 7.78% 14 
Neither agree nor disagree 12.78% 23 
Disagree 5.00% 9 
Strongly disagree 17.22% 31 
Q74. Most of my male family members and friends have had 
a DRE.     
Strongly agree 55.56% 100 
Agree 5.00% 9 
Neither agree nor disagree 10.56% 19 
Disagree 8.89% 16 
Strongly disagree 20.00% 36 
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Appendix H: Responses to the PSA Blood Test Questions  
 
Question/Responses                                                                Percentage 
 
 
     n 
 
 
Q75. I intend to get the blood test for PCA this year 
Strongly agree 81.01% 145 
Agree 5.59% 10 
Neither agree nor disagree 5.59% 10 
Disagree 2.79% 5 
Strongly disagree 5.03% 9 
  
Q76. I have already scheduled an appointment to get the 
blood test for PCA this year.     
Strongly agree 52.25% 93 
Agree 1.12% 2 
Neither agree nor disagree 3.37% 6 
Disagree 12.92% 23 
Strongly disagree 30.34% 54 
Q77. I believe that it would be valuable for me to get the 
blood test for PCA.     
Strongly agree 78.21% 140 
Agree 7.26% 13 
Neither agree nor disagree 4.47% 8 
Disagree 2.79% 5 
Strongly disagree 7.26% 13 
Q78. I believe that the blood test for PCA will be harmful to 
me     
Strongly agree 63.69% 114 
Agree 2.79% 5 
Neither agree nor disagree 7.26% 13 
Disagree 8.38% 15 
Strongly disagree 17.88% 32 
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Question/Responses 
 
 
Percentage 
 
 
  n 
 
 
Q79. I believe that the blood test for PCA will be a painful 
experience for me 
Strongly agree 62.57% 112 
Agree 6.15% 11 
Neither agree nor disagree 6.70% 12 
Disagree 8.38% 15 
Strongly disagree 16.20% 29 
Q80. Getting the blood test for PCA is embarrassing to me.     
Strongly agree 63.13% 113 
Agree 5.59% 10 
Neither agree nor disagree 5.59% 10 
Disagree 9.50% 17 
Strongly disagree 16.20% 29 
Q81. Thinking about getting the blood test for PCA scares 
me.     
Strongly agree 67.04% 120 
Agree 7.82% 14 
Neither agree nor disagree 2.23% 4 
Disagree 7.82% 14 
Strongly disagree 15.08% 27 
Q82. It will be easy for me to go get the blood test for PCA.     
Strongly agree 62.36% 111 
Agree 11.80% 21 
Neither agree nor disagree 7.30% 13 
Disagree 5.62% 10 
Strongly disagree 12.92% 23 
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Question/Responses 
 
 
Percentage 
 
 
   n 
 
 
Q83. I believe it is useless for me to get the blood test for 
PCA. 
Strongly agree 59.22% 106 
Agree 5.03% 9 
Neither agree nor disagree 5.59% 10 
Disagree 11.17% 20 
Strongly disagree 18.99% 34 
Q84. The people in my life whose opinions I value think that 
I should have the blood test for PCA.     
Strongly agree 61.45% 110 
Agree 6.15% 11 
Neither agree nor disagree 8.38% 15 
Disagree 4.47% 8 
Strongly disagree 19.55% 35 
Q85. Most of my male family members and friends have had 
the blood test for PCA.     
Strongly agree 59.22% 106 
Agree 3.91% 7 
Neither agree nor disagree 6.15% 11 
Disagree 12.29% 22 
Strongly disagree 18.44% 33 
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Appendix I: Responses to the Prostate Cancer Belief Questions  
 
Questions/Responses 
 
Percentage 
 
     n 
 
Q86. I believe that PCA is a serious disease. 
Strongly agree 86.11%    155 
Agree 5.56%    10 
Neither agree nor disagree 3.89%    7 
Disagree 1.11%    2 
Strongly disagree 3.33%    6 
Q87. PCA would threaten my relationship with my partner.   
Strongly agree 70.39%    126 
Agree 8.94%    16 
Neither agree nor disagree 6.70%    12 
Disagree 5.03%    9 
Strongly disagree 8.94%    16 
Q88. I worry about getting PCA.     
Strongly agree 73.74%    132 
Agree 7.26%    13 
Neither agree nor disagree 3.91%    7 
Disagree 5.59%    10 
Strongly disagree 9.50%    17 
Q89. I believe that I am at risk of getting PCA.     
Strongly agree 71.11%    128 
Agree 5.56%   10 
Neither agree nor disagree 6.67%    12 
Disagree 8.33%    15 
Strongly disagree 8.33%    15 
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Question/Responses 
 
 
Percentage 
 
 
       n 
 
 
Q90. I believe that I am at higher risk for getting PCA than 
other men 
Strongly agree 65.56%    118 
Agree 8.33%     15 
Neither agree nor disagree 6.11%     11 
Disagree 8.89%     16 
Strongly disagree 11.11%     20 
Q91. It is likely that I will get PCA in the future     
Strongly agree 68.89%     124 
Agree 5.56%     10 
Neither agree nor disagree 6.67%     12 
Disagree 7.22%     13    
Strongly disagree 11.67%     21 
Q92. I believe there is nothing I can do to prevent me from 
getting PCA     
Strongly agree 63.89%     115 
Agree 5.00%     9 
Neither agree nor disagree 5.56%     10 
Disagree 10.00%    18 
Strongly disagree 15.56%    28 
Q93. Doing what my family and friends think I should do is 
very important to me.     
Strongly agree 63.33%     114 
Agree 6.67%     12 
Neither agree nor disagree 6.11%     11 
Disagree 3.89%     7 
Strongly disagree 20.00%     36 
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Appendix J: Responses to the Healthy Lifestyle Questions  
  
Question/Responses 
 
 
Percentage 
 
 
           n 
 
 
Q94. I eat well-balanced meals daily     
Strongly agree 43.58% 78 
Agree 10.06% 18 
Neither agree nor disagree 13.97% 25 
Disagree 6.15% 11 
Strongly disagree 26.26% 47 
Q95. I get yearly physical check-ups     
Strongly agree 32.78% 59 
Agree 10.00% 18 
Neither agree nor disagree 11.11% 20 
Disagree 16.67% 30 
Strongly disagree 29.44% 53 
Q96. I exercise at least three times a week.     
Strongly agree 31.11% 56 
Agree 8.33% 15 
Neither agree nor disagree 10.56% 19 
Disagree 15.00% 27 
Strongly disagree 35.00% 63 
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Question/Responses 
 
 
Percentage 
 
 
          n 
 
 
Q97. I go see the doctor even when I’m not sick     
Strongly agree 27.22% 49 
Agree 6.11% 11 
Neither agree nor disagree 8.33% 15 
Disagree 16.11% 29 
Strongly disagree 42.22% 76 
Q98. I eat at least five servings of fruits/vegetables daily.     
Strongly agree 25.84% 46 
Agree 8.43% 15 
Neither agree nor disagree 12.36% 22 
Disagree 14.04% 25 
Strongly disagree 39.33% 70 
Q99. I am confident that I can talk to my healthcare provider 
about the benefits and risks of PCA screening.     
Strongly agree 30.56% 55 
Agree 8.89% 16 
Neither agree nor disagree 6.11% 11 
Disagree 7.22% 13 
Strongly disagree 47.22% 85 
 
 
 
 
 
 
 
 
 
